<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Alcoholics Anonymous and other 12‐step programs for alcohol use disorder - Kelly, JF - 2020 | Cochrane Library</title> <meta content="Alcoholics Anonymous and other 12‐step programs for alcohol use disorder - Kelly, JF - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012880.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Alcoholics Anonymous and other 12‐step programs for alcohol use disorder - Kelly, JF - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012880.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012880.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Alcoholics Anonymous and other 12‐step programs for alcohol use disorder" name="citation_title"/> <meta content="John F Kelly" name="citation_author"/> <meta content="Massachusetts General Hospital and Harvard Medical School" name="citation_author_institution"/> <meta content="JKELLY11@mgh.harvard.edu" name="citation_author_email"/> <meta content="Keith Humphreys" name="citation_author"/> <meta content="Stanford University Stanford School of Medicine" name="citation_author_institution"/> <meta content="Marica Ferri" name="citation_author"/> <meta content="European Monitoring Centre for Drugs and Drug Addiction" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD012880.pub2" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/03/11" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012880.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012880.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012880.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Alcoholics Anonymous; Alcoholism [*psychology, *therapy]; Cognitive Behavioral Therapy; Health Care Costs; Motivational Interviewing [methods]; Psychotherapy; Randomized Controlled Trials as Topic; Treatment Outcome" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012880.pub2&amp;doi=10.1002/14651858.CD012880.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="BqmVIxTs";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012880\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012880\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","th","ms","ja","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012880.pub2",title:"Alcoholics Anonymous and other 12\\u2010step programs for alcohol use disorder",firstPublishedDate:"Mar 11, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Drugs and Alcohol Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=BqmVIxTs&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012880.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012880.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012880.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012880.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012880.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012880.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012880.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012880.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012880.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012880.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>106724 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012880.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-sec-0122"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-sec-0116"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/appendices#CD012880-sec-0127"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/table_n/CD012880StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/table_n/CD012880StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Alcoholics Anonymous and other 12‐step programs for alcohol use disorder</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/information#CD012880-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>John F Kelly</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/information#CD012880-cr-0005">Keith Humphreys</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012880.pub2/information#CD012880-cr-0006">Marica Ferri</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/information/en#CD012880-sec-0134">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 11 March 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012880.pub2">https://doi.org/10.1002/14651858.CD012880.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012880-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012880-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012880-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012880-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012880-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD012880-abs-0004">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012880-abs-0001" lang="en"> <section id="CD012880-sec-0001"> <h3 class="title" id="CD012880-sec-0001">Background</h3> <p>Alcohol use disorder (AUD) confers a prodigious burden of disease, disability, premature mortality, and high economic costs from lost productivity, accidents, violence, incarceration, and increased healthcare utilization. For over 80 years, Alcoholics Anonymous (AA) has been a widespread AUD recovery organization, with millions of members and treatment free at the point of access, but it is only recently that rigorous research on its effectiveness has been conducted. </p> </section> <section id="CD012880-sec-0002"> <h3 class="title" id="CD012880-sec-0002">Objectives</h3> <p>To evaluate whether peer‐led AA and professionally‐delivered treatments that facilitate AA involvement (Twelve‐Step Facilitation (TSF) interventions) achieve important outcomes, specifically: abstinence, reduced drinking intensity, reduced alcohol‐related consequences, alcohol addiction severity, and healthcare cost offsets. </p> </section> <section id="CD012880-sec-0003"> <h3 class="title" id="CD012880-sec-0003">Search methods</h3> <p>We searched the Cochrane Drugs and Alcohol Group Specialized Register, Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, CINAHL and PsycINFO from inception to 2 August 2019. We searched for ongoing and unpublished studies via ClinicalTrials.gov and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) on 15 November 2018. All searches included non‐English language literature. We handsearched references of topic‐related systematic reviews and bibliographies of included studies. </p> </section> <section id="CD012880-sec-0004"> <h3 class="title" id="CD012880-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs), quasi‐RCTs and non‐randomized studies that compared AA or TSF (AA/TSF) with other interventions, such as motivational enhancement therapy (MET) or cognitive behavioral therapy (CBT), TSF treatment variants, or no treatment. We also included healthcare cost offset studies. Participants were non‐coerced adults with AUD. </p> </section> <section id="CD012880-sec-0005"> <h3 class="title" id="CD012880-sec-0005">Data collection and analysis</h3> <p>We categorized studies by: study design (RCT/quasi‐RCT; non‐randomized; economic); degree of standardized manualization (all interventions manualized versus some/none); and comparison intervention type (i.e. whether AA/TSF was compared to an intervention with a different theoretical orientation or an AA/TSF intervention that varied in style or intensity). For analyses, we followed Cochrane methodology calculating the standard mean difference (SMD) for continuous variables (e.g. percent days abstinent (PDA)) or the relative risk (risk ratios (RRs)) for dichotomous variables. We conducted random‐effects meta‐analyses to pool effects wherever possible. </p> </section> <section id="CD012880-sec-0006"> <h3 class="title" id="CD012880-sec-0006">Main results</h3> <p>We included 27 studies containing 10,565 participants (21 RCTs/quasi‐RCTs, 5 non‐randomized, and 1 purely economic study). The average age of participants within studies ranged from 34.2 to 51.0 years. AA/TSF was compared with psychological clinical interventions, such as MET and CBT, and other 12‐step program variants. </p> <p>We rated selection bias as being at high risk in 11 of the 27 included studies, unclear in three, and as low risk in 13. We rated risk of attrition bias as high risk in nine studies, unclear in 14, and low in four, due to moderate (&gt; 20%) attrition rates in the study overall (8 studies), or in study treatment group (1 study). Risk of bias due to inadequate researcher blinding was high in one study, unclear in 22, and low in four. Risks of bias arising from the remaining domains were predominantly low or unclear. </p> <p><b>AA/TSF (manualized) compared to treatments with a different theoretical orientation (e.g. CBT) (randomized/quasi‐randomized evidence)</b> </p> <p>RCTs comparing manualized AA/TSF to other clinical interventions (e.g. CBT), showed AA/TSF improves rates of continuous abstinence at 12 months (risk ratio (RR) 1.21, 95% confidence interval (CI) 1.03 to 1.42; 2 studies, 1936 participants; high‐certainty evidence). This effect remained consistent at both 24 and 36 months. </p> <p>For percentage days abstinent (PDA), AA/TSF appears to perform as well as other clinical interventions at 12 months (mean difference (MD) 3.03, 95% CI ‐4.36 to 10.43; 4 studies, 1999 participants; very low‐certainty evidence), and better at 24 months (MD 12.91, 95% CI 7.55 to 18.29; 2 studies, 302 participants; very low‐certainty evidence) and 36 months (MD 6.64, 95% CI 1.54 to 11.75; 1 study, 806 participants; very low‐certainty evidence). </p> <p>For longest period of abstinence (LPA), AA/TSF may perform as well as comparison interventions at six months (MD 0.60, 95% CI ‐0.30 to 1.50; 2 studies, 136 participants; low‐certainty evidence). </p> <p>For drinking intensity, AA/TSF may perform as well as other clinical interventions at 12 months, as measured by drinks per drinking day (DDD) (MD ‐0.17, 95% CI ‐1.11 to 0.77; 1 study, 1516 participants; moderate‐certainty evidence) and percentage days heavy drinking (PDHD) (MD ‐5.51, 95% CI ‐14.15 to 3.13; 1 study, 91 participants; low‐certainty evidence). </p> <p>For alcohol‐related consequences, AA/TSF probably performs as well as other clinical interventions at 12 months (MD ‐2.88, 95% CI ‐6.81 to 1.04; 3 studies, 1762 participants; moderate‐certainty evidence). </p> <p>For alcohol addiction severity, one study found evidence of a difference in favor of AA/TSF at 12 months (P &lt; 0.05; low‐certainty evidence). </p> <p><b>AA/TSF (non‐manualized) compared to treatments with a different theoretical orientation (e.g. CBT) (randomized/quasi‐randomized evidence)</b> </p> <p>For the proportion of participants completely abstinent, non‐manualized AA/TSF may perform as well as other clinical interventions at three to nine months follow‐up (RR 1.71, 95% CI 0.70 to 4.18; 1 study, 93 participants; low‐certainty evidence). </p> <p>Non‐manualized AA/TSF may also perform slightly better than other clinical interventions for PDA (MD 3.00, 95% CI 0.31 to 5.69; 1 study, 93 participants; low‐certainty evidence). </p> <p>For drinking intensity, AA/TSF may perform as well as other clinical interventions at nine months, as measured by DDD (MD ‐1.76, 95% CI ‐2.23 to ‐1.29; 1 study, 93 participants; very low‐certainty evidence) and PDHD (MD 2.09, 95% CI ‐1.24 to 5.42; 1 study, 286 participants; low‐certainty evidence). </p> <p>None of the RCTs comparing non‐manualized AA/TSF to other clinical interventions assessed LPA, alcohol‐related consequences, or alcohol addiction severity. </p> <p><b>Cost‐effectiveness studies</b> </p> <p>In three studies, AA/TSF had higher healthcare cost savings than outpatient treatment, CBT, and no AA/TSF treatment. The fourth study found that total medical care costs decreased for participants attending CBT, MET, and AA/TSF treatment, but that among participants with worse prognostic characteristics AA/TSF had higher potential cost savings than MET (moderate‐certainty evidence). </p> </section> <section id="CD012880-sec-0007"> <h3 class="title" id="CD012880-sec-0007">Authors' conclusions</h3> <p>There is high quality evidence that manualized AA/TSF interventions are more effective than other established treatments, such as CBT, for increasing abstinence. Non‐manualized AA/TSF may perform as well as these other established treatments. AA/TSF interventions, both manualized and non‐manualized, may be at least as effective as other treatments for other alcohol‐related outcomes. AA/TSF probably produces substantial healthcare cost savings among people with alcohol use disorder. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012880-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012880-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012880-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012880-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012880-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012880-abs-0007">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012880-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD012880-abs-0012">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012880-abs-0003">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD012880-abs-0005">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012880-abs-0002" lang="en"> <h3>Alcoholics Anonymous (AA) and other 12‐step programs for alcohol use disorder</h3> <p><b>Review question</b> </p> <p>This review summarized research comparing the Alcoholics Anonymous (AA) and similarTwelve‐Step Facilitation (TSF) programs (AA/TSF) to other treatments to see if they help people with drinking problems to stay sober, or reduce alcohol consumption and drinking‐related consequences. We also examined whether AA/TSF reduces healthcare costs relative to other treatments. </p> <p><b>Background</b> </p> <p>Alcohol use disorder (i.e. alcoholism) is a concerning individual and public health problem worldwide. Treatment is expensive. AA is a widespread and free mutual‐help fellowship that helps people to recover from alcoholism and to improve their quality of life. </p> <p><b>Search date</b> </p> <p>The evidence is current to 2 August 2019.</p> <p><b>Study characteristics</b> </p> <p>We identified 27 relevant studies that had included 10,565 participants. The studies varied in design; and whether treatments were delivered according to standardized procedures (i.e. manualized); and whether AA/TSF was compared to a treatment that had a different theoretical basis (e.g. cognitive behavioral therapy (CBT)), or to a different type of TSF (i.e. one that varied in style or intensity from the AA TSF). </p> <p><b>Study funding sources</b> </p> <p>The Included studies were funded through one or more grants from the United States National Institutes of Health (18 studies), the USA Department of Veterans Affairs (8 studies), and other organizations (e.g. private foundations or academic institutions; 8 studies). Two studies did not report their source of funding. </p> <p><b>Key results</b> </p> <p>Manualized AA/TSF interventions usually produced higher rates of continuous abstinence than the other established treatments investigated. Non‐manualized AA/TSF performed as well as other established treatments. </p> <p>AA/TSF may be superior to other treatments for increasing the percentage of days of abstinence, particularly in the longer‐term. AA/TSF probably performs as well as other treatments for reducing the intensity of drinking (of alcohol). AA/TSF probably performs as well as other treatments for alcohol‐related consequences and addiction severity. Four of the five economics studies found substantial cost‐saving benefits for AA/TSF, which indicate that AA/TSF interventions probably reduce healthcare costs substantially. </p> <p>In conclusion, clinically‐delivered TSF interventions designed to increase AA participation usually lead to better outcomes over the subsequent months to years in terms of producing higher rates of continuous abstinence. This effect is achieved largely by fostering increased AA participation beyond the end of the TSF intervention. AA/TSF will probably produce substantial healthcare cost savings while simultaneously improving alcohol abstinence. </p> <p><b>Certainty of evidence</b> </p> <p>Our certainty in the evidence ranged from very low to high for the different outcomes. Most of the high‐certainty evidence was based on the results from studies with reliable study designs (randomized controlled trials) and good measurement methods. We considered some evidence to be of low certainty, partly because of inadequate methods for deciding which treatment each person in the study was to receive, which can allow factors other than the treatments to affect the results.There was some inconsistency in the evidence across studies that could be due to variation in the clinical characteristics of the participants, times of follow‐up, error in participant recall of certain outcomes, and differences in intervention durations, or therapist effects. Some studies had small sample sizes, which led to less precise estimates of the longest periods of abstinence, and high variability around estimates of drinks per drinking day. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012880-sec-0122" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012880-sec-0122"></div> <h3 class="title" id="CD012880-sec-0123">Implications for practice</h3> <section id="CD012880-sec-0123"> <p>The evidence suggests that compared to other well‐established treatments, clinical linkage using well‐articulated Twelve‐Step Facilitation (TSF) manualized interventions intended to increase Alcoholics Anonymous (AA) participation during and following alcohol use disorder (AUD) treatment probably will lead to enhanced abstinence outcomes over the next few months and for up to three years. Findings also indicate AA/TSF may perform as well as other clinical interventions for drinking intensity outcomes; however, these results are based largely on low certainty evidence and so should be regarded with caution. </p> <p>Economic analyses suggest probable substantial healthcare cost savings can be obtained when treatment programs proactively and systematically link people with AUD to AA using TSF strategies, such as those used in the studies included in this review. The analyses indicate that the reason for this benefit is due to the ability of the AA/TSF to increase AA participation, and thereby increase abstinence rates. Thus, a relatively brief clinical intervention (AA/TSF) can help people with AUD to become engaged in a long‐term, freely available, community‐based, recovery support resource that can help them sustain ongoing remission. </p> <p>If people with AUD are opposed to attending AA, despite the strong evidence for its potential to aid recovery, clinicians might consider linkage to alternative mutual‐help organizations as they may confer benefits at similar levels of engagement. Alternatives might also be considered when a patient has made a sustained effort to engage AA, but not derived sufficient benefit from it. </p> </section> <h3 class="title" id="CD012880-sec-0124">Implications for research</h3> <section id="CD012880-sec-0124"> <p>Since the publication of the National Institutes of Health‐sponsored AA research monograph summarizing the research on AA up until the early 1990s (<a href="./references#CD012880-bbs2-0084" title="McCradyBS , MillerWR . Research on Alcoholics Anonymous: Opportunities and Alternatives. New Brunswick (NJ): Rutgers Center of Alcohol Studies, 1993.">McCrady 1993</a>), numerous RCTs/quasi‐RCTs and well‐controlled comparative non‐randomized studies have been conducted using professionally‐delivered TSF interventions. In addition, research into sophisticated mechanisms of behavior change has been conducted to delineate the precise ways that AA participation confers recovery benefit (see <a href="./references#CD012880-bbs2-0068" title="KellyJF , McCradyBS . Twelve-step facilitation in non-specialty settings. In: Research on alcoholism: Alcoholics Anonymous and spiritual aspects of recovery. New York, NY: Springer, 2009:797-836.">Kelly 2009a</a>; <a href="./references#CD012880-bbs2-0075" title="KellyJ . Is Alcoholics Anonymous religious, spiritual, neither? Findings from 25 years of mechanisms of behavior change research. Addiction2017;112(6):929-36. [DOI: 10.1111/add.13590]">Kelly 2017a</a>). While these reviews have advanced our knowledge in this area, several further avenues of research remain to be explored. </p> <p>Most of this research was conducted in the USA; further research is needed to determine the degree to which results observed here differ in other countries. </p> <p>None of the studies included in this review reported on any outcomes regarding quality of life, functioning, or psychological well‐being. There is increasing interest and importance being placed on these important indices in addition to substance‐related outcomes (<a href="./references#CD012880-bbs2-0076" title="KellyJF , GreeneMC , BergmanBG . Beyond abstinence: changes in indices of quality of life with time in recovery in a nationally representative sample of U.S. adults. Alcoholism: Clinical and Experimental Research2018;42(4):770-80. [DOI: 10.1111/acer.13604]">Kelly 2018</a>), and new studies should gather data for these outcomes. </p> <p>It is plausible that participation of family members in 12‐step organizations designed specifically to help family members cope with the effects of active addiction in their loved one (i.e. Al‐Anon) may partially mediate the effects of AA participation on the individual with an AUD by altering the family and relationship dynamics in a therapeutic way. Future research should examine this and also the broader impact of AA/TSF on other special populations such as adolescents, senior citizens, and those who identify as LGBTQ (lesbian, gay, bisexual, transgender, questioning). </p> <p>Some research has examined the utility of AA for people suffering from other common substance use disorders (e.g. disorders relating to cocaine, cannabis, opioids use, etc.) either alone or in combination with AUD (<a href="./references#CD012880-bbs2-0074" title="KellyJF , GreeneMC , BergmanBG . Do drug dependent patients attending Alcoholics Anonymous rather than Narcotics Anonymous do as well? A prospective, lagged, matching analysis. Alcohol and Alcoholism2014;49(6):645-53. [DOI: doi.org/10.1093/alcalc/agu066]">Kelly 2014</a>). More research is needed to understand the degree to which these people might benefit from, or be a better fit in, other mutual‐help organizations, such as Narcotics Anonymous, or Cocaine Anonymous (<a href="./references#CD012880-bbs2-0045" title="BøgM , FilgesT , BrännströmL , JørgensenAM , FredrikssonMK . 12-step programs for reducing illicit drug use: a systematic review. Cambell Systematic Reviews2017;2. [DOI: 10.4073/csr.2017.2]">Bøg 2017</a>). Studies also suggest there may be an immense clinical and public health value and economic benefit of AA participation in reducing healthcare costs. Such analyses could be expanded to include the potential gains in economic revenue from increased employment or productivity, or both, and also reductions in criminal justice costs related to lowered criminal activity that might result from increased AA participation. </p> <p>Finally, although this review focused on AA/TSF interventions and alcohol use outcomes, it is plausible that other AUD recovery‐supportive, mutual‐help organizations, such as Self‐Management and Recovery Training (SMART), LifeRing, and Women for Sobriety, that have been growing in recent years, may confer similar benefits (<a href="./references#CD012880-bbs2-0070" title="KellyJF , WhiteWL . Broadening the base of addiction mutual-help organizations. Journal of Groups in Addiction and Recover2012;7(2-4):82-101. [DOI: doi.org/10.1080/1556035X.2012.705646]">Kelly 2012</a>; <a href="./references#CD012880-bbs2-0069" title="KellyJF , MagillM , StoutRL . How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous. Addiction Research &amp; Theory2009;17(3):236-59. [http://dx.doi.org/10.1080/16066350902770458]">Kelly 2009b</a>). While these organizations may espouse different theoretical orientations and variations in their approaches to help people attain and maintain recovery from AUD, there may be more similarity than differences in the therapeutic dynamics operating within these groups (<a href="./references#CD012880-bbs2-0069" title="KellyJF , MagillM , StoutRL . How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous. Addiction Research &amp; Theory2009;17(3):236-59. [http://dx.doi.org/10.1080/16066350902770458]">Kelly 2009b</a>; <a href="./references#CD012880-bbs2-0075" title="KellyJ . Is Alcoholics Anonymous religious, spiritual, neither? Findings from 25 years of mechanisms of behavior change research. Addiction2017;112(6):929-36. [DOI: 10.1111/add.13590]">Kelly 2017a</a>), and we need more research to understand whether participants who engage with these other entities may derive benefits of similar magnitude to those derived from AA (<a href="./references#CD012880-bbs2-0104" title="ZemoreSE , KaskutasLA , MericleA , HembergJ . Comparison of 12-step groups to mutual help alternatives for AUD in a large, national study: differences in membership characteristics and group participation, cohesion, and satisfaction. Journal of Substance Abuse Treatment2017;73:16-26. [DOI: 10.1016/j.jsat.2016.10.004]">Zemore 2017</a>). More research is needed to support this conjecture, but such preliminary results are promising from a public health and long‐term recovery management perspective because AUD tends to be highly heterogeneous in its clinical course and impact, and those suffering can often have different preferences as to the kinds of recovery pathways they wish to follow (<a href="./references#CD012880-bbs2-0073" title="KellyJF , HumphreysK , YeterianJ . Mutual-Help Groups. In: HerieM , SkinnerWJW , editors(s). Fundamentals of Addiction: A Practical Guide for Counsellors. Toronto (ON): Centre on Addiction and Mental Health, 2013:321-48.">Kelly 2013c</a>). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012880-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012880-sec-0008"></div> <div class="table" id="CD012880-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol use disorder (1A)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol use disorder (RCT/quasi‐RCT evidence)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults (&gt; 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence<br/><b>Setting:</b> outpatient treatment<br/><b>Intervention:</b> AA/TSF (manualized)<br/><b>Comparison:</b> other clinical interventions (e.g. CBT) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with other clinical interventions</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with AA/TSF</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="middle"> <p>Abstinence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Proportion of participants (%) completely abstinent</p> <p>Follow‐up: 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.21<br/>(1.03 to 1.42) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1936<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>345 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>418 per 1000<br/>(356 to 490) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDA</p> <p>Follow‐up: 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PDA in the comparison group ranged from 62.3% to 84.0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 3.03 higher<br/>(4.36 lower to 10.43 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1999<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<br/><sup>a, b, c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>LPA</p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean LPA in the comparison group ranged from 0.47 to 1.71 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD 0.60 higher</p> <p>(0.30 lower to 1.50 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>136<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>d, e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Drinking Intensity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>DDD</p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DDD in the comparison group ranged from 4.66 to 5.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD 0.17 lower<br/>(1.11 lower to 0.77 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1516<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate <sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDHD</p> <p>Follow‐up: 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PDHD in the comparison group was 13.4%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 5.51 lower<br/>(14.15 lower to 3.13 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol‐related consequences (assessed with DrInC)</p> <p>Follow‐up: 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DrInC in the comparison group ranged from 21.8% to 72.9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.88 lower<br/>(6.81 lower to 1.04 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1762<br/>(3 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate <sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Alcohol addiction severity<br/>(assessed with ASI) </p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign=""> <p>One study found an advantage for the AA/TSF intervention relative to the comparison intervention in the slope for improvement over a 12‐month follow‐up period (<a href="./references#CD012880-bbs2-0005" title="BrooksAJ , PennPE . Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training. American Journal of Drug and Alcohol Abuse2003;29(2):359-83. [DOI: 10.1081/ADA-120020519]">Brooks 2003</a>), as measured by the ASI alcohol composite score (P &lt; 0.05). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112<br/>(1 quasi‐RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>a, g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AA:</b> Alcoholics Anonymous; <b>ASI:</b> Addiction Severity Index; <b>CBT:</b> cognitive behavioral therapy; <b>CI:</b> confidence interval; <b>DDD:</b> drinks per drinking day; <b>DrInC:</b> Drinker Inventory of Consequences; <b>LPA:</b> longest period of abstinence; <b>MD:</b> mean difference; <b>PDA:</b> percentage days abstinent; <b>PDHD:</b> percentage days heavy drinking; <b>RCT:</b> randomized controlled trial; <b>RR</b> : risk ratio; <b>TSF:</b> Twelve‐Step Facilitation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Quasi‐RCT: studies where due to potential intervention contamination effects within single sites, it was not possible to do parallel, simultaneous randomization, but instead, sequential designs were used where the intervention was implemented and then not implemented and then reimplemented with subsequent groups of participants in an 'ON/OFF' type design. </p> <p>Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup> Downgraded due to study limitations (high risk of selection bias) </p> <p><sup>b</sup> Downgraded two levels due to inconsistency (I<sup>2</sup> = 91%) </p> <p><sup>c</sup> Downgraded due to imprecision (CI fails to exclude important benefit or important harm) </p> <p><sup>d</sup> Downgraded due to imprecision (moderate sample size (n = 148)) </p> <p><sup>e</sup> Downgraded due to study limitations (potential attrition bias and potential blinding of outcome bias) </p> <p><sup>f</sup> Downgraded due to imprecision (small sample size (n = 91) and wide confidence interval) </p> <p><sup>g</sup> Downgraded as narrative synthesis was conducted, therefore estimates are not precise </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012880-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to other clinical interventions for alcohol use disorder (1B)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to other clinical interventions for alcohol use disorder (RCT/quasi‐RCT evidence)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults (&gt; 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence<br/><b>Setting:</b> outpatient treatment; inpatient/residential facility<br/><b>Intervention:</b> AA/TSF (non‐manualized)<br/><b>Comparison:</b> other clinical interventions (e.g. CBT) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with other clinical interventions</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with AA/TSF</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Abstinence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Proportion of participants (%) completely abstinent</p> <p>Follow‐up: 9 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.71</p> <p>(0.70 to 4.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>167 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118 more per 1000<br/>(50 fewer to 530 more) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDA<br/>Follow‐up: 9 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PDA in the comparison group was 70%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 3.00 higher</p> <p>(0.31 higher to 5.69 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>LPA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Drinking Intensity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>DDD<br/>Follow‐up: 9 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DDD in the comparison group was 8.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 1.76 lower</p> <p>(2.23 lower to 1.29 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDHD</p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of heavy drinking days in the comparison group ranged from 1.44 to 3.89 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.09 higher</p> <p>(1.24 lower to 5.42 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>e,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol‐related consequences</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Alcohol addiction severity</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AA:</b> Alcoholics Anonymous; <b>CBT:</b> cognitive behavioral therapy; <b>CI</b> : confidence interval; <b>DDD:</b> drinks per drinking day; <b>LPA:</b> longest period of abstinence; <b>MD:</b> mean difference; <b>PDA:</b> percentage days abstinent; <b>PDHD:</b> percentage days heavy drinking; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio; <b>TSF:</b> Twelve‐Step Facilitation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Quasi‐RCT: studies where due to potential intervention contamination effects within single sites, it was not possible to do parallel, simultaneous randomization, but instead, sequential designs were used where the intervention was implemented and then not implemented and then reimplemented with subsequent groups of participants in an 'ON/OFF' type design. </p> <p>Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup>Downgraded two levels due to imprecision (small sample size (n = 93)).<br/><sup>b</sup>Downgraded due to study limitations (risk of attrition bias).<br/><sup>c</sup>Downgraded due to imprecision (moderate sample size (n = 121)).<br/><sup>d</sup>Downgraded due to indirectness (the focus on dual diagnosis participants with severe mental illness which may not be the population of interest most associated with AA/TSF).<br/><sup>e</sup>Downgraded due to imprecision (moderate sample size (n = 286)).<br/><sup>f</sup>Downgraded due to study limitations (having no information reported to assess four different types of bias). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012880-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to a different type of TSF for alcohol use disorder (2A)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to a different type of Twelve‐Step Facilitation for alcohol use disorder (RCT/quasi‐RCT evidence)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults (&gt; 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence<br/><b>Setting:</b> outpatient treatment; inpatient/residential facility<br/><b>Intervention:</b> AA/TSF (manualized)<br/><b>Comparison:</b> a different type of TSF (i.e. varying in TSF style or intensity) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with different type of TSF</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with AA/TSF</b> </p> </th> </tr> <tr class="separated"> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="middle"> <p>Abstinence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Proportion of participants (%) completely abstinent</p> <p>Follow‐up: 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.28</p> <p>(1.00 to 1.63)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>307<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>404 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113 more per 1000<br/>(0 fewer to 255 more) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDA</p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PDA in the comparison group was 67.41%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 16.40 higher</p> <p>(5.12 higher to 27.68 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>LPA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Drinking Intensity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>DDD</p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DDD in the comparison group was 6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 4.10 lower</p> <p>(10.44 lower to 2.24 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDHD</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol‐related consequences</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol addiction severity<br/>(assessed with ASI) </p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ASI in the comparison group was 0.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD 0.08 higher</p> <p>(0.02 higher to 0.15 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>307</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AA:</b> Alcoholics Anonymous; <b>ASI:</b> Addiction Severity Index; <b>CI</b> : confidence interval; <b>DDD:</b> drinks per drinking day; <b>LPA:</b> longest period of abstinence; <b>MD:</b> mean difference; <b>PDA:</b> percentage days abstinent; <b>PDHD:</b> percentage days heavy drinking; <b>RCT:</b> randomized controlled trial; <b>RR</b> : risk ratio; <b>TSF:</b> Twelve‐Step Facilitation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Quasi‐RCT: studies where due to potential intervention contamination effects within single sites, it was not possible to do parallel, simultaneous randomization, but instead, sequential designs were used where the intervention was implemented and then not implemented and then reimplemented with subsequent groups of participants in an 'ON/OFF' type design. </p> <p>Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup>Downgraded due to imprecision (moderate sample size (n = 307)).<br/><sup>b</sup>Downgraded due to imprecision (small sample size (n = 95)).<br/><sup>c</sup>Downgraded due to imprecision (small sample size (n = 48)). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012880-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to a different type of TSF for alcohol use disorder (2B)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized)</b> <b>compared to a different type of TSF for alcohol use disorder (RCT/quasi‐RCT evidence)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults (&gt; 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence<br/><b>Setting:</b> outpatient treatment; inpatient/residential facility<br/><b>Intervention:</b> AA/TSF (non‐manualized)<br/><b>Comparison:</b> a different type of TSF (i.e. varying in TSF style or intensity) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with different type of TSF</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with AA/TSF</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Abstinence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Proportion of participants (%) completely abstinent</p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.15</p> <p>(1.02 to 1.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>382<br/>(1 quasi‐RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>713 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107 more per 1000<br/>(14 more to 207 more) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>PDA</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>LPA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="middle"> <p>Drinking intensity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>DDD</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>PDHD</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol‐related consequences</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Alcohol addiction severity</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AA:</b> Alcoholics Anonymous; <b>CI</b> : confidence interval; <b>DDD:</b> drinks per drinking day; <b>LPA:</b> longest period of abstinence; <b>PDA:</b> percentage days abstinent; <b>PDHD:</b> percentage days heavy drinking; <b>RCT:</b> randomized controlled trial; <b>RR</b> : risk ratio; <b>TSF:</b> Twelve‐Step Facilitation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Quasi‐RCT: studies where due to potential intervention contamination effects within single sites, it was not possible to do parallel, simultaneous randomization, but instead, sequential designs were used where the intervention was implemented and then not implemented and then reimplemented with subsequent groups of participants in an 'ON/OFF' type design. </p> <p>Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup>Downgraded due to study limitations (risk of random sequence generation, allocation concealment, and attrition bias). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012880-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol use disorder: non‐randomized studies (3B)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized)</b> <b>compared to other clinical interventions for alcohol use disorder: non‐randomized studies</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults (&gt; 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence<br/><b>Setting:</b> outpatient treatment; inpatient/residential facility<br/><b>Intervention:</b> AA/TSF (manualized)<br/><b>Comparison:</b> other clinical interventions (e.g. CBT) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with other clinical interventions</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with AA/TSF</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="middle"> <p>Abstinence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>Proportion of participants (%) completely abstinent</p> <p>Follow‐up: 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.25<br/>(1.09 to 1.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2692<br/>(2 non‐ randomized) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>286 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>358 per 1000<br/>(312 to 409) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDA</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>LPA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign=""> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Drinking intensity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>DDD<br/>Follow‐up: 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DDD in the comparison group was 6.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.00</p> <p>(3.38 lower to 3.38 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>201<br/>(1 non‐ randomized) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDHD</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol‐related consequences (assessed with SIP)</p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean SIP in the comparison group ranged from 4.1 to 5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.71 lower</p> <p>(1.68 lower to 0.27 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>647</p> <p>(1 non‐ randomized)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol addiction severity<br/>(assessed with ADS) </p> <p>Follow‐up: 36 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ADS in the comparison group was 3.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.30 lower</p> <p>(2.20 lower to 1.60 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>201<br/>(1 non‐ randomized) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AA:</b> Alcoholics Anonymous; <b>ADS:</b> Alcohol Dependence Scale; <b>CI</b> : confidence interval; <b>DDD:</b> drinks per drinking day; <b>LPA:</b> longest period of abstinence; <b>MD:</b> mean difference; <b>PDA:</b> percentage days abstinent; <b>PDHD:</b> percentage days heavy drinking; <b>RCT:</b> randomized controlled trial; <b>RR</b> : risk ratio; <b>SIP:</b> Short Inventory of Problems; <b>TSF:</b> Twelve‐Step Facilitation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Non‐randomized: prospective, parallel, group design studies in which intact intervention groups receive either an AA/TSF intervention or a comparison intervention without being randomly assigned to interventions. </p> <p>Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup>Downgraded due to study limitations (the lack of control of sample selection and non‐randomized nature).<br/><sup>b</sup>Downgraded due to indirectness (comparability of cohorts for baseline characteristics and outcome measures, and protection against contamination).<br/><sup>c</sup>Downgraded due to imprecision (being a single study with a moderate sample size (N = 201)). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012880-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to a different type of TSF for alcohol use disorder: non‐randomized studies (4B)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized)</b> <b>compared to a different type of TSF for alcohol use disorder: non‐randomized studies</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults (&gt; 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence<br/><b>Setting:</b> inpatient/residential facility<br/><b>Intervention:</b> AA/TSF (non‐manualized)<br/><b>Comparison:</b> a different type of TSF (i.e. varying in TSF style or intensity) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with different type of TSF</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with AA/TSF</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Abstinence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Proportion of participants (%) completely abstinent</p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.24</p> <p>(1.05 to 1.46)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1870</p> <p>(1 non‐</p> <p>randomized)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>203 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49 more per 1000<br/>(10 more to 94 more) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDA</p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PDA in the comparison group was 92.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.01 lower</p> <p>(7.14 lower to 7.12 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>195<br/>(1 non‐randomized) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>LPA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="middle"> <p>Drinking Intensity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>DDD<br/>Follow‐up: 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>One study (<a href="./references#CD012880-bbs2-0008" title="GrantKM , YoungLB , TylerKA , SimpsonJL , PulidoRD , TimkoC . Intensive referral to mutual-help groups: a field trial of adaptations for rural veterans. Patient Education and Counseling2018;101(1):79-84. [DOI: 10.1016/j.pec.2017.07.012]">Grant 2018</a>) reported DDD based on n = 25 across both groups who were participants who drank any alcohol during the follow‐up period and found no evidence of a difference between the more (mean 17.63, SD 23.71) and less (mean 11.47, SD 5.94) intensive AA/TSF interventions, P = 0.49. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>195<br/>(1 non‐ randomized) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were not pooled because authors reported only those participants that drank any alcohol and not the total proportion of participants that drank. They also did not provide numbers by treatment intervention. </p> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDHD</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol‐related consequences</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Alcohol addiction severity (assessed with ASI‐L)</p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ASI‐L in the comparison group was 0.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.01 higher</p> <p>(0.05 lower to 0.07 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140<br/>(1 non‐ randomized) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AA:</b> Alcoholics Anonymous; <b>ASI‐L:</b> Addiction Severity Index‐Lite; <b>CI:</b> confidence interval; <b>DDD:</b> drinks per drinking day; <b>LPA:</b> longest period of abstinence; <b>MD:</b> mean difference; <b>PDA:</b> percentage days abstinent; <b>PDHD:</b> percentage days heavy drinking; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio; <b>TSF:</b> Twelve‐Step Facilitation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Non‐randomized: prospective, parallel, group design studies whereby intact intervention groups receive either an AA/TSF intervention or a comparison intervention without being randomly assigned to interventions. </p> <p>Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup>Downgraded due to study limitations (risk of attrition bias).<br/><sup>b</sup>Downgraded due to imprecision (a single study with a moderate sample size (N = 195)).<br/><sup>c</sup>Downgraded as narrative synthesis was conducted, therefore estimates are not precise. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012880-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) compared to other clinical interventions and a different type of TSF for alcohol use disorder: cost‐effectiveness studies (5)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) compared to other clinical interventions and a different type of TSF for alcohol use disorder: cost‐effectiveness studies</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> alcohol use disorder<br/><b>Setting:</b> outpatient treatment; inpatient/residential facility<br/><b>Intervention:</b> AA/TSF<br/><b>Comparison:</b> other clinical interventions and a different type of TSF </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Impact</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthcare cost savings<br/>(assessed with total medical care cost savings) </p> <p>Follow‐up: 6 months to 7 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5348<br/>(4 studies) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Four studies contributed five separate published reports. In three studies (four study reports), AA/TSF had higher healthcare cost savings than outpatient treatment, CBT, and no AA/TSF treatment. One other study found that total medical care costs decreased for participants attending CBT, MET, and AA/TSF treatment, but that AA/TSF had higher cost‐savings potential compared to MET among participants with worse prognostic characteristics. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>AA/TSF:</b> Alcoholics Anonymous/Twelve‐Step Facilitation; <b>CBT:</b> cognitive behavioral therapy; <b>MET:</b> motivational enhancement therapy </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>a</sup>Downgraded due to random sequence generation bias, and problems with comparability of cohorts at baseline; protection against contamination between study interventions. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012880-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012880-sec-0009"></div> <section id="CD012880-sec-0010"> <h3 class="title" id="CD012880-sec-0010">Description of the condition</h3> <p>Alcohol use disorder (AUD) confers a prodigious burden of disease, disability, and premature mortality, particularly in middle‐ and high‐income countries (<a href="./references#CD012880-bbs2-0095" title="StahreM , RoeberJ , KannyD , BrewerR , ZhangX . Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States. Preventing Chronic Disease2014;11:E109. [DOI: dx.doi.org/10.5888/pcd11.130293]">Stahre 2014</a>). With 3.3 million attributable deaths each year globally, alcohol is responsible for approximately 10 times the mortality rate for all illicit drugs combined, as well as 5.1% of the total global burden of disease (<a href="./references#CD012880-bbs2-0101" title="World Health Organization. Global Status Report on Alcohol and Health. Geneva, Switzerland: World Health Organization, 2014.">WHO 2014</a>). Alcohol misuse is the leading risk factor for death and disability among 15‐ to 59‐year‐olds worldwide (<a href="./references#CD012880-bbs2-0101" title="World Health Organization. Global Status Report on Alcohol and Health. Geneva, Switzerland: World Health Organization, 2014.">WHO 2014</a>) and, on average, moderate‐to‐severe AUD shortens lifespan by 20 to 30 years (<a href="./references#CD012880-bbs2-0090" title="RosenbaumBP , KshettryVR , KellyML , WeilRJ . Diagnoses associated with the greatest years of potential life lost for in-hospital deaths in the United States, 1988-2010. Public Health2015;129(2):173-81. [DOI: 10.1016/j.puhe.2014.11.011]">Rosenbaum 2015</a>). The financial burden associated with alcohol misuse is also enormous ‐ amounting to approximately USD 250 billion annually in the USA alone due to lost productivity, crime and incarceration, and increased healthcare utilization (<a href="./references#CD012880-bbs2-0091" title="SacksJJ , GonzalesKR , BoucheryEE , TomediLE , BrewerRD . 2010 National and State Costs of Excessive Alcohol Consumption. American Journal of Preventive Medicine2015;49(5):e73-9. [DOI: http://dx.doi.org/10.1016/j.amepre.2015.05.031]">Sacks 2015</a>). The response to these problems is multipronged, and includes a broad array of specific professional treatment services in diverse settings. In addition, a number of low‐cost or free recovery support services have emerged to prevent relapse and aid recovery (e.g. mutual‐help organizations, sober living environments) (<a href="./references#CD012880-bbs2-0099" title="WhiteWL , KellyJF , RothJD . New addiction recovery support institutions: Mobilizing support beyond professional addiction treatment and recovery mutual aid. Journal of Groups in Addiction &amp; Recovery2012;7:297-317. [DOI: doi.org/10.1080/1556035X.2012.705719]">White 2012</a>). Alcohol‐focused recovery mutual‐help organizations include Blue Cross (Austria), Vie Libre (France), Danshuakai (Japan), Abstainer's Clubs (Poland), and the Links (Sweden) (<a href="./references#CD012880-bbs2-0061" title="HumphreysK . Circles of Recovery: Self-Help Organizations for Addictions. Cambridge, UK: Cambridge University Press, 2004.">Humphreys 2004</a>). The oldest and by far the largest of these AUD recovery supports is Alcoholics Anonymous (AA). </p> </section> <section id="CD012880-sec-0011"> <h3 class="title" id="CD012880-sec-0011">Description of the intervention</h3> <p>AA consists of several million members in 181 countries (<a href="./references#CD012880-bbs2-0061" title="HumphreysK . Circles of Recovery: Self-Help Organizations for Addictions. Cambridge, UK: Cambridge University Press, 2004.">Humphreys 2004</a>), and is a worldwide, nonprofessional, peer‐to‐peer support organization intended to help those suffering from AUD to achieve abstinence from alcohol and increase quality of life (<a href="./references#CD012880-bbs2-0041" title="Alcoholics Anonymous. Alcoholics Anonymous: The Story of How Thousands of Men and Women have Recovered from Alcoholism. 4th edition. New York (NY): Alcoholics Anonymous World Services, 2001.">Alcoholics Anonymous 2001</a>). In many world regions, AA is widely accessed. In North America, for example, it is the most commonly sought source of help for AUD (<a href="./references#CD012880-bbs2-0046" title="CaetanoR , ClarkCL , GreenfieldTK . Prevalence, trends, and incidence of alcohol withdrawal symptoms: analysis of general population and clinical samples. Alcohol Health and Research World1998;22(1):73-9.">Caetano 1998</a>; <a href="./references#CD012880-bbs2-0052" title="HeddenSL , KennetJ , LipariR , MedleyG , TiceP , CopelloEA , et al, SAMHSA. Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health. www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf (accessed prior to 25 November 2019).">Hedden 2015</a>; <a href="./references#CD012880-bbs2-0089" title="RoomR , MakelaP , SchmidtL , RehmJ . Alcohol, Health Disparities and Development. www.robinroom.net/Alchealth.pdf (accessed 9 November 2017).">Room 2006</a>). Although it was originally an all‐male and white organization, AA now attracts a diverse membership of women and men from a wide range of racial and ethnic backgrounds (<a href="./references#CD012880-bbs2-0056" title="HoffmanF . Cultural adaptations of Alcoholics Anonymous to serve Hispanic populations. International Journal of the Addictions2009;29(4):445-60. [DOI: http://doi.org/10.3109/10826089409047392]">Hoffman 2009</a>; <a href="./references#CD012880-bbs2-0058" title="HumphreysK , MavisBE , StöffelmayrBE . Are twelve step programs appropriate for disenfranchised groups? Evidence from a study of posttreatment mutual help group involvement. Prevention in Human Services1994;11(1):165-80.">Humphreys 1994</a>; <a href="./references#CD012880-bbs2-0064" title="Jilek-AallL . Acculturation, alcoholism, and Indian-style Alcoholics Anonymous. Journal of Studies on Alcohol, Supplement1981;S9:143-58. [DOI: http://doi.org/10.15288/jsas.1981.s9.143]">Jilek‐Aall 1981</a>; <a href="./references#CD012880-bbs2-0088" title="US Department of Health and Human Services (HHS), Office of the Surgeon General. Facing addiction in America: the surgeon general’s spotlight on opioids. addiction.surgeongeneral.gov/sites/default/files/Spotlight-on-Opioids_09192018.pdf September 2018.">OSG 2018</a>). As such, AA is part of the de facto system of care for AUD. Given that AUD is highly prevalent worldwide, especially in middle‐ and high‐income countries, and is susceptible to relapse and reinstatement over the long term, the free and widespread availability of AA gives the organization potential to serve large numbers of people for extended periods. AA holds meetings in local community, rented accommodation (e.g. churches/synagogues, hospitals, community centers, colleges). Group meetings typically last 60 to 90 minutes, during which members share personal narratives of their alcohol addiction and recovery experiences, and help one another practice the principles encompassed in a 12‐step program that is intended to increase psychological well‐being, improve interpersonal skills, enhance the ability to cope with stress, and facilitate adaptation to abstinence and a sober lifestyle (<a href="./references#CD012880-bbs2-0068" title="KellyJF , McCradyBS . Twelve-step facilitation in non-specialty settings. In: Research on alcoholism: Alcoholics Anonymous and spiritual aspects of recovery. New York, NY: Springer, 2009:797-836.">Kelly 2009a</a>). The widespread adoption of AA and its influence on the professional treatment industry in some countries has spurred increasing efforts to evaluate its clinical and public health impact. </p> <p>In addition to peer‐led AA mutual‐help groups, researchers have also evaluated clinical interventions that have adapted the methodology and concepts of AA. These Twelve‐Step Facilitation (TSF) interventions include extended counseling, adopting some of the techniques and principles of AA, as well as brief interventions designed to link individuals to community AA groups (<a href="./references#CD012880-bbs2-0059" title="HumphreysK . Professional interventions that facilitate 12-step self-help group involvement. Alcohol Health and Research World1999;23(2):93-8.">Humphreys 1999</a>). These interventions vary in session length, format, and duration of treatment. For example, TSF interventions can consist of a single session lasting a few minutes to multiple, hour‐long sessions delivered over several months (see <a href="#CD012880-tbl-0008">Table 1</a>). TSF interventions can also be delivered clinically in individual or group sessions. The goal of TSF interventions is to engage people with AUD with AA during and, importantly, post treatment, to sustain remission over time. TSF interventions have been studied to determine whether they succeed at linking individuals with AA, and whether this, in turn, results in better alcohol‐related and other outcomes (<a href="./references#CD012880-bbs2-0048" title="DucharmeLJ , KnudsenHK , RomanPM . Trends in the adoption of medication for alcohol dependence. Journal of Clinical Psychopharmacology2006;26(6):S13-9. [DOI: 10.1097/01.jcp.0000246209.18777.14]">Ducharme 2006</a>; <a href="./references#CD012880-bbs2-0071" title="KellyJK , YeterianJ . Mutual-help groups for alcohol and other substance use disorders. In: McCradyBS , EpsteinEE , editors(s). Addictions: A Comprehensive Guidebook. 2nd edition. New York, NY: Oxford University Press, 2013:500-25.">Kelly 2013a</a>; <a href="./references#CD012880-bbs2-0075" title="KellyJ . Is Alcoholics Anonymous religious, spiritual, neither? Findings from 25 years of mechanisms of behavior change research. Addiction2017;112(6):929-36. [DOI: 10.1111/add.13590]">Kelly 2017a</a>; <a href="./references#CD012880-bbs2-0077" title="KnudsenHK , RomanPM . Service delivery and pharmacotherapy for alcohol use disorder in the era of health reform: data from a national sample of treatment organizations. Substance Abuse2016;37(1):230-7. [DOI: 10.1080/08897077.2015.1028699]">Knudsen 2016</a>; <a href="./references#CD012880-bbs2-0079" title="LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]]">Longabaugh 1998</a>; <a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a>; <a href="./references#CD012880-bbs2-0080" title="MannRE , ZalcmanRF , SmartRG , RushBR , SuurvaliH . Alcohol consumption, alcoholics anonymous membership, and homicide mortality rates in Ontario 1968 to 1991. Alcoholism: Clinical and Experimental Research2006;30(10):1743-51. [DOI: 10.1111/j.1530-0277.2006.00216.x]">Mann 2006a</a>; <a href="./references#CD012880-bbs2-0081" title="MannRE , ZalcmanRF , SmartRG , RushBR , SuurvaliH . Alcohol consumption, alcoholics anonymous membership, and suicide mortality rates, Ontario, 1968-1991. Journal of Studies on Alcohol and Drugs2006;67(3):445-53.">Mann 2006b</a>; <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a>; <a href="./references#CD012880-bbs2-0026" title="WalitzerKS , DeffenbacherJL , ShyhallaK . Alcohol-adapted anger management treatment: a randomized controlled trial of an innovative therapy for alcohol dependence. Journal of Substance Abuse Treatment2015;59:83-93. [DOI: 10.1016/j.jsat.2015.08.003]">Walitzer 2015</a>). In this review, we use the abbreviation 'AA/TSF' to refer to these 12‐step programs and AA interventions in order to reflect both types of 12‐step effects of interest. </p> <div class="table" id="CD012880-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Follow‐up time points, treatment duration and treatment setting</span></div> <tbody> <tr> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Follow‐up time period (months)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Treatment duration</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Setting</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0001" title="BlondellRD , LooneySW , NorthingtonAP , LaschME , RhodesSB , McDanielsRL . Using recovering alcoholics to help hospitalized patients with alcohol problems. Journal of Family Practice2001;50(5):1-15. ">Blondell 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A single session of either a <b>peer intervention</b> (30‐60 minutes), <b>brief intervention</b> (5‐15 minutes), or <b>usual care</b> (60 minutes) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0002" title="BlondellRD , FrydrychLM , JaanimaqiU , AshrafiounL , HomishGG , FoschioEM , et al. A randomized trial of two behavioral interventions to improve outcomes following inpatient detoxification for alcohol dependence. Journal of Addictive Diseases2011;30(2):136-48. [DOI: 10.1080/10550887.2011.554777]">Blondell 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TAU:</b> 3 to 5 calendar days treatment<br/><b>TSF:</b> TAU + single 45‐ to 60‐minute session of TSF </p> <p><b>MET:</b> TAU + single 45‐ to 60‐minute session of MET </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0003" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12-step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403-11. [DOI: 10.1016/j.jsat.2013.12.009]">Bogenschutz 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TSF:</b> TAU + 12 weekly sessions of TSF therapy </p> <p><b>TAU:</b> TAU in the clinical dual diagnosis program </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0004" title="BowenS , WitkiewitzK , ClifasefiSL , GrowJ , ChawlaN , HsuSH , et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry2014;71(5):547-56. [DOI: 10.1001/jamapsychiatry.2013.4546]">Bowen 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks of either <b>MBRP</b> (1 weekly 2‐hour session), <b>RP</b> (1 weekly 2‐hour session), </p> <p>or <b>TAU</b> (1‐2 sessions/week for 1.5 hours) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0005" title="BrooksAJ , PennPE . Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training. American Journal of Drug and Alcohol Abuse2003;29(2):359-83. [DOI: 10.1081/ADA-120020519]">Brooks 2003</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both treatment groups met for 5 hours per day, 5 days per week over a 6‐month course of treatment </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0006" title="BrownTG , SeraganianP , TremlayJ , AnnisH . Process and outcome changes with relapse prevention versus 12-step aftercare programs for substance abusers. Addiction2002;976(6):677-89. ">Brown 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TSF:</b> 10 weekly 90‐minute 12‐step aftercare group sessions<br/><b>RP:</b> 10 weekly 90‐minute relapse prevention aftercare group sessions<br/><b>UC:</b> non‐specific support groups that encourage participants to maintain their substance use goals and include discussion of problems and potential solutions </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0007" title="DavisWT , CampbellL , TaxJ , LieberCS . A trial of 'standard' outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment2002;23(1):9-19. [DOI: 10.1016/S0740-5472(02)00227-1]">Davis 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months of either <b>MT</b> (1 weekly session during which participants viewed an alcoholism education movie, with a post‐film discussion held once per month) or <b>ST</b> (3‐week orientation period consisting of 6 group therapy sessions, 3 alcohol education sessions during which alcohol education films were shown, 3 community meetings and a minimum of 6 AA meetings, followed by weekly group and/or individual therapy sessions for the remainder of the treatment period, and optional alcohol education sessions beyond the orientation period) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0008" title="GrantKM , YoungLB , TylerKA , SimpsonJL , PulidoRD , TimkoC . Intensive referral to mutual-help groups: a field trial of adaptations for rural veterans. Patient Education and Counseling2018;101(1):79-84. [DOI: 10.1016/j.pec.2017.07.012]">Grant 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RAIR:</b> standard treatment + rural‐adapted intensive referral (3 sessions) </p> <p><b>SR:</b> standard treatment and referral </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0009" title="HermanSE , FrankKA , MowbrayCT , RibislKM , Davidson WS 2nd, Boots MillerB , et al. Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. Journal of Behavioral Health Services &amp; Research2000;27(3):286-302. [DOI: doi.org/10.1007/BF02291740]">Herman 2000</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>STW:</b> treatment in the standard short‐term treatment ward only (average length of stay = 31.1 days; staff not trained in substance use treatment)<br/><b>MHCD program:</b> treatment provided by mental health staff trained in substance use treatment and included educational lectures, AA and/or NA groups (participants required to attend at least 2 meetings per week), gender‐specific support groups, and family education sessions (average length of stay = 51.4 days) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0057" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [10.1046/j.1360-0443.2000.9579993.x]">Holder 2000</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks of either <b>TSF/CBT</b> with weekly treatment sessions, or <b>MET</b> with four sessions that occurred during weeks 1, 2, 6, and 12 </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous assessment of community‐based AA participation during the follow‐up period (i.e. 36 months) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See footnote*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0060" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-6.">Humphreys 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 to 28 days</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0062" title="HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]">Humphreys 2007</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 to 28 days</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0011" title="KahlerCW , ReadJP , RamseySE , StuartGL , McCradyBS , BrownRA . Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology2004;72(4):736-41. [DOI: 10.1037/0022-006X.72.4.736]">Kahler 2004</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>ME‐12:</b> one 60‐minute session<br/><b>BA:</b> one 5‐minute session<br/>Both interventions also included daily sessions with a psychiatrist, daily AA/NA meetings, and one group session per day (range of program stay = 2 to 8 days (mean 4.6, SD 1.6)) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0012" title="KaskutasLA , SubbaramanMS , WitbrodtJ , ZemoreSE . Effectiveness of making alcoholics anonymous easier: a group format 12-step facilitation approach. Journal of Substance Abuse Treatment2009;37(3):228-39. [DOI: 10.1016/j.jsat.2009.01.004]">Kaskutas 2009b</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MAAEZ:</b> six 90‐minute MAAEZ sessions replaced six usual care 12‐step education groups<br/><b>TAU:</b> usual care groups only </p> <p>(mean length of program stay was 112 days (SD 80) for long‐term residents, 33 days (SD 32) for short‐term residents, 44 days (SD 42) for outpatients) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient,</p> <p>inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0013" title="KellyJF , KaminerY , KahlerCW , HoeppnerB , YeterianJ , CristelloJV , et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction2017;112(12):2155-66. [DOI: 10.1111/add.13920]">Kelly 2017b</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weekly sessions: <b>iTSF</b> consisted of one 60‐ to 75‐minute individual session, one 30‐ to 50‐minute individual session, and eight 90‐minute group sessions; <b>MET/CBT</b> consisted of two 60‐minute individual MET sessions and eight 90‐minute group CBT sessions </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 &amp; 24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks (weekly 60‐minute sessions)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0015" title="LittMD , KaddenRM , TennenH , Kabela-CormierE . Network Support II: randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug and Alcohol Dependence2016;165:203-12. [DOI: 10.1016/j.drugalcdep.2016.06.010]">Litt 2016</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks (weekly 60‐minute sessions)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0016" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453-65. [DOI: 10.1037/a0019943]">Lydecker 2010</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 weeks. Both interventions consisted of two consecutive phases of treatment. Phase I included bi‐weekly hour‐long group sessions and monthly individual medication management visits. Phase II included weekly hour‐long group sessions and monthly medication management. </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0017" title="ManningV , BestD , FaulknerN , TitheringtonE , MorinanA , KeaneyF , et al. Does active referral by a doctor or 12-step peer improve 12-step meeting attendance? Results from a pilot randomised control trial. Drug and Alcohol Dependence2012;126(1-2):131-7. [DOI: 10.1016/j.drugalcdep.2012.05.004]">Manning 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PI:</b> one 30‐ to 45‐minute session </p> <p><b>DI:</b> one 30‐ to 45‐minute session </p> <p><b>NI:</b> participants provided with a list of meetings only </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12, 36 &amp; EOT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks: <b>TSF/CBT</b> consisted of weekly treatment sessions; <b>MET</b> consisted of four sessions that occurred during weeks 1, 2, 6, and 12 </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0019" title="McCradyBS , EpsteinEE , HirschLS . Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]McCradyBS , EpsteinEE , HirschLS . Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x]McCradyBS , EpsteinEE , KahlerCW . Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870]">McCrady 1996</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6, 18 &amp; EOT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 weeks (weekly 90‐minute sessions)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0020" title="MundtMP , ParthasarathyS , ChiFW , SterlingS , CampbellCI . 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002]">Mundt 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous assessment of community‐based AA participation during the follow‐up period (i.e. 60 months) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 to 28 days</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0022" title="TimkoC , DeBenedettiA . A randomized controlled trial of intensive referral to 12-step self-help groups: One-year outcomes. Drug and Alcohol Dependence2007;90(2-3):270-9. TimkoC , DebenedettiA , BillowR . Intensive referral to 12-step self-help groups and 6-month substance use disorder outcomes. Addiction2006;101(5):678-88. [DOI: 10.1111/j.1360-0443.2006.01391.x]">Timko 2006</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 &amp; 12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 sessions of either <b>IR</b> or <b>SR</b> across the course of 1 month </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0023" title="TimkoC , SutkowiA , CronkiteRC , Makin-ByrdK , MoosRH . Intensive referral to 12-step dual-focused mutual-help groups. Drug and Alcohol Dependence2011;118(2-3):194-201. [DOI: 10.1016/j.drugalcdep.2011.03.019]">Timko 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>IR:</b> standard outpatient mental health care + four additional outpatient group sessions within one month<br/><b>SR:</b> standard outpatient mental health care during which counselors gave participants a schedule of local dual‐focused 12‐step meetings </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0024" title="VederhusJK , TimkoC , KristensenO , HjemdahlB , ClausenT . Motivational intervention to enhance post‐detoxification 12‐step group affiliation: a randomized controlled trial. Addiction2014;109(5):766-73. [DOI: 10.1111/add.12471]">Vederhus 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MI:</b> two weekly, 30‐minute education sessions + standard detox<br/><b>BA:</b> brief advice to attend 12‐step groups in participants' home communities + standard detox (days on the ward averaged 12.6 days (SD 6.5) in the MI group and 9.9 days (SD 3.2) in the BA group) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 x 60‐minute sessions and one 90‐minute session over the course of 12 weeks</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0026" title="WalitzerKS , DeffenbacherJL , ShyhallaK . Alcohol-adapted anger management treatment: a randomized controlled trial of an innovative therapy for alcohol dependence. Journal of Substance Abuse Treatment2015;59:83-93. [DOI: 10.1016/j.jsat.2015.08.003]">Walitzer 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 x 60‐minute sessions over the course of 12 weeks</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0027" title="ZemoreSE , LuiC , MericleA , HembergJ , KaskutasLA . A longitudinal study of the comparative efficacy of Women for Sobriety, LifeRing, SMART Recovery, and 12-step groups for those with AUD. Journal of Substance Abuse Treatment2018;88:18-26. [DOI: 10.1016/j.jsat.2018.02.004]">Zemore 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous assessment of community‐based AA participation during the follow‐up period (i.e. 12 months) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*This study consisted of participants recruited from inpatient/residential facilities as well as those seeking treatment through an information and referral helpline (<a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a>), and were naturalistically followed. </p> <p><b>AA:</b> Alcoholics Anonymous<br/><b>BA:</b> brief advice<br/><b>CBT:</b> cognitive behavioral therapy<br/><b>DI:</b> doctor intervention<br/><b>EOT:</b> end of treatment<br/><b>IR:</b> intensive referral<br/><b>iTSF:</b> integrated 12‐Step Facilitation<br/><b>MAAEZ:</b> Making AA Easier<br/><b>ME‐12:</b> extended motivational enhancement<br/><b>MET:</b> motivational enhancement therapy<br/><b>MBRP:</b> mindfulness‐based relapse prevention<br/><b>MHCD:</b> Mental Health Chemical Dependence<br/><b>MI:</b> motivational intervention<br/><b>MT:</b> minimal treatment<br/><b>NA:</b> Narcotics Anonymous<br/><b>NI:</b> no intervention<br/><b>PI:</b> peer intervention<br/><b>RAIR:</b> rural‐adapted intensive referral<br/><b>RP:</b> relapse prevention<br/><b>SD:</b> standard deviation<br/><b>SR:</b> standard referral<br/><b>ST:</b> standard outpatient treatment<br/><b>STW:</b> standard short‐term treatment ward<br/><b>TAU:</b> treatment as usual<br/><b>TSF:</b> Twelve‐Step Facilitation<br/><b>UC:</b> usual care </p> </div> </div> </section> <section id="CD012880-sec-0012"> <h3 class="title" id="CD012880-sec-0012">How the intervention might work</h3> <p>The original AA intervention is purported to work via its social fellowship and 12‐step program (<a href="./references#CD012880-bbs2-0041" title="Alcoholics Anonymous. Alcoholics Anonymous: The Story of How Thousands of Men and Women have Recovered from Alcoholism. 4th edition. New York (NY): Alcoholics Anonymous World Services, 2001.">Alcoholics Anonymous 2001</a>). The social components operate through peer support and role modeling of successful AUD recovery, and through providing close mentoring and recovery management oversight through 'sponsorship'. The common suffering of AA group members may provide a sense of belonging or universality that can help to diminish negative affect, particularly shame, loneliness and guilt, which is similar to some forms of group psychotherapy (<a href="./references#CD012880-bbs2-0102" title="YalomID , LeszczM . The Theory and Practice of Group Psychotherapy. 5th edition. New York (NY): Basic Books, 2008.">Yalom 2008</a>). Furthermore, the observation of others who are sustaining recovery in AA can instill much‐needed hope for a better future. AA also provides an arena for members to learn, and model, effective communication and coping skills, as well as specific strategies for abstaining from alcohol. Members are encouraged to obtain a 'sponsor' ‐ a recovery mentor well‐established in sobriety ‐ who can offer guidance, daily support, and accountability to help new members stay sober. The 12‐step program is intended to facilitate the internal psychological, emotional, and spiritual changes deemed necessary to sustain abstinence and lead to enhanced psychological well‐being and improved relationships that can compete with the more immediate rewards provided by alcohol use (<a href="./references#CD012880-bbs2-0041" title="Alcoholics Anonymous. Alcoholics Anonymous: The Story of How Thousands of Men and Women have Recovered from Alcoholism. 4th edition. New York (NY): Alcoholics Anonymous World Services, 2001.">Alcoholics Anonymous 2001</a>; <a href="./references#CD012880-bbs2-0072" title="KellyJF , GreeneMC . The twelve promises of Alcoholics Anonymous: psychometric validation and mediational testing as a 12-step specific mechanism of behavior change. Drug and Alcohol Dependence2013;133(2):633-40. [DOI: 10.1016/j.drugalcdep.2013.08.006]">Kelly 2013b</a>). AA has an ostensibly 'spiritual' basis, which some members consider central to the program, and which may underlie the altruistic behavior that can help promote recovery (<a href="./references#CD012880-bbs2-0103" title="ZemoreSE , KaskutasLA , AmmonLN . In 12-step groups, helping helps the helper. Addiction2004;99(8):1015-23. [DOI: 10.1111/j.1360-0443.2004.00782.x]">Zemore 2004</a>). Yet many members do not consider the spiritual aspects of the program central (<a href="./references#CD012880-bbs2-0042" title="Alcoholics Anonymous. One Big Tent. New York (NY): AA Grapevine, Inc, 2018.">Alcoholics Anonymous 2018</a>; <a href="./references#CD012880-bbs2-0061" title="HumphreysK . Circles of Recovery: Self-Help Organizations for Addictions. Cambridge, UK: Cambridge University Press, 2004.">Humphreys 2004</a>). Rigorous reviews of the mechanisms of behavior change through which AA enhances recovery have found that AA typically confers benefits by mobilizing multiple therapeutic factors simultaneously ‐ mostly through facilitating adaptive changes in the social networks of participants, but also by boosting members’ recovery coping skills, recovery motivation, abstinence self‐efficacy, and psychological well‐being, and by reducing impulsivity and craving (<a href="./references#CD012880-bbs2-0069" title="KellyJF , MagillM , StoutRL . How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous. Addiction Research &amp; Theory2009;17(3):236-59. [http://dx.doi.org/10.1080/16066350902770458]">Kelly 2009b</a>; <a href="./references#CD012880-bbs2-0075" title="KellyJ . Is Alcoholics Anonymous religious, spiritual, neither? Findings from 25 years of mechanisms of behavior change research. Addiction2017;112(6):929-36. [DOI: 10.1111/add.13590]">Kelly 2017a</a>). </p> <p>It is likely that TSF interventions have quite similar change mechanisms, as they have been adapted directly from AA interventions, but, as they are of short duration and AUD is typically chronic, any long‐term impact of TSF would be due less to the intervention itself than to its ability to connect an individual to long‐term participation in AA. </p> </section> <section id="CD012880-sec-0013"> <h3 class="title" id="CD012880-sec-0013">Why it is important to do this review</h3> <p>AA is not controlled or standardized by professionals, so historically it has been harder to study than professionally‐designed and delivered treatments for which manuals are written, doses can be randomly assigned, and length of contact can be standardized and predetermined (<a href="./references#CD012880-bbs2-0061" title="HumphreysK . Circles of Recovery: Self-Help Organizations for Addictions. Cambridge, UK: Cambridge University Press, 2004.">Humphreys 2004</a>; <a href="./references#CD012880-bbs2-0071" title="KellyJK , YeterianJ . Mutual-help groups for alcohol and other substance use disorders. In: McCradyBS , EpsteinEE , editors(s). Addictions: A Comprehensive Guidebook. 2nd edition. New York, NY: Oxford University Press, 2013:500-25.">Kelly 2013a</a>). However, AA researchers have become increasingly sophisticated at finding methods to rigorously evaluate AA, including in randomized clinical trials. Reviews of this research have been conducted, including a prior Cochrane Review (<a href="./references#CD012880-bbs2-0105" title="FerriM , AmatoL , DavoliM . 12-step programmes and Alcoholics Anonymous for alcohol dependence. Cochrane Database of Systematic Reviews2004, Issue 4. Art. No: CD005032. [DOI: 10.1002/14651858.CD005032.pub2]">Ferri 2006a</a>; <a href="./references#CD012880-bbs2-0106" title="FerriM , AmatoL , DavoliM . Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database of Systematic Reviews2006, Issue 3. Art. No: CD005032. [DOI: 10.1002/14651858.CD005032.pub2]">Ferri 2006b</a>; <a href="./references#CD012880-bbs2-0065" title="KaskutasLA . Alcoholics Anonymous effectiveness: faith meets science. Journal of Addictive Diseases2009;28(2):145-57. [DOI: 10.1080/10550880902772464]">Kaskutas 2009a</a>; <a href="./references#CD012880-bbs2-0069" title="KellyJF , MagillM , StoutRL . How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous. Addiction Research &amp; Theory2009;17(3):236-59. [http://dx.doi.org/10.1080/16066350902770458]">Kelly 2009b</a>), but a flurry of additional empirical investigations since these reviews were conducted signifies a need for a major update. Consequently, an additional rigorous, high‐quality systematic review is needed that includes more recent studies to provide information about the clinical and public health utility, effectiveness, and cost‐effectiveness of AA and TSF. This review updates and supercedes the previously conducted Cochrane Review (<a href="./references#CD012880-bbs2-0106" title="FerriM , AmatoL , DavoliM . Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database of Systematic Reviews2006, Issue 3. Art. No: CD005032. [DOI: 10.1002/14651858.CD005032.pub2]">Ferri 2006b</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012880-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012880-sec-0014"></div> <p>To evaluate whether peer‐led AA and professionally‐delivered treatments that facilitate AA involvement (Twelve‐Step Facilitation (TSF) interventions) achieve important outcomes, specifically: abstinence, reduced drinking intensity, reduced alcohol‐related consequences, alcohol addiction severity, and healthcare cost offsets. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012880-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012880-sec-0015"></div> <section id="CD012880-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012880-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included studies that compared AA or TSF with other interventions, such as motivational enhancement therapy (MET) or cognitive behavioral therapy (CBT), 12‐step program variants, or no treatment. </p> <p>We included the following study designs:</p> <p> <ul id="CD012880-list-0001"> <li> <p>randomized controlled trials (RCTs);</p> </li> <li> <p>quasi‐RCTs (i.e. studies where due to potential contamination of intervention effects within single sites, it was not possible to do parallel, simultaneous randomization, but instead, sequential designs were used, where either random blocks were assigned to one intervention followed by the other; or where the intervention was implemented, then not implemented, and then reimplemented with subsequent random groups of participants in an 'on/off' type design); and </p> </li> <li> <p>non‐randomized studies (i.e. prospective, parallel, group design studies, with intact intervention groups that received either an Alcoholics Anonymous/Twelve‐Step Facilitation (AA/TSF) intervention or a comparison intervention without random assignment). </p> </li> </ul> </p> <p>Given the potential healthcare cost savings of people using freely available community‐based mutual‐help groups such as AA ( either spontaneously or in response to receiving a TSF/12‐step treatment) we considered any type of economic study that examined formal healthcare cost offsets in relation to these interventions (e.g. cost‐effectiveness, cost utility, cost‐benefit analyses). Despite the fairly large number of RCTs and quasi‐RCTs available, we included non‐randomized comparative designs in order to compare and contrast results from these studies with the more scientifically rigorous RCT designs. </p> </section> <section id="CD012880-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included male and female adults (18 years or older) with alcohol use disorder (AUD), alcohol abuse, or alcohol dependence, as defined using standardized criteria (i.e. the <i>Diagnostic and Statistical Manual of Mental Disorders</i>, 4th and 5th editions (<a href="./references#CD012880-bbs2-0043" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington (DC): American Psychiatric Association, 1994.">APA 1994</a>; <a href="./references#CD012880-bbs2-0044" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Washington (DC): American Psychiatric Association, 2013.">APA 2013</a>); the 9th and 10th revisions of the <i>International Statistical Classification of Diseases and Related Health Problems</i> (<a href="./references#CD012880-bbs2-0100" title="World Health Organization. International Statistical Classification of Diseases and Related Health Problems: ICD-10. 10th edition. Vol. 2. Geneva: World Health Organization, 2010.">WHO 2010</a>); and validated screening or diagnostic tools). We excluded studies that involved participants who had been coerced to attend AA meetings (e.g. by court order, employer, etc.). </p> </section> <section id="CD012880-sec-0019"> <h4 class="title">Types of interventions</h4> <p>In this review, AA participation and TSFs were compared with at least one of the following interventions. </p> <p> <ul id="CD012880-list-0002"> <li> <p>Other theoretically distinct clinical interventions (e.g. motivational enhancement therapy (MET), cognitive‐behavioral therapies (CBT), etc.). </p> </li> <li> <p>Other 12‐step program variants (e.g. studies comparing different types of 12‐step interventions that varied in style of intensity). </p> </li> <li> <p>No treatment (e.g. wait‐list control).</p> </li> </ul> </p> <p>'Treatment as usual' (TAU) was used in several studies to refer to a variety of psychosocial interventions delivered in individual and group formats that pertained to aspects of psychoeducation around addiction, relapse prevention skills building, and linking to recovery‐specific social support. For a more detailed description of each intervention, please see the <a href="./references#CD012880-sec-0140" title="">Characteristics of included studies</a>. </p> </section> <section id="CD012880-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>We examined four primary outcomes and two secondary outcomes across the included studies.</p> <section id="CD012880-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012880-list-0003"> <li> <p>Abstinence, measured as:</p> <ul id="CD012880-list-0004"> <li> <p>proportion of individuals who are continuously abstinent.</p> </li> <li> <p>longest period of abstinence (LPA)</p> </li> <li> <p>percentage days abstinent (PDA)</p> </li> </ul> </li> <li> <p>Drinking intensity, measured as:</p> <ul id="CD012880-list-0005"> <li> <p>drinks consumed per drinking day (DDD)</p> </li> <li> <p>percentage days of heavy drinking (PDHD)</p> </li> <li> <p>grams of pure alcohol consumed</p> </li> </ul> </li> <li> <p>Alcohol‐related consequences, measured as: self‐reports of physical, social, and psychological sequelae resulting from alcohol use (e.g. Drinker Inventory of Consequences (DRINC) (<a href="./references#CD012880-bbs2-0086" title="MillerWR , ToniganJS , LongabaughR . The Drinker Inventory of Consequences (DrInC): An Instrument for Assessing Adverse Consequences of Alcohol Abuse: Test Manual. Vol. 4, Project MATCH Monograph. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism, 1995.">Miller 1995</a>), Short Inventory of Problems (SIP) (<a href="./references#CD012880-bbs2-0086" title="MillerWR , ToniganJS , LongabaughR . The Drinker Inventory of Consequences (DrInC): An Instrument for Assessing Adverse Consequences of Alcohol Abuse: Test Manual. Vol. 4, Project MATCH Monograph. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism, 1995.">Miller 1995</a>), or similar measures) </p> </li> <li> <p>Alcohol addiction severity, measured by: the Addiction Severity Index (ASI; <a href="./references#CD012880-bbs2-0085" title="McLellanAT , LuborskyL , O’BrienCP , WoodyGE . An improved diagnostic instrument for substance abuse patients: the addiction severity index. Journal of Nervous &amp; Mental Diseases1980;168(1):26-33.">McLellan 1980</a>); or similar measures. </p> </li> </ul> </p> <p>These outcomes were measured through self‐report and, when available and appropriate, confirmed via bioassay. </p> </section> <section id="CD012880-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012880-list-0006"> <li> <p>Healthcare cost offsets, measured as:</p> <ul id="CD012880-list-0007"> <li> <p>changes in addiction</p> </li> <li> <p>mental health‐related service utilization</p> </li> <li> <p>related monetary impacts</p> </li> </ul> </li> <li> <p>Indices reflecting quality of life and/or psychological well‐being</p> </li> </ul> </p> </section> </section> </section> <section id="CD012880-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012880-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We imposed no language, publication year or publication status restrictions. We identified published, unpublished, and ongoing studies by searching the following databases from their inception. </p> <p> <ul id="CD012880-list-0008"> <li> <p>Cochrane Drugs and Alcohol Group Specialised Register (CDAG) Specialised Register (inception to 2 August 2019). </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (inception to 2 August 2019).</p> </li> <li> <p>MEDLINE PubMed (from 1946 to 2 August 2019).</p> </li> <li> <p>Embase Ovid (from 1974 to 2 August 2019).</p> </li> <li> <p>CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature; from 1982 to 2 August 2019). </p> </li> <li> <p>PsycINFO EBSCO (from 1935 to 2 August 2019).</p> </li> </ul> </p> <p>We modeled the subject strategies for databases on the search strategy designed for CENTRAL (<a href="./appendices#CD012880-sec-0128">Appendix 1</a>). </p> <p>We searched the following trial registries.</p> <p> <ul id="CD012880-list-0009"> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://www.who.int/ictrp/search/en/" target="_blank">www.who.int/trialsearch</a>) (15 November 2018). </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>) (15 November 2018). </p> </li> </ul> </p> <p>We also searched the above databases for health economics evidence.</p> </section> <section id="CD012880-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We attempted to identify other potentially eligible studies by searching the reference lists of retrieved included studies, systematic reviews, and meta‐analyses. We discovered five additional articles through these methods and through handsearching. </p> </section> </section> <section id="CD012880-sec-0026"> <h3 class="title" id="CD012880-sec-0026">Data collection and analysis</h3> <section id="CD012880-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors (JK and KH) independently scanned the abstract, title, or both, of every record retrieved to determine which studies should be evaluated further for inclusion. We retrieved all potentially relevant articles as full text, and resolved any discrepancies between the two review authors through consultation and discussion with the third review author (MF). When a potential study for inclusion that had been conducted by one of the review authors was detected, the study reports were screened independently by one of the other authors of this review who was not associated with that study. After discussion among the authors, we added studies that remained questionable for review inclusion to the list of articles awaiting assessment. We contacted study authors for clarification when necessary. We delineated the study selection process in a PRISMA flow chart (<a href="./references#CD012880-bbs2-0078" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GotzschePC , IoannidisJP , et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine2009;6(7):e1000100.">Liberati 2009</a>; <a href="./references#CD012880-bbs2-0087" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLos Medicine2009;6(7):e1000097. [DOI: 10.1371/journal.pmed1000097]">Moher 2009</a>). </p> </section> <section id="CD012880-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Using a standardized data extraction form, two review authors (JK and KH) independently abstracted the relevant elements of the study, including study design, sample characteristics, description of the experimental and control interventions, outcomes, study funding, and conflicts of interest. Any disagreements regarding these details were resolved among all review authors by discussion. We contacted study authors for clarification when necessary. </p> </section> <section id="CD012880-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (KH and MF) independently assessed the risk of bias in the included studies using the criteria recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012880-bbs2-0054" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011a</a>). When included reports had been authored by one of the authors of this review (e.g. <a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a>), the risk of bias was rated by the other two review authors to prevent conflicts of interest and potential bias. The recommended Cochrane approach for assessing risk of bias in studies comprises the assessment of seven domains: </p> <p> <ul id="CD012880-list-0010"> <li> <p>sequence generation;</p> </li> <li> <p>allocation concealment (selection bias);</p> </li> <li> <p>blinding of participants and personnel;</p> </li> <li> <p>blinding of outcome assessors (detection bias);</p> </li> <li> <p>incomplete outcome data (attrition bias);</p> </li> <li> <p>selective outcome reporting (reporting bias); and</p> </li> <li> <p>other sources of bias including:</p> <ul id="CD012880-list-0011"> <li> <p>comparability of cohorts for baseline characteristics and outcome measures on the basis of the design or analysis; </p> </li> <li> <p>selection of the non‐exposed cohort; and</p> </li> <li> <p>protection against cross‐contamination of the intervention.</p> </li> </ul> </li> </ul> </p> <p>The first part of the assessment process involved describing what was reported to have happened in the study. The second part involved assigning a judgment relating to the risk of bias for that entry, in terms of low, high, or unclear risk. To make these judgments, we used the criteria indicated in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Higgins 2011b)<i>,</i> adapted to the addiction field (see <a href="./appendices#CD012880-sec-0129">Appendix 2</a> for details). </p> <p>We addressed the domains of sequence generation and allocation concealment (avoidance of selection bias) using a single entry for each study. </p> <p>Blinding of participants and personnel (performance bias) was not possible given that the focus of this review was on psychosocial interventions. In fact, knowledge of participation in a psychosocial intervention is part of the therapeutic effect; therefore, we think that lack of blinding of participants and personnel does not introduce bias. For this reason, we judged all studies as being at low risk of performance bias. </p> <p>We had planned initially to assess blinding of outcome assessor separately for objective and subjective outcomes, but all the outcomes reported in the included studies were subjective (self‐reported data), even though many of these were supported by objective biological assay (e.g. urine toxicology screens). </p> <p>We provided a separate rating of bias for economic studies so that they could be rated independently from the clinical outcome analysis. This was done because, even though they came from the same study, the analytic method for each type of analysis is very different. Also, one study was purely an economic study and did not contribute data to the estimate of AA/TSF effects because it did not have a true comparison group (<a href="./references#CD012880-bbs2-0020" title="MundtMP , ParthasarathyS , ChiFW , SterlingS , CampbellCI . 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002]">Mundt 2012</a>). </p> <p>We considered incomplete outcome data (while also taking due note of any observed attrition bias) for all outcomes. </p> <p>We operationalized 'Risk of bias' tables to be used for the assessment of RCTs, quasi‐RCTs, and prospective observational studies that included a comparison intervention, according to the criteria recommended by Cochrane Drugs and Alcohol (see <a href="./appendices#CD012880-sec-0129">Appendix 2</a> for details). </p> <p>We evaluated any economic studies using the appropriate Cochrane 'Risk of bias' criteria, along two dimensions, as specified in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (section 15.5.2; <a href="./references#CD012880-bbs2-0093" title="ShemiltI , MugfordM , ByfordS , DrummondM , EisensteinE , KnappM , et al. Chapter 15: Incorporating economics evidence. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Shemilt 2011a</a>). This included two types of bias ratings: </p> <p> <ul id="CD012880-list-0012"> <li> <p>assessment of the risk of bias in results of the effectiveness study on which the full economic evaluation study is based, informed by a recognized checklist for effectiveness studies; and </p> </li> <li> <p>assessment of the methodological quality of the full economic evaluation study, informed by a recognized checklist for economic evaluations conducted alongside single study designs. </p> </li> </ul> </p> <p>As recommended by Cochrane (<a href="./references#CD012880-bbs2-0093" title="ShemiltI , MugfordM , ByfordS , DrummondM , EisensteinE , KnappM , et al. Chapter 15: Incorporating economics evidence. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Shemilt 2011a</a>), we utilized the Evers checklist for rating the certainty of economic studies in the current review (<a href="./references#CD012880-bbs2-0050" title="EversS , GoossensM , deVetH , vanTulderM , AmentA . Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. International Journal of Technology Assessment in Health Care2005;21(2):240-5.">Evers 2005</a>; <a href="./appendices#CD012880-sec-0130">Appendix 3</a>). </p> </section> <section id="CD012880-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated the standardized mean difference (SMD) for continuous variables (e.g. percentage days abstinent (PDA)), or the relative risk (i.e. risk ratios (RRs)) for dichotomous variables (e.g. proportion of participants completely abstinent), with the uncertainty of the estimate expressed using 95% confidence intervals (CIs). We pooled and analyzed study effects wherever possible using meta‐analyses. We used random‐effects estimates to account for potential heterogeneity among studied interventions in the included studies. We described any remaining studies in table format and described results in the narrative. These are referred to below in the Results section as <a href="./references#CD012880-fig-0006" title="">Analysis 1.1</a>, <a href="./references#CD012880-fig-0018" title="">Analysis 2.3</a>, and <a href="./references#CD012880-fig-0035" title="">Analysis 6.3</a>, and appear in the 'Data and Analyses' section tables as 'Other Data'. </p> </section> <section id="CD012880-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>In order to avoid double‐counting (i.e. unit of analysis errors that can inflate statistical significance) (<a href="./references#CD012880-bbs2-0055" title="HigginsJP , DeeksJJ , AltmanDG , editor(s). Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011b</a>), and analyze studies properly where there was one AA/TSF intervention group compared to two or more comparison groups, we split the population of the AA/TSF intervention group in the meta‐analyses, based on the guidelines outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (How to include multiple groups from one study) (<a href="./references#CD012880-bbs2-0055" title="HigginsJP , DeeksJJ , AltmanDG , editor(s). Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011b</a>). This method was preferred over the two alternative methods: averaging the effects of the comparison interventions, or conducting completely separate analyses by distinct type of comparison intervention. This is because, firstly, averaging effects of different comparison interventions artificially assumes these interventions are conceptually similar and confer similar benefit; and secondly, there are insufficient numbers of the same comparison intervention to justify separate analyses by comparison group type. </p> </section> <section id="CD012880-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We appraised the presence and impact of missing data on study findings. We detailed this in the narrative as appropriate. We also detailed in a table how the included studies handled missing data. When necessary, we contacted the original study authors to attempt to obtain missing data and information of their potential impact. </p> </section> <section id="CD012880-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>Given the potential high level of heterogeneity across experimental treatments and comparison treatments, we conducted a quantitative aggregation (meta‐analysis) that included statistical estimation of the degree of heterogeneity calculated using the Q value and I<sup>2</sup>statistic. </p> </section> <section id="CD012880-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to use visual inspection of funnel plots (plots of the effect estimate from each study against the sample size or effect standard error) to indicate possible publication bias if there were at least 10 studies included in the meta‐analysis. We did not inspect funnel plots because there were always less than 10 studies in any given meta‐analysis (<a href="./references#CD012880-bbs2-0096" title="SterneJAC , EggerM , Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention.. Available from handbook.cochrane.org.">Sterne 2011</a>). </p> </section> <section id="CD012880-sec-0035"> <h4 class="title">Data synthesis</h4> <p>Wherever possible, we conducted pooled analysis and aggregation of data using a random‐effects model, because we expected a certain degree of heterogeneity among trials. This was possible for the proportion of participants completely abstinent, PDA, DDD, and PDHD. We analyzed the five observational, prospective, non‐randomized studies we included separately (see <a href="./references#CD012880-fig-0028" title="">Analysis 5.1</a>, <a href="./references#CD012880-fig-0029" title="">Analysis 5.2</a>, <a href="./references#CD012880-fig-0030" title="">Analysis 5.3</a>, <a href="./references#CD012880-fig-0031" title="">Analysis 5.4</a>, <a href="./references#CD012880-fig-0032" title="">Analysis 5.5</a>, <a href="./references#CD012880-fig-0033" title="">Analysis 6.1</a>, <a href="./references#CD012880-fig-0034" title="">Analysis 6.2</a>, <a href="./references#CD012880-fig-0035" title="">Analysis 6.3</a> and <a href="./references#CD012880-fig-0036" title="">Analysis 6.4</a>). </p> <p>As detailed in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (section 15.6.3) (<a href="./references#CD012880-bbs2-0093" title="ShemiltI , MugfordM , ByfordS , DrummondM , EisensteinE , KnappM , et al. Chapter 15: Incorporating economics evidence. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Shemilt 2011a</a>), there is currently no consensus regarding appropriate methods for pooling combined estimates of cost‐effectiveness studies, in addition, there are potential issues concerning the validity of such methods when combining metrics across cost‐effectiveness studies. For these reasons, rather than conduct a meta‐analysis, we summarized results from any cost‐effectiveness studies in the narrative. </p> </section> <section id="CD012880-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We describe subgroup analyses according to AUD severity, where appropriate (e.g. according to the DSM IV criteria 'abuse' versus 'dependence'; <a href="./references#CD012880-bbs2-0043" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington (DC): American Psychiatric Association, 1994.">APA 1994</a>). </p> </section> <section id="CD012880-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted sensitivity analyses by examining studies across three major dimensions:</p> <p> <ul id="CD012880-list-0013"> <li> <p>type of study design (e.g. RCT/quasi‐RCT, non‐randomized);</p> </li> <li> <p>degree of manualization and verified clinical fidelity in implementation of the intervention (e.g. documentation of regular audio/video‐taped clinical supervision to monitor adherence to the treatment manual and measurement of clinical competence in its delivery); and </p> </li> <li> <p>the type of intervention to which AA/TSF was compared (e.g. an intervention based on a different theory, such as cognitive behavioral therapy (CBT), or an intervention based on the same type of TSF‐orientation but that varied in TSF style of intensity). </p> </li> </ul> </p> </section> <section id="CD012880-sec-0038"> <h4 class="title">Grading of evidence</h4> <p>We assessed the overall certainty of evidence for the primary outcomes using the GRADE system (<a href="./references#CD012880-bbs2-0051" title="GRADE Working Group, McMaster UniversityGRADEpro GDT. Hamilton (ON): GRADE Working Group, McMaster University, 2015. Available at gradepro.org.">GRADEpro GDT 2015</a>; <a href="./references#CD012880-bbs2-0092" title="SchunemannH , BrozekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schunemann 2013</a>), which takes into account issues related to internal and external validity, such as risk of bias, directness, consistency, precision of results, and publication bias. These ratings were based on studies that had the 12‐month assessment outcome time point. If there was no 12‐month outcome within a particular subgrouping for a given outcome, then GRADE ratings were based on the next closest outcome time point from the evidence available. We used GRADEpro GDT to create the 'Summary of findings' tables (<a href="./references#CD012880-bbs2-0051" title="GRADE Working Group, McMaster UniversityGRADEpro GDT. Hamilton (ON): GRADE Working Group, McMaster University, 2015. Available at gradepro.org.">GRADEpro GDT 2015</a>). These tables present the main findings of the review in a transparent and simple tabular format. Outcomes are presented where possible for 12‐month follow‐ups,and key information concerning the certainty of evidence, the magnitude of effect of the interventions, and the sum of available data for the main outcomes is also shown. </p> <p>The GRADE system uses the following criteria for assigning grades of evidence.</p> <p> <ul id="CD012880-list-0014"> <li> <p>High certainty: we are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p>Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </li> <li> <p>Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p>Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> <p>Grading can be decreased for any of the following reasons.</p> <p> <ul id="CD012880-list-0015"> <li> <p>Serious (‐1 grade) or very serious (‐2) study limitation for risk of bias.</p> </li> <li> <p>Serious (‐1) or very serious (‐2) inconsistency between study results.</p> </li> <li> <p>Some (‐1) or major (‐2) uncertainty about directness (the correspondence between the population, the intervention, or the outcomes measured in the studies actually found and those under consideration in our systematic review). </p> </li> <li> <p>Serious (‐1) or very serious (‐2) imprecision of the pooled estimate.</p> </li> <li> <p>Publication bias strongly suspected.</p> </li> </ul> </p> <p>By default, according to the Cochrane system for grading evidence, all non‐randomized studies are automatically rated as 'low certainty', and then downgraded from there based on any of the above‐listed reasons. Evidence from non‐randomized studies can be upgraded for large effects, specifically, evidence of dose response and confounding which would be expected to result in an effect opposite to that observed. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012880-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012880-sec-0039"></div> <section id="CD012880-sec-0040"> <h3 class="title">Description of studies</h3> <p>We included 27 primary studies with a total of 10,565 participants. Twenty‐six of these primary studies contributed data to the estimate of the effectiveness of Alcoholics Anonymous/Twelve‐Step Facilitation (AA/TSF). Twenty‐one of these 27 studies were randomized controlled trials (RCTs)/quasi‐RCTs; five were non‐randomized studies, and one study was used for purely economic purposes (<a href="./references#CD012880-bbs2-0020" title="MundtMP , ParthasarathyS , ChiFW , SterlingS , CampbellCI . 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002]">Mundt 2012</a>), and did not contribute to the estimate of the effectiveness of AA/TSF, because it did not include a comparison intervention. Three other studies also included economic analyses (classified as cost‐benefit studies; e.g. see <a href="./references#CD012880-bbs2-0047" title="DrummondMF , SculpherMJ , TorranceGW , O'BrienBJ , StoddartGL . Methods for the Economic Evaluation of Health Care Programmes. 3rd edition. Oxford (UK): Oxford University Press, 2005.">Drummond 2005</a>; <a href="./references#CD012880-bbs2-0093" title="ShemiltI , MugfordM , ByfordS , DrummondM , EisensteinE , KnappM , et al. Chapter 15: Incorporating economics evidence. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Shemilt 2011a</a>), making a total of four included economic studies reported across five included papers. </p> <section id="CD012880-sec-0041"> <h4 class="title">Results of the search</h4> <p>Electronic searches yielded 12,733 articles from the databases specified in <a href="#CD012880-sec-0024">Electronic searches</a>. We identified an additional five studies through author correspondence, and three through clinical trial records, making a total of 12,741 articles. After duplicates were removed, 5808 records remained. We removed 5758 of these after screening titles and abstracts, as they were irrelevant to the current study. This left a total of 50 full‐text reports, which we examined in detail. We excluded 13 of these because they did not meet the inclusion criteria (documented in <a href="#CD012880-fig-0001">Figure 1</a>; see also <a href="./references#CD012880-sec-0141" title="">Characteristics of excluded studies</a>). This left a total of 37 published study reports relating to the 27 primary studies that met our inclusion criteria. </p> <div class="figure" id="CD012880-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA study flow diagram." data-id="CD012880-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA study flow diagram.</p> </div> </div> </div> </section> <section id="CD012880-sec-0042"> <h4 class="title">Included studies</h4> <p>Most studies were conducted in the USA, with one study from the UK (<a href="./references#CD012880-bbs2-0017" title="ManningV , BestD , FaulknerN , TitheringtonE , MorinanA , KeaneyF , et al. Does active referral by a doctor or 12-step peer improve 12-step meeting attendance? Results from a pilot randomised control trial. Drug and Alcohol Dependence2012;126(1-2):131-7. [DOI: 10.1016/j.drugalcdep.2012.05.004]">Manning 2012</a>), and one from Norway (<a href="./references#CD012880-bbs2-0024" title="VederhusJK , TimkoC , KristensenO , HjemdahlB , ClausenT . Motivational intervention to enhance post‐detoxification 12‐step group affiliation: a randomized controlled trial. Addiction2014;109(5):766-73. [DOI: 10.1111/add.12471]">Vederhus 2014</a>). Details of characteristics and bias ratings for each study are included in the <a href="./references#CD012880-sec-0140" title="">Characteristics of included studies</a>. Where there were two or more papers describing different follow‐up time points for a given study, we combined the papers describing the results of the different time points under that study. </p> <p>Although all of the study populations were extremely likely to have had various proportions of participants meeting clinical criteria for other psychiatric disorders (e.g. major depression, anxiety disorders etc.) in addition to alcohol use disorder (AUD), these proportions were rarely explicitly documented. There were four studies, however, that met the inclusion criteria that did explicitly document the degree of psychiatric comorbidity (<a href="./references#CD012880-bbs2-0003" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12-step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403-11. [DOI: 10.1016/j.jsat.2013.12.009]">Bogenschutz 2014</a>; <a href="./references#CD012880-bbs2-0005" title="BrooksAJ , PennPE . Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training. American Journal of Drug and Alcohol Abuse2003;29(2):359-83. [DOI: 10.1081/ADA-120020519]">Brooks 2003</a>; <a href="./references#CD012880-bbs2-0009" title="HermanSE , FrankKA , MowbrayCT , RibislKM , Davidson WS 2nd, Boots MillerB , et al. Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. Journal of Behavioral Health Services &amp; Research2000;27(3):286-302. [DOI: doi.org/10.1007/BF02291740]">Herman 2000</a>; <a href="./references#CD012880-bbs2-0023" title="TimkoC , SutkowiA , CronkiteRC , Makin-ByrdK , MoosRH . Intensive referral to 12-step dual-focused mutual-help groups. Drug and Alcohol Dependence2011;118(2-3):194-201. [DOI: 10.1016/j.drugalcdep.2011.03.019]">Timko 2011</a>). Although, such dually‐diagnosed samples are sometimes reviewed separately (e.g. <a href="./references#CD012880-bbs2-0098" title="ToniganJS , PearsonMR , MagillM , HaglerKJ . AA attendance and abstinence for dually diagnosed patients: a meta-analytic review. Addiction2018;113(11):1970-81. [DOI: 10.1111/add.14268]">Tonigan 2018</a>), we included these studies here because they otherwise met our inclusion criteria. When we performed sensitivity analyses, we did not find differences in the overall pattern of findings when we included or excluded these studies. </p> <p>The <a href="./references#CD012880-sec-0140" title="">Characteristics of included studies</a> tables also include two additional ratings for each study as follows. </p> <p> <ul id="CD012880-list-0016"> <li> <p>Grading criteria for study adherence/competence rating:</p> </li> </ul> </p> <p> <ul class="plain" id="CD012880-list-0017"> <li> <ul id="CD012880-list-0018"> <li> <p>0 = non‐manualized (i.e. treatments were unlikely to be replicable), or no report of attempts to ensure adherence/competence of intervention implementation; </p> </li> <li> <p>1 = report of attempts to ensure adherence/competence without audio or videotape;</p> </li> <li> <p>2 = report of attempts to ensure adherence/competence with audio or videotape monitoring and rating. </p> </li> </ul> </li> </ul> </p> <p> <ul id="CD012880-list-0019"> <li> <p>Manualization and non‐manualization of study interventions:</p> </li> </ul> </p> <p> <ul class="plain" id="CD012880-list-0020"> <li> <ul id="CD012880-list-0021"> <li> <p>M = manualized: treatments were replicable because they followed a session‐to‐session outline of procedures </p> </li> <li> <p>NM = non‐manualized: treatments were unlikely to be replicable</p> </li> </ul> </li> </ul> </p> <section id="CD012880-sec-0043"> <h5 class="title">Study design</h5> <p>We included a total of 27 primary studies (21 RCTs/quasi‐RCTs, 5 non‐randomized, and 1 purely economic study) that reported follow‐up results across a total of 36 reports. </p> </section> <section id="CD012880-sec-0044"> <h5 class="title">Participants</h5> <p>The total number of participants across the 27 included studies was 10,565, including 2456 participants who contributed to the economic analyses. </p> <p>The average sample age ranged from 34.2 years old in <a href="./references#CD012880-bbs2-0005" title="BrooksAJ , PennPE . Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training. American Journal of Drug and Alcohol Abuse2003;29(2):359-83. [DOI: 10.1081/ADA-120020519]">Brooks 2003</a> to 51.0 years old in <a href="./references#CD012880-bbs2-0023" title="TimkoC , SutkowiA , CronkiteRC , Makin-ByrdK , MoosRH . Intensive referral to 12-step dual-focused mutual-help groups. Drug and Alcohol Dependence2011;118(2-3):194-201. [DOI: 10.1016/j.drugalcdep.2011.03.019]">Timko 2011</a>; </p> <p>The proportion of female participants ranged from 0% in <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a> and <a href="./references#CD012880-bbs2-0019" title="McCradyBS , EpsteinEE , HirschLS . Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]McCradyBS , EpsteinEE , HirschLS . Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x]McCradyBS , EpsteinEE , KahlerCW . Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870]">McCrady 1996</a> to 49.1% in <a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a>. </p> <p>The racial composition varied from 7.3% non‐white participants in <a href="./references#CD012880-bbs2-0015" title="LittMD , KaddenRM , TennenH , Kabela-CormierE . Network Support II: randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug and Alcohol Dependence2016;165:203-12. [DOI: 10.1016/j.drugalcdep.2016.06.010]">Litt 2016</a> to 54% in <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a>. </p> <p>In the economic evaluations, the average sample age ranged from 16.1 years old at baseline in <a href="./references#CD012880-bbs2-0020" title="MundtMP , ParthasarathyS , ChiFW , SterlingS , CampbellCI . 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002]">Mundt 2012</a> to 43 years old in <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a>; from 0% female in <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a> to 49.1% female in <a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a>; and from 8% non‐white participants in <a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a> to 76.9% in <a href="./references#CD012880-bbs2-0009" title="HermanSE , FrankKA , MowbrayCT , RibislKM , Davidson WS 2nd, Boots MillerB , et al. Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. Journal of Behavioral Health Services &amp; Research2000;27(3):286-302. [DOI: doi.org/10.1007/BF02291740]">Herman 2000</a>. </p> </section> <section id="CD012880-sec-0045"> <h5 class="title">Types of comparisons</h5> <p>Experimental interventions included AA participation and TSF. Comparison interventions included other psychological clinical interventions (e.g. motivational enhancement therapy (MET), cognitive behavioral therapy (CBT), etc.), other 12‐step program variants (e.g. studies comparing different styles/intensities of 12‐step interventions), and no treatment (e.g. wait‐list control). However, we identified no included studies that contained a no treatment/wait‐list comparison group. Interventions and comparisons varied by degree of therapy manualization, duration/number of treatment sessions, whether they were clinician or peer‐led, in a clinical or community setting, and in clinical population focus. </p> <p>There were three broad dimensions that characterized these included studies: the type of study used; the degree of treatment manualization (signifying the degree of intervention standardization and replicability); and the types of treatments to which AA/TSF was compared (see <a href="#CD012880-fig-0002">Figure 2</a> and <a href="#CD012880-fig-0003">Figure 3</a> (the latter includes the number of participants in each of these subcategories)). </p> <div class="figure" id="CD012880-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Manualized = the treatment covers standardized content in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment." data-id="CD012880-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Manualized = the treatment covers standardized content in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> </div> </div> </div> <div class="figure" id="CD012880-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="S = number of studies from Cochrane ReviewR = number of reports from Cochrane ReviewN = number of participants in the cell subcategoryManualized = the treatment covers standardized content in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment.aThe total Ns added across study types will not add to 10,565 because some of the participants that are in the other groupings (e.g. non‐randomized designs) are also in the economic category. bWalitzer 2009 and its participants are included in both the 1A and 2A grouping in the review, but for the purposes of this table, the study and its participants (n = 169) are only counted once in the 1A group. cOuimette 1997 and its participants are included in both the 3B and 4B grouping, but for the purposes of this table, the study and its participants (n = 3018) are only counted in the 3B group." data-id="CD012880-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>S = number of studies from Cochrane Review</p> <p>R = number of reports from Cochrane Review</p> <p>N = number of participants in the cell subcategory</p> <p>Manualized = the treatment covers standardized content in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup>The total Ns added across study types will not add to 10,565 because some of the participants that are in the other groupings (e.g. non‐randomized designs) are also in the economic category.<br/><sup>b</sup><a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a> and its participants are included in both the 1A and 2A grouping in the review, but for the purposes of this table, the study and its participants (n = 169) are only counted once in the 1A group.<br/><sup>c</sup><a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a> and its participants are included in both the 3B and 4B grouping, but for the purposes of this table, the study and its participants (n = 3018) are only counted in the 3B group. </p> </div> </div> </div> <p>Within design types, studies varied in whether treatments were manualized or non‐manualized, and whether they compared AA/TSF to a different theoretical orientation (e.g. CBT), or to a different type of TSF (i.e. one that varied in TSF style or intensity). Among the 21 RCT/quasi‐RCT designs (5787 participants; 28 reports), 15 studies were manualized (10 compared AA/TSF to a different theoretical orientation; 4 compared AA/TSF variants, 1 compared AA/TSF to both another theoretical orientation and an AA/TSF variant); 4 studies had one or more non‐manualized interventions (2 compared AA/TSF to a different theoretical orientation, 2 compared AA/TSF variants); two studies were non‐manualized (both compared AA/TSF to a different theoretical orientation). Among the five studies that were non‐randomized (4375 participants; 7 reports), two studies had at least one intervention non‐manualized (1 compared AA/TSF to a different theoretical orientation and 1 compared AA/TSF to an AA/TSF variant); three studies had treatments that were all non‐manualized (2 compared AA/TSF to a different theoretical orientation and 1 compared AA/TSF to a different theoretical orientation as well as an AA/TSF variant). Together, 26 primary studies contributed data to the estimate of the effectiveness of AA/TSF. We utilized the final included study purely for its economic analysis (<a href="./references#CD012880-bbs2-0020" title="MundtMP , ParthasarathyS , ChiFW , SterlingS , CampbellCI . 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002]">Mundt 2012</a>; 403 participants); this study did not contribute to the estimate of the effectiveness of AA/TSF, because it did not include a comparison intervention. </p> <p>Keeping these dimensions in mind, below we have reported the findings from the included studies in five summary categories with subcategories as follows. </p> <p> <ul id="CD012880-list-0022"> <li> <p>1a: studies that employed a RCT/quasi‐RCT design with all treatments manualized and compared AA/TSF to a treatment with a different theoretical orientation (e.g. CBT) (11 studies). </p> </li> <li> <p>1b: studies that employed a RCT/quasi‐RCT design where at least one comparison treatment was non‐manualized and AA/TSF was compared to a treatment with a different theoretical orientation (e.g. CBT) (4 studies). </p> </li> <li> <p>2a: studies that employed a RCT/quasi‐RCT design with all treatments manualized and AA/TSF was compared to a different type of TSF (i.e. varying in TSF style or intensity) (5 studies). </p> </li> <li> <p>2b: studies that employed a RCT/quasi‐RCT design where at least one comparison treatment was non‐manualized and AA/TSF was compared to a different type of TSF (i.e. varying in TSF style or intensity) (2 studies). </p> </li> <li> <p>3a: studies that employed a non‐randomized design with all treatments manualized and where AA/TSF was compared to a different theoretical orientation (e.g. CBT) (note: there are no studies included in this category<i>).</i> </p> </li> <li> <p>3b: studies that employed a non‐randomized design with at least one non‐manualized treatment intervention and where AA/TSF was compared to a different theoretical treatment orientation (e.g. CBT) (4 studies). </p> </li> <li> <p>4a: studies that employed a non‐randomized design with all treatments manualized and where AA/TSF was compared to a different type of TSF (i.e. varying in style or intensity) (note: there are no studies included in this category<i>).</i> </p> </li> <li> <p>4b: studies that employed a non‐randomized design with at least one non‐manualized treatment intervention and where AA/TSF was compared to a different TSF variant (i.e. in varying in TSF style or intensity) (2 studies). </p> </li> <li> <p>5: economic studies (e.g. healthcare cost offset) (4 studies).</p> </li> </ul> </p> </section> <section id="CD012880-sec-0046"> <h5 class="title">Length of follow‐up</h5> <p>Follow‐up length ranged from the end of treatment through to five years (<a href="#CD012880-tbl-0008">Table 1</a>). For the economic studies, follow‐up length ranged from one year to seven years. </p> </section> <section id="CD012880-sec-0047"> <h5 class="title">Outcomes assessed in the studies</h5> <p>We examined our four primary outcomes and two secondary outcomes across the included studies. The primary outcomes assessed in the studies were as follows. </p> <p> <ul id="CD012880-list-0023"> <li> <p>Abstinence, measured as:</p> <ul id="CD012880-list-0024"> <li> <p>proportion of individuals who are continuously abstinent (17 studies; 23 reports);</p> </li> <li> <p>longest period of abstinence (LPA) (2 studies; 2 reports); and</p> </li> <li> <p>percentage days abstinent (PDA) (16 studies; 21 reports).</p> </li> </ul> </li> <li> <p>Drinking intensity, measured as:</p> <ul id="CD012880-list-0025"> <li> <p>drinks consumed per drinking day (DDD) (9 studies; 11 reports ‐ note: 1 study was based on grams of pure alcohol consumed, converted into USA standard drinks per drinking day); </p> </li> <li> <p>percentage days of heavy drinking (PDHD) (4 studies; 4 reports).</p> </li> </ul> </li> <li> <p>Alcohol‐related consequences, measured as: self‐reports of physical, social, and psychological sequelae resulting from alcohol use (e.g. Drinker Inventory of Consequences (DRINC; <a href="./references#CD012880-bbs2-0086" title="MillerWR , ToniganJS , LongabaughR . The Drinker Inventory of Consequences (DrInC): An Instrument for Assessing Adverse Consequences of Alcohol Abuse: Test Manual. Vol. 4, Project MATCH Monograph. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism, 1995.">Miller 1995</a>), Short Inventory of Problems (SIP; <a href="./references#CD012880-bbs2-0086" title="MillerWR , ToniganJS , LongabaughR . The Drinker Inventory of Consequences (DrInC): An Instrument for Assessing Adverse Consequences of Alcohol Abuse: Test Manual. Vol. 4, Project MATCH Monograph. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism, 1995.">Miller 1995</a>), or similar measures; 8 studies; 10 reports). </p> </li> <li> <p>Alcohol addiction severity (7 studies; 8 reports), measured by: the Addiction Severity Index (ASI; <a href="./references#CD012880-bbs2-0085" title="McLellanAT , LuborskyL , O’BrienCP , WoodyGE . An improved diagnostic instrument for substance abuse patients: the addiction severity index. Journal of Nervous &amp; Mental Diseases1980;168(1):26-33.">McLellan 1980</a>) (6 studies; 7 reports), Alcohol Dependence Scale (ADS; 1 study; 1 report). </p> </li> </ul> </p> <p>Secondary outcomes assessed in the studies consisted of the economic analyses (4 studies; 5 reports) measured by cost‐benefit analysis (see <a href="./references#CD012880-sec-0140" title="">Characteristics of included studies</a> tables for specific examples). In some instances either the means or standard deviations (SDs), or both, were missing from the published reports. On each occasion, we were able to obtain these directly from the study authors through personal correspondence (i.e. <a href="./references#CD012880-bbs2-0011" title="KahlerCW , ReadJP , RamseySE , StuartGL , McCradyBS , BrownRA . Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology2004;72(4):736-41. [DOI: 10.1037/0022-006X.72.4.736]">Kahler 2004</a>; <a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a>; <a href="./references#CD012880-bbs2-0015" title="LittMD , KaddenRM , TennenH , Kabela-CormierE . Network Support II: randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug and Alcohol Dependence2016;165:203-12. [DOI: 10.1016/j.drugalcdep.2016.06.010]">Litt 2016</a>; <a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a>; <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a>). None of the included studies reported indices reflecting quality of life or psychological well‐being. </p> <p>Thirteen studies included a bioassay (either a breathalyzer, blood, urinalysis, saliva, or a combination of these), while 13 did not report the use of one; the final study was an economic analysis only, for which use of a bioassay was not appropriate. The included studies were conducted prior to the introduction of biological assays such as ethyl glucuronide (EtG) and phosphatidylethanol (PetH), both of which can detect alcohol for much longer than the assays used in the studies. Since, at that time, there was a limited window for detecting alcohol use using breathalyzers and urinalysis bioassay, use of bioassays to corroborate self‐report was less common than it is now. Regardless, it is unlikely that any systematic bias would occur across comparison treatment interventions because all participants were subjected to the same procedures and protocols. </p> </section> <section id="CD012880-sec-0048"> <h5 class="title">Funding sources</h5> <p>Included studies were funded through grants from one or more of the following sources: the United States National Institutes of Health (18 studies); the USA Department of Veterans Affairs (8 studies); and through various other organizations (e.g. private foundations, (academic) or institutions; 8 studies). For two studies researchers did not report their funding source (<a href="./references#CD012880-bbs2-0007" title="DavisWT , CampbellL , TaxJ , LieberCS . A trial of 'standard' outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment2002;23(1):9-19. [DOI: 10.1016/S0740-5472(02)00227-1]">Davis 2002</a>; <a href="./references#CD012880-bbs2-0011" title="KahlerCW , ReadJP , RamseySE , StuartGL , McCradyBS , BrownRA . Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology2004;72(4):736-41. [DOI: 10.1037/0022-006X.72.4.736]">Kahler 2004</a>). </p> </section> </section> <section id="CD012880-sec-0049"> <h4 class="title">Excluded studies</h4> <p>We excluded 24 studies from the review because they did not meet the inclusion criteria in terms of: study design (13 studies), interventions evaluated (3 studies), participants (6 studies), study design plus intervention (1 study), or study design plus outcomes (1 study). </p> </section> </section> <section id="CD012880-sec-0050"> <h3 class="title">Risk of bias in included studies</h3> <p>As noted in <a href="#CD012880-sec-0029">Assessment of risk of bias in included studies</a>, we rated all reports across seven risk of bias dimensions using the standard Cochrane 'Risk of bias' ratings criteria (see <a href="./appendices#CD012880-sec-0129">Appendix 2</a>; <a href="#CD012880-fig-0004">Figure 4</a>; <a href="#CD012880-fig-0005">Figure 5</a>). These criteria apply to risk of bias ratings for randomized as well as for observational, prospective, studies. In the latter case, random sequence generation and allocation concealment are automatically rated as 'high risk'; we awarded such ratings in this review (i.e. for the 5 included observational, prospective studies). In future updates of this review, if we include a larger number of observational, prospective studies, then it may also be prudent to conduct a separate 'Risk of bias' rating specifically designed for evaluating risks in such studies, for example ROBINS‐I (<a href="./references#CD012880-bbs2-0097" title="SterneJA , HernánMA , ReevesBC , SavovićJ , BerkmanND , ViswanathanM , et al. ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. BMJ2016;355:i4919. [DOI: 10.1136/bmj.i4919.]">Sterne 2016</a>). </p> <div class="figure" id="CD012880-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD012880-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012880-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study.Note: 27 primary studies" data-id="CD012880-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> <p>Note: 27 primary studies</p> </div> </div> </div> <section id="CD012880-sec-0051"> <h4 class="title">Allocation</h4> <p>For random sequence generation, we rated 11 of the 27 primary studies as potentially high risk for selection bias because they either used alternation as a non‐random component in the sequence generation process (6 studies) or were non‐randomized (5 studies). We rated half of the studies (13 studies) as low risk, and three studies as being at unclear risk of bias. For allocation concealment, we rated 13 studies as low risk and three as unclear risk. We rated 11 studies as high risk of selection bias because they were either non‐randomized (6 studies) or researchers who were enrolling participants could possibly foresee assignment to treatment interventions (5 studies). </p> </section> <section id="CD012880-sec-0052"> <h4 class="title">Blinding</h4> <p>For detection bias we rated 22 studies as being at unclear risk because insufficient information was provided to enable us to make a judgement of high or low risk, four studies as low risk, and one study as high risk because there was no blinding of outcome assessments. For the economic analyses (4 studies; 5 reports), we rated three studies as being at unclear risk of bias (<a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a>; <a href="./references#CD012880-bbs2-0020" title="MundtMP , ParthasarathyS , ChiFW , SterlingS , CampbellCI . 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002]">Mundt 2012</a>; <a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a>), and one study as low risk (<a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a>). </p> <p>We rated blinding of participants and personnel (performance bias) as high in six studies, low in five studies, and unclear in 15 studies. </p> </section> <section id="CD012880-sec-0053"> <h4 class="title">Incomplete outcome data</h4> <p>We rated attrition bias as unclear in approximately half of the studies (14 studies) and low in four studies. In nine studies, we rated attrition bias as high risk because the studies had moderate (≥ 20%) attrition rates (8 studies), or there was a significant difference in attrition rates in the intervention groups (1 study). </p> <p>Of the 27 included studies, 12 did not report how they handled missing data; 5 used intention‐to‐treat analyses (with worst case scenario); and the remaining 10 studies used a variety of procedures to impute or compensate for any missing data (see <a href="#CD012880-tbl-0009">Table 2</a>). </p> <div class="table" id="CD012880-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">How studies handled any missing data</span></div> <tbody> <tr> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Study</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Missing data</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0001" title="BlondellRD , LooneySW , NorthingtonAP , LaschME , RhodesSB , McDanielsRL . Using recovering alcoholics to help hospitalized patients with alcohol problems. Journal of Family Practice2001;50(5):1-15. ">Blondell 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0002" title="BlondellRD , FrydrychLM , JaanimaqiU , AshrafiounL , HomishGG , FoschioEM , et al. A randomized trial of two behavioral interventions to improve outcomes following inpatient detoxification for alcohol dependence. Journal of Addictive Diseases2011;30(2):136-48. [DOI: 10.1080/10550887.2011.554777]">Blondell 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0003" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12-step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403-11. [DOI: 10.1016/j.jsat.2013.12.009]">Bogenschutz 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Missing data were reconstructed by participant self‐report when participants returned for later follow‐up assessments. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0004" title="BowenS , WitkiewitzK , ClifasefiSL , GrowJ , ChawlaN , HsuSH , et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry2014;71(5):547-56. [DOI: 10.1001/jamapsychiatry.2013.4546]">Bowen 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intention‐to‐treat analyses conducted using sample size weighted orthogonal contrasts and parameters estimated using maximum likelihood estimation, which provides the estimated variance‐covariance matrix for the available data. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0005" title="BrooksAJ , PennPE . Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training. American Journal of Drug and Alcohol Abuse2003;29(2):359-83. [DOI: 10.1081/ADA-120020519]">Brooks 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hierarchical linear modeling used to analyze change over time in the whole sample and to test for treatment intervention differences on the outcome variables. Hierarchical linear modeling allows for the inclusion of cases with incomplete data, weighting cases with more complete data and reliable trajectories more heavily. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0006" title="BrownTG , SeraganianP , TremlayJ , AnnisH . Process and outcome changes with relapse prevention versus 12-step aftercare programs for substance abusers. Addiction2002;976(6):677-89. ">Brown 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0007" title="DavisWT , CampbellL , TaxJ , LieberCS . A trial of 'standard' outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment2002;23(1):9-19. [DOI: 10.1016/S0740-5472(02)00227-1]">Davis 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0008" title="GrantKM , YoungLB , TylerKA , SimpsonJL , PulidoRD , TimkoC . Intensive referral to mutual-help groups: a field trial of adaptations for rural veterans. Patient Education and Counseling2018;101(1):79-84. [DOI: 10.1016/j.pec.2017.07.012]">Grant 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0009" title="HermanSE , FrankKA , MowbrayCT , RibislKM , Davidson WS 2nd, Boots MillerB , et al. Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. Journal of Behavioral Health Services &amp; Research2000;27(3):286-302. [DOI: doi.org/10.1007/BF02291740]">Herman 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0057" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [10.1046/j.1360-0443.2000.9579993.x]">Holder 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Providers, hospitals and insurance companies were contacted to provide cost and utilization data for all patient contacts in order to collect data that may have otherwise been unreported by participants via self‐report. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intention‐to‐treat analyses were conducted with worst case scenarios attributed to participants who were lost to follow‐up. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0060" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-6.">Humphreys 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No missing data (healthcare utilization data extracted from Veterans Affair's centralized database) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0062" title="HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]">Humphreys 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No missing data (Veterans Affairs healthcare data available for all participants)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0011" title="KahlerCW , ReadJP , RamseySE , StuartGL , McCradyBS , BrownRA . Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology2004;72(4):736-41. [DOI: 10.1037/0022-006X.72.4.736]">Kahler 2004</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only participants who provided outcome data for at least two‐thirds of follow‐up (i.e. 4 months) were included in the analyses. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0012" title="KaskutasLA , SubbaramanMS , WitbrodtJ , ZemoreSE . Effectiveness of making alcoholics anonymous easier: a group format 12-step facilitation approach. Journal of Substance Abuse Treatment2009;37(3):228-39. [DOI: 10.1016/j.jsat.2009.01.004]">Kaskutas 2009b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intention‐to‐treat analyses were conducted with worst case scenarios attributed to participants who were lost to follow‐up. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0013" title="KellyJF , KaminerY , KahlerCW , HoeppnerB , YeterianJ , CristelloJV , et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction2017;112(12):2155-66. [DOI: 10.1111/add.13920]">Kelly 2017b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intention‐to‐treat analyses were conducted with worst case scenarios attributed to participants who were lost to follow‐up. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intention‐to‐treat analyses were conducted with worst case scenarios attributed to participants who were lost to follow‐up. Participants who had missing data were excluded from the analyses. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0015" title="LittMD , KaddenRM , TennenH , Kabela-CormierE . Network Support II: randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug and Alcohol Dependence2016;165:203-12. [DOI: 10.1016/j.drugalcdep.2016.06.010]">Litt 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Generalized estimating equations were used to maximize use of all available data.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0016" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453-65. [DOI: 10.1037/a0019943]">Lydecker 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>To compensate for missing observations and variation in covariate values, comparisons of outcome summary data were made with adjusted means. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0017" title="ManningV , BestD , FaulknerN , TitheringtonE , MorinanA , KeaneyF , et al. Does active referral by a doctor or 12-step peer improve 12-step meeting attendance? Results from a pilot randomised control trial. Drug and Alcohol Dependence2012;126(1-2):131-7. [DOI: 10.1016/j.drugalcdep.2012.05.004]">Manning 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participants who missed a follow‐up assessment were asked at the next assessment period to provide data regarding their alcohol consumption for the previous period. Participants for whom more than 4 of the 12 months of drinking outcome data were missing were excluded from latent growth analyses. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0019" title="McCradyBS , EpsteinEE , HirschLS . Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]McCradyBS , EpsteinEE , HirschLS . Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x]McCradyBS , EpsteinEE , KahlerCW . Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870]">McCrady 1996</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0020" title="MundtMP , ParthasarathyS , ChiFW , SterlingS , CampbellCI . 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002]">Mundt 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data was analyzed for the 403 participants who completed at least 1 follow‐up interview.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0022" title="TimkoC , DeBenedettiA . A randomized controlled trial of intensive referral to 12-step self-help groups: One-year outcomes. Drug and Alcohol Dependence2007;90(2-3):270-9. TimkoC , DebenedettiA , BillowR . Intensive referral to 12-step self-help groups and 6-month substance use disorder outcomes. Addiction2006;101(5):678-88. [DOI: 10.1111/j.1360-0443.2006.01391.x]">Timko 2006</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0023" title="TimkoC , SutkowiA , CronkiteRC , Makin-ByrdK , MoosRH . Intensive referral to 12-step dual-focused mutual-help groups. Drug and Alcohol Dependence2011;118(2-3):194-201. [DOI: 10.1016/j.drugalcdep.2011.03.019]">Timko 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0024" title="VederhusJK , TimkoC , KristensenO , HjemdahlB , ClausenT . Motivational intervention to enhance post‐detoxification 12‐step group affiliation: a randomized controlled trial. Addiction2014;109(5):766-73. [DOI: 10.1111/add.12471]">Vederhus 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Missing data imputed using the expectation maximization algorithm in Statistical Package for the Social Sciences and cases were only included if participants had completed at least one post‐treatment Timeline Followback. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0026" title="WalitzerKS , DeffenbacherJL , ShyhallaK . Alcohol-adapted anger management treatment: a randomized controlled trial of an innovative therapy for alcohol dependence. Journal of Substance Abuse Treatment2015;59:83-93. [DOI: 10.1016/j.jsat.2015.08.003]">Walitzer 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mixed effects models were used to accommodate for missing data with maximum likelihood estimation. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0027" title="ZemoreSE , LuiC , MericleA , HembergJ , KaskutasLA . A longitudinal study of the comparative efficacy of Women for Sobriety, LifeRing, SMART Recovery, and 12-step groups for those with AUD. Journal of Substance Abuse Treatment2018;88:18-26. [DOI: 10.1016/j.jsat.2018.02.004]">Zemore 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preliminary and main analyses were conducted using cases with outcome data at 6 and/or 12 months and data on all model covariates. </p> </td> </tr> </tbody> </table> </div> </section> <section id="CD012880-sec-0054"> <h4 class="title">Selective reporting</h4> <p>There was no evidence of selective reporting bias of outcomes in any of the reviewed studies; thus, we rated all 27 studies as low risk for reporting bias. </p> </section> <section id="CD012880-sec-0055"> <h4 class="title">Other potential sources of bias</h4> <p>There is a possibility of inadvertent contamination of 12‐step effects because comparison interventions, while not explicitly facilitating AA participation, cannot realistically prevent participants from attending AA, and it is almost inevitable that some participants will elect to attend AA while in a comparison group (e.g. participants assigned to a CBT comparison may choose to go to AA of their own accord). Because AA participation predicts improved outcomes (<a href="./references#CD012880-bbs2-0063" title="HumphreysK , BlodgettJC , WagnerTH . Estimating the efficacy of Alcoholics Anonymous without self-selection bias: an instrumental variables re-analysis of randomized clinical trials. Alcoholism, Clinical and Experimental Research2014;38(11):2688-94. [DOI: 10.1111/acer.12557]">Humphreys 2014</a>), this may diminish any potential between‐intervention effects. Between‐intervention estimates in this review are thus conservative estimates of the effectiveness of AA/TSF. </p> </section> </section> <section id="CD012880-sec-0056"> <h3 class="title" id="CD012880-sec-0056">Effects of interventions</h3> <p>See: <a href="./full#CD012880-tbl-0001"><b>Summary of findings 1</b> Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol use disorder (1A)</a>; <a href="./full#CD012880-tbl-0002"><b>Summary of findings 2</b> Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to other clinical interventions for alcohol use disorder (1B)</a>; <a href="./full#CD012880-tbl-0003"><b>Summary of findings 3</b> Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to a different type of TSF for alcohol use disorder (2A)</a>; <a href="./full#CD012880-tbl-0004"><b>Summary of findings 4</b> Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to a different type of TSF for alcohol use disorder (2B)</a>; <a href="./full#CD012880-tbl-0005"><b>Summary of findings 5</b> Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol use disorder: non‐randomized studies (3B)</a>; <a href="./full#CD012880-tbl-0006"><b>Summary of findings 6</b> Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to a different type of TSF for alcohol use disorder: non‐randomized studies (4B)</a>; <a href="./full#CD012880-tbl-0007"><b>Summary of findings 7</b> Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) compared to other clinical interventions and a different type of TSF for alcohol use disorder: cost‐effectiveness studies (5)</a> </p> <section id="CD012880-sec-0057"> <h4 class="title">1a Studies that employed a RCT/quasi‐RCT design with all treatments manualized and compared AA/TSF to a treatment with a different theoretical orientation (e.g. CBT) </h4> <p>We included 11 studies reported in 16 articles in this study grouping (<a href="./references#CD012880-bbs2-0005" title="BrooksAJ , PennPE . Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training. American Journal of Drug and Alcohol Abuse2003;29(2):359-83. [DOI: 10.1081/ADA-120020519]">Brooks 2003</a>; <a href="./references#CD012880-bbs2-0006" title="BrownTG , SeraganianP , TremlayJ , AnnisH . Process and outcome changes with relapse prevention versus 12-step aftercare programs for substance abusers. Addiction2002;976(6):677-89. ">Brown 2002</a>; <a href="./references#CD012880-bbs2-0007" title="DavisWT , CampbellL , TaxJ , LieberCS . A trial of 'standard' outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment2002;23(1):9-19. [DOI: 10.1016/S0740-5472(02)00227-1]">Davis 2002</a>; <a href="./references#CD012880-bbs2-0013" title="KellyJF , KaminerY , KahlerCW , HoeppnerB , YeterianJ , CristelloJV , et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction2017;112(12):2155-66. [DOI: 10.1111/add.13920]">Kelly 2017b</a>; <a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a>; <a href="./references#CD012880-bbs2-0015" title="LittMD , KaddenRM , TennenH , Kabela-CormierE . Network Support II: randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug and Alcohol Dependence2016;165:203-12. [DOI: 10.1016/j.drugalcdep.2016.06.010]">Litt 2016</a>; <a href="./references#CD012880-bbs2-0016" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453-65. [DOI: 10.1037/a0019943]">Lydecker 2010</a>; <a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a>; <a href="./references#CD012880-bbs2-0019" title="McCradyBS , EpsteinEE , HirschLS . Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]McCradyBS , EpsteinEE , HirschLS . Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x]McCradyBS , EpsteinEE , KahlerCW . Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870]">McCrady 1996</a>; <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a>; <a href="./references#CD012880-bbs2-0026" title="WalitzerKS , DeffenbacherJL , ShyhallaK . Alcohol-adapted anger management treatment: a randomized controlled trial of an innovative therapy for alcohol dependence. Journal of Substance Abuse Treatment2015;59:83-93. [DOI: 10.1016/j.jsat.2015.08.003]">Walitzer 2015</a>). See <a href="./full#CD012880-tbl-0001">summary of findings Table 1</a> for a summary of the results for our main outcomes and certainty of evidence for each result. </p> <section id="CD012880-sec-0058"> <h5 class="title">Abstinence</h5> <section id="CD012880-sec-0059"> <h6 class="title">Proportion of participants completely abstinent (continuous abstinence)</h6> <p>Six studies with 2367 participants contributed data to this outcome (<a href="./references#CD012880-bbs2-0007" title="DavisWT , CampbellL , TaxJ , LieberCS . A trial of 'standard' outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment2002;23(1):9-19. [DOI: 10.1016/S0740-5472(02)00227-1]">Davis 2002</a>; <a href="./references#CD012880-bbs2-0013" title="KellyJF , KaminerY , KahlerCW , HoeppnerB , YeterianJ , CristelloJV , et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction2017;112(12):2155-66. [DOI: 10.1111/add.13920]">Kelly 2017b</a>; <a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a>; <a href="./references#CD012880-bbs2-0015" title="LittMD , KaddenRM , TennenH , Kabela-CormierE . Network Support II: randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug and Alcohol Dependence2016;165:203-12. [DOI: 10.1016/j.drugalcdep.2016.06.010]">Litt 2016</a>; <a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a>; <a href="./references#CD012880-bbs2-0019" title="McCradyBS , EpsteinEE , HirschLS . Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]McCradyBS , EpsteinEE , HirschLS . Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x]McCradyBS , EpsteinEE , KahlerCW . Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870]">McCrady 1996</a>). </p> <p>There was no evidence of a difference for AA/TSF at the end of treatment on this outcome (risk ratio (RR) 1.07, 95% confidence interval (CI) 0.92 to 1.25; P = 0.37; 1 study, 1726 participants), but there were advantages for AA/TSF at all of the other follow‐up time points (<a href="./references#CD012880-fig-0006" title="">Analysis 1.1</a>): </p> <p> <ul id="CD012880-list-0026"> <li> <p>6 months: RR 1.66, 95% CI 1.09 to 2.54; P = 0.02; 3 studies, 238 participants;</p> </li> <li> <p>12 months: RR 1.21, 95% CI 1.03 to 1.42; P = 0.02; 2 studies, 1936 participants;</p> </li> <li> <p>24 months: RR 1.37, 95% CI 1.04 to 1.82; P = 0.03; 2 studies, 403 participants;</p> </li> <li> <p>36 months: RR 1.42, 95% CI 1.17 to 1.73; P = 0.00; 1 study, 952 participants.</p> </li> </ul> </p> <p>Formal tests of between‐study heterogeneity indicated low probability of potential heterogeneity ranging from Tau<sup>2</sup>= 0.00, P = 0.98; I<sup>2</sup> = 0% at the six‐month follow‐up to Tau<sup>2</sup>= 0.01, P = 0.16; I<sup>2</sup> = 37% at the 12‐month follow‐up, suggesting consistency across reported findings. </p> <p>The GRADE certainty rating for this evidence was high.</p> </section> <section id="CD012880-sec-0060"> <h6 class="title">Percentage days abstinent</h6> <p>Nine studies, with 2818 participants, assessed this outcome (<a href="./references#CD012880-bbs2-0007" title="DavisWT , CampbellL , TaxJ , LieberCS . A trial of 'standard' outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment2002;23(1):9-19. [DOI: 10.1016/S0740-5472(02)00227-1]">Davis 2002</a>; <a href="./references#CD012880-bbs2-0013" title="KellyJF , KaminerY , KahlerCW , HoeppnerB , YeterianJ , CristelloJV , et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction2017;112(12):2155-66. [DOI: 10.1111/add.13920]">Kelly 2017b</a>; <a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a>; <a href="./references#CD012880-bbs2-0015" title="LittMD , KaddenRM , TennenH , Kabela-CormierE . Network Support II: randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug and Alcohol Dependence2016;165:203-12. [DOI: 10.1016/j.drugalcdep.2016.06.010]">Litt 2016</a>; <a href="./references#CD012880-bbs2-0016" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453-65. [DOI: 10.1037/a0019943]">Lydecker 2010</a>; <a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a>; <a href="./references#CD012880-bbs2-0019" title="McCradyBS , EpsteinEE , HirschLS . Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]McCradyBS , EpsteinEE , HirschLS . Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x]McCradyBS , EpsteinEE , KahlerCW . Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870]">McCrady 1996</a>; <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a>; <a href="./references#CD012880-bbs2-0026" title="WalitzerKS , DeffenbacherJL , ShyhallaK . Alcohol-adapted anger management treatment: a randomized controlled trial of an innovative therapy for alcohol dependence. Journal of Substance Abuse Treatment2015;59:83-93. [DOI: 10.1016/j.jsat.2015.08.003]">Walitzer 2015</a>), but we were only able to meta‐analyze data from eight of them. </p> <p>AA/TSF showed a small to moderate advantage for this outcome, but only at the 24‐month (mean difference (MD) 12.91, 95% CI 7.55 to 18.27; P &lt; 0.001; 2 studies, 302 participants); and 36‐month (MD 6.64, 95% CI 1.54 to 11.75; P = 0.01; 1 study, 806 participants) time points (<a href="./references#CD012880-fig-0007" title="">Analysis 1.2</a>). There was no evidence of a difference between AA/TSF and comparison interventions at the remaining time points: </p> <p> <ul id="CD012880-list-0027"> <li> <p>end of treatment: MD 1.91, 95% CI ‐1.42 to 5.24; P = 0.26; 1 study, 1586 participants;</p> </li> <li> <p>6 months: MD ‐1.21, 95% CI ‐10.82 to 8.41; P = 0.54; 3 studies, 191 participants;</p> </li> <li> <p>12 months MD 3.03, 95% CI ‐4.36 to 10.43; P = 0.42; 4 studies, 1999 participants;</p> </li> <li> <p>18 months MD ‐8.89, 95% CI ‐30.65 to 12.87; P = 0.38; 1 study; 58 participants.</p> </li> </ul> </p> <p>Formal tests of between‐study heterogeneity across points found high heterogeneity at the 12‐month follow‐up (Tau<sup>2</sup>= 100.00, P &lt; 0.001P &lt; 0.00001; I<sup>2</sup> = 91%), but otherwise heterogeneity was very low: </p> <p> <ul id="CD012880-list-0028"> <li> <p>6 months (Tau<sup>2</sup> = 0.00, P = 0.54; I<sup>2</sup> = 0%); </p> </li> <li> <p>18 months (Tau<sup>2</sup> = 0.00, P = 0.86; I<sup>2</sup> = 0%); </p> </li> <li> <p>24 months (Tau<sup>2</sup> = 0.00, P = 0.38; I<sup>2</sup> = 0%); </p> </li> <li> <p>36 months (Tau<sup>2</sup> = 0.00, P = 0.56; I<sup>2</sup> = 0%). </p> </li> </ul> </p> <p>We excluded one study (<a href="./references#CD012880-bbs2-0007" title="DavisWT , CampbellL , TaxJ , LieberCS . A trial of 'standard' outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment2002;23(1):9-19. [DOI: 10.1016/S0740-5472(02)00227-1]">Davis 2002</a>), and another study report examining end of treatment outcome (<a href="./references#CD012880-bbs2-0019" title="McCradyBS , EpsteinEE , HirschLS . Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]McCradyBS , EpsteinEE , HirschLS . Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x]McCradyBS , EpsteinEE , KahlerCW . Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870]">McCrady 1996</a>), from the meta‐analysis because they reported the proportion of days of alcohol use and we were unable to calculate the standard deviation. However, we were able to include the two follow‐up reports at six and 18 months for <a href="./references#CD012880-bbs2-0019" title="McCradyBS , EpsteinEE , HirschLS . Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]McCradyBS , EpsteinEE , HirschLS . Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x]McCradyBS , EpsteinEE , KahlerCW . Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870]">McCrady 1996</a> (<a href="./references#CD012880-fig-0007" title="">Analysis 1.2</a>). </p> <p>Also, because <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a> compared two types of AA/TSF interventions (the 12‐step more intensive and prescriptive directive approach to facilitating AA (DIR) and the 12‐step less intensive, client‐centered, motivational enhancement approach to facilitating AA (MOT)) to standard cognitive behavioral therapy (the study authors referred to this as 'treatment as usual' (TAU), but it was a manualized CBT intervention), we included the comparison between DIR and TAU in this section (because this comparison is comparing an AA/TSF intervention with a different theoretical orientation, i.e. CBT) and in section 2a below, we compare DIR to MOT. </p> <p>The GRADE certainty rating for this evidence was very low; we downgraded due to study limitations, inconsistency and imprecision. </p> </section> <section id="CD012880-sec-0061"> <h6 class="title">Longest period of abstinence</h6> <p>Two studies with a total of 136 participants provided data for this outcome (<a href="./references#CD012880-bbs2-0007" title="DavisWT , CampbellL , TaxJ , LieberCS . A trial of 'standard' outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment2002;23(1):9-19. [DOI: 10.1016/S0740-5472(02)00227-1]">Davis 2002</a>; <a href="./references#CD012880-bbs2-0013" title="KellyJF , KaminerY , KahlerCW , HoeppnerB , YeterianJ , CristelloJV , et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction2017;112(12):2155-66. [DOI: 10.1111/add.13920]">Kelly 2017b</a>). There was no clear difference between AA/TSF and comparison interventions at 6‐month follow‐up (MD 0.60, 95% CI ‐0.30 to 1.50; P = 0.19; 2 studies, 136 participants; very low certainty evidence; <a href="./references#CD012880-fig-0008" title="">Analysis 1.3</a>). Measurements of heterogeneity were moderate to substantial: Tau<sup>2</sup>= 0.28, P = 0.12; I<sup>2</sup> = 60%. </p> <p>The GRADE certainty rating for this evidence was low; we downgraded due to study limitations, and imprecision. </p> </section> </section> <section id="CD012880-sec-0062"> <h5 class="title">Drinking intensity</h5> <section id="CD012880-sec-0063"> <h6 class="title">Drinks per drinking day (DDD)</h6> <p>Five studies, with 2295 participants, assessed this outcome (<a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a>; <a href="./references#CD012880-bbs2-0015" title="LittMD , KaddenRM , TennenH , Kabela-CormierE . Network Support II: randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug and Alcohol Dependence2016;165:203-12. [DOI: 10.1016/j.drugalcdep.2016.06.010]">Litt 2016</a>; <a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a>; <a href="./references#CD012880-bbs2-0019" title="McCradyBS , EpsteinEE , HirschLS . Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]McCradyBS , EpsteinEE , HirschLS . Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x]McCradyBS , EpsteinEE , KahlerCW . Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870]">McCrady 1996</a>; <a href="./references#CD012880-bbs2-0026" title="WalitzerKS , DeffenbacherJL , ShyhallaK . Alcohol-adapted anger management treatment: a randomized controlled trial of an innovative therapy for alcohol dependence. Journal of Substance Abuse Treatment2015;59:83-93. [DOI: 10.1016/j.jsat.2015.08.003]">Walitzer 2015</a>). </p> <p>AA/TSF showed a small advantage on this outcome at the 36‐month follow‐up only (MD ‐1.02, 95% CI ‐1.83 to ‐0.21; 1 study, 806 participants; P = 0.01; <a href="./references#CD012880-fig-0009" title="">Analysis 1.4</a>). Formal tests of between‐study heterogeneity for each time point found no evidence of heterogeneity between study groups, and ranged from very low (at the end of treatment, 24‐month, and 36‐month follow‐ups) to moderate at the 12‐month follow‐up (Tau<sup>2</sup> = 0.29, P = 0.22, I<sup>2</sup> = 32%). </p> <p>The GRADE certainty rating for this evidence was moderate; we downgraded due to study imprecision. </p> </section> <section id="CD012880-sec-0064"> <h6 class="title">Percentage days heavy drinking (PDHD)</h6> <p>Three studies, with 452 participants, assessed this outcome: (<a href="./references#CD012880-bbs2-0015" title="LittMD , KaddenRM , TennenH , Kabela-CormierE . Network Support II: randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug and Alcohol Dependence2016;165:203-12. [DOI: 10.1016/j.drugalcdep.2016.06.010]">Litt 2016</a>; <a href="./references#CD012880-bbs2-0019" title="McCradyBS , EpsteinEE , HirschLS . Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]McCradyBS , EpsteinEE , HirschLS . Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x]McCradyBS , EpsteinEE , KahlerCW . Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870]">McCrady 1996</a>; <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a>). We found no difference between treatment interventions at any time point (<a href="./references#CD012880-fig-0010" title="">Analysis 1.5</a>). Formal tests of between‐study heterogeneity were only conducted at the 6‐month follow‐up time point (Tau<sup>2</sup>= 0.00, P = 0.79, I<sup>2</sup> = 0%). The other time points only had one study each that contributed data, and so we did not conduct any formal tests for heterogeneity. </p> <p>The GRADE certainty rating for the evidence at 12 month follow‐up was low; we downgraded two levels due to imprecision and wide confidence interval. </p> </section> </section> <section id="CD012880-sec-0065"> <h5 class="title">Alcohol‐related consequences</h5> <p>In terms of alcohol‐related consequences, six studies with 2433 participants (<a href="./references#CD012880-bbs2-0013" title="KellyJF , KaminerY , KahlerCW , HoeppnerB , YeterianJ , CristelloJV , et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction2017;112(12):2155-66. [DOI: 10.1111/add.13920]">Kelly 2017b</a>; <a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a>; <a href="./references#CD012880-bbs2-0015" title="LittMD , KaddenRM , TennenH , Kabela-CormierE . Network Support II: randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug and Alcohol Dependence2016;165:203-12. [DOI: 10.1016/j.drugalcdep.2016.06.010]">Litt 2016</a>; <a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a>; <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a>; <a href="./references#CD012880-bbs2-0026" title="WalitzerKS , DeffenbacherJL , ShyhallaK . Alcohol-adapted anger management treatment: a randomized controlled trial of an innovative therapy for alcohol dependence. Journal of Substance Abuse Treatment2015;59:83-93. [DOI: 10.1016/j.jsat.2015.08.003]">Walitzer 2015</a>), and two additional reports (<a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a>; <a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a>), reported this outcome. Six of these studies used the same standardized metric, the Drinker Inventory of Consequences (DRINC), and thus, could be compared using meta‐analysis. There were no differences on this measure at any point (<a href="./references#CD012880-fig-0011" title="">Analysis 1.6</a>). Formal tests of between‐study heterogeneity for each time point found no evidence of heterogeneity between study groups. </p> <p><a href="./references#CD012880-bbs2-0026" title="WalitzerKS , DeffenbacherJL , ShyhallaK . Alcohol-adapted anger management treatment: a randomized controlled trial of an innovative therapy for alcohol dependence. Journal of Substance Abuse Treatment2015;59:83-93. [DOI: 10.1016/j.jsat.2015.08.003]">Walitzer 2015</a> used the Short Inventory of Problems (SIP), and found no evidence of a difference between the AA/TSF and the anger management comparison intervention at the six‐month follow‐up (MD 0.71, 95% CI ‐4.51 to 5.93; P = 0.79; 1 study, 76 participants; <a href="./references#CD012880-fig-0012" title="">Analysis 1.7</a>). <a href="./references#CD012880-bbs2-0013" title="KellyJF , KaminerY , KahlerCW , HoeppnerB , YeterianJ , CristelloJV , et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction2017;112(12):2155-66. [DOI: 10.1111/add.13920]">Kelly 2017b</a> used the SIP Second Edition, Revised (SIP‐2R)), and found a benefit in favor of AA/TSF compared to MET/CBT at the six‐month follow‐up (MD ‐0.10, 95% CI ‐0.43 to 0.23; 1 study, 59 participants; P = 0.01; <a href="./references#CD012880-fig-0013" title="">Analysis 1.8</a>). </p> <p>The GRADE certainty rating for this evidence was moderate; we downgraded due to study imprecision. </p> </section> <section id="CD012880-sec-0066"> <h5 class="title">Alcohol addiction severity</h5> <p>Two studies with 448 participants reported this outcome (<a href="./references#CD012880-bbs2-0005" title="BrooksAJ , PennPE . Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training. American Journal of Drug and Alcohol Abuse2003;29(2):359-83. [DOI: 10.1081/ADA-120020519]">Brooks 2003</a>; <a href="./references#CD012880-bbs2-0006" title="BrownTG , SeraganianP , TremlayJ , AnnisH . Process and outcome changes with relapse prevention versus 12-step aftercare programs for substance abusers. Addiction2002;976(6):677-89. ">Brown 2002</a>). <a href="./references#CD012880-bbs2-0006" title="BrownTG , SeraganianP , TremlayJ , AnnisH . Process and outcome changes with relapse prevention versus 12-step aftercare programs for substance abusers. Addiction2002;976(6):677-89. ">Brown 2002</a> found a difference on the Alcohol Severity Index (ASI) alcohol composite score between the AA/TSF and comparison interventions that favored AA/TSF (MD ‐0.05, 95% CI ‐0.09 to ‐0.01; P = 0.02; 1 study, 336 participants; <a href="./references#CD012880-fig-0014" title="">Analysis 1.9</a>). <a href="./references#CD012880-bbs2-0005" title="BrooksAJ , PennPE . Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training. American Journal of Drug and Alcohol Abuse2003;29(2):359-83. [DOI: 10.1081/ADA-120020519]">Brooks 2003</a> found an advantage for AA/TSF over the Self‐Management and Recovery Training (SMART) intervention in the slope for improvement over a 12‐month follow‐up period (<a href="./references#CD012880-fig-0015" title="">Analysis 1.10</a>), as measured by the ASI alcohol composite score (P &lt; 0.05). </p> <p>The GRADE certainty rating for this evidence was low; we downgraded due to study limitations and because a narrative synthesis was conducted and therefore estimates are not precise. </p> </section> <section id="CD012880-sec-0067"> <h5 class="title">Indices reflecting quality of life or psychological well‐being, or both</h5> <p>None of the studies in this category reported this outcome.</p> </section> </section> <section id="CD012880-sec-0068"> <h4 class="title">1b Studies that employed a RCT/quasi‐RCT design where at least one comparison treatment was non‐manualized and AA/TSF was compared to a treatment with a different theoretical orientation (e.g. CBT) </h4> <p>We included four studies in this category (<a href="./references#CD012880-bbs2-0002" title="BlondellRD , FrydrychLM , JaanimaqiU , AshrafiounL , HomishGG , FoschioEM , et al. A randomized trial of two behavioral interventions to improve outcomes following inpatient detoxification for alcohol dependence. Journal of Addictive Diseases2011;30(2):136-48. [DOI: 10.1080/10550887.2011.554777]">Blondell 2011</a>; <a href="./references#CD012880-bbs2-0003" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12-step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403-11. [DOI: 10.1016/j.jsat.2013.12.009]">Bogenschutz 2014</a>; <a href="./references#CD012880-bbs2-0004" title="BowenS , WitkiewitzK , ClifasefiSL , GrowJ , ChawlaN , HsuSH , et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry2014;71(5):547-56. [DOI: 10.1001/jamapsychiatry.2013.4546]">Bowen 2014</a>; <a href="./references#CD012880-bbs2-0009" title="HermanSE , FrankKA , MowbrayCT , RibislKM , Davidson WS 2nd, Boots MillerB , et al. Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. Journal of Behavioral Health Services &amp; Research2000;27(3):286-302. [DOI: doi.org/10.1007/BF02291740]">Herman 2000</a>). See <a href="./full#CD012880-tbl-0002">summary of findings Table 2</a> for a summary of the results for our main outcomes and certainty of evidence for each result. </p> <section id="CD012880-sec-0069"> <h5 class="title">Abstinence</h5> <section id="CD012880-sec-0070"> <h6 class="title">Proportion of participants completely abstinent</h6> <p>Two studies with 271 participants reported this outcome (<a href="./references#CD012880-bbs2-0002" title="BlondellRD , FrydrychLM , JaanimaqiU , AshrafiounL , HomishGG , FoschioEM , et al. A randomized trial of two behavioral interventions to improve outcomes following inpatient detoxification for alcohol dependence. Journal of Addictive Diseases2011;30(2):136-48. [DOI: 10.1080/10550887.2011.554777]">Blondell 2011</a>; <a href="./references#CD012880-bbs2-0003" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12-step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403-11. [DOI: 10.1016/j.jsat.2013.12.009]">Bogenschutz 2014</a>). <a href="./references#CD012880-bbs2-0002" title="BlondellRD , FrydrychLM , JaanimaqiU , AshrafiounL , HomishGG , FoschioEM , et al. A randomized trial of two behavioral interventions to improve outcomes following inpatient detoxification for alcohol dependence. Journal of Addictive Diseases2011;30(2):136-48. [DOI: 10.1080/10550887.2011.554777]">Blondell 2011</a> found no difference between AA/TSF and the comparison intervention at the three‐month follow‐up (RR 1.18, 95% CI 0.80 to 1.73; P = 0.41; 1 study, 126 participants; <a href="./references#CD012880-fig-0016" title="">Analysis 2.1</a>). Similarly, at the nine‐month follow‐up, <a href="./references#CD012880-bbs2-0003" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12-step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403-11. [DOI: 10.1016/j.jsat.2013.12.009]">Bogenschutz 2014</a> observed no difference between interventions (RR 1.71, 95% CI 0.70 to 4.18; P = 0.24; 1 study, 93 participants). </p> <p>The GRADE certainty rating for this evidence was low; we downgraded two levels due to small sample size. </p> </section> <section id="CD012880-sec-0071"> <h6 class="title">Percentage days abstinent (PDA)</h6> <p>Three studies reported this outcome (<a href="./references#CD012880-bbs2-0002" title="BlondellRD , FrydrychLM , JaanimaqiU , AshrafiounL , HomishGG , FoschioEM , et al. A randomized trial of two behavioral interventions to improve outcomes following inpatient detoxification for alcohol dependence. Journal of Addictive Diseases2011;30(2):136-48. [DOI: 10.1080/10550887.2011.554777]">Blondell 2011</a>; <a href="./references#CD012880-bbs2-0003" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12-step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403-11. [DOI: 10.1016/j.jsat.2013.12.009]">Bogenschutz 2014</a>; <a href="./references#CD012880-bbs2-0009" title="HermanSE , FrankKA , MowbrayCT , RibislKM , Davidson WS 2nd, Boots MillerB , et al. Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. Journal of Behavioral Health Services &amp; Research2000;27(3):286-302. [DOI: doi.org/10.1007/BF02291740]">Herman 2000</a>), with two observing no difference between the AA/TSF and comparison interventions. <a href="./references#CD012880-bbs2-0002" title="BlondellRD , FrydrychLM , JaanimaqiU , AshrafiounL , HomishGG , FoschioEM , et al. A randomized trial of two behavioral interventions to improve outcomes following inpatient detoxification for alcohol dependence. Journal of Addictive Diseases2011;30(2):136-48. [DOI: 10.1080/10550887.2011.554777]">Blondell 2011</a> found no difference between AA/TSF and the comparison at the three‐month follow‐up (MD ‐3.94, 95% CI ‐14.73 to 6.85; P = 0.47; 1 study, 125 participants; <a href="./references#CD012880-fig-0017" title="">Analysis 2.2</a>). At the nine‐month follow‐up, untransformed data from <a href="./references#CD012880-bbs2-0003" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12-step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403-11. [DOI: 10.1016/j.jsat.2013.12.009]">Bogenschutz 2014</a> showed a higher PDA for AA/TSF than the comparison (MD 3.00, 95% CI 0.31 to 5.69; P = 0.03; 1 study, 93 participants). </p> <p>Using a log‐transformed days of drinking variable, <a href="./references#CD012880-bbs2-0009" title="HermanSE , FrankKA , MowbrayCT , RibislKM , Davidson WS 2nd, Boots MillerB , et al. Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. Journal of Behavioral Health Services &amp; Research2000;27(3):286-302. [DOI: doi.org/10.1007/BF02291740]">Herman 2000</a> found a slight advantage at two‐months post‐treatment (P = 0.03) that favored AA/TSF relative to the comparison (<a href="./references#CD012880-fig-0018" title="">Analysis 2.3</a>), but between two and 18 months post‐treatment, there was no evidence of a difference between the two groups (P = 0.05). The treatment by time interaction was not reported. </p> <p>The GRADE certainty rating for this evidence was low; we downgraded two levels due to small sample size. </p> </section> <section id="CD012880-sec-0072"> <h6 class="title">Longest period of abstinence</h6> <p>None of the studies in this category reported this outcome.</p> </section> </section> <section id="CD012880-sec-0073"> <h5 class="title">Drinking intensity</h5> <p><a href="./references#CD012880-bbs2-0003" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12-step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403-11. [DOI: 10.1016/j.jsat.2013.12.009]">Bogenschutz 2014</a>, using the untransformed measure of drinks per drinking day (DDD), found an advantage for AA/TSF compared to the comparison at the nine‐month follow‐up (MD ‐1.76, 95% CI ‐2.23 to ‐1.29; P &lt; 0.001;1 study, 93 participants; <a href="./references#CD012880-fig-0019" title="">Analysis 2.4</a>). </p> <p>The GRADE certainty rating for this evidence was very low; we downgraded due to study limitations (risk of attrition bias); imprecision (moderate sample size); and indirectness (the focus was on dual diagnosis participants with severe mental illness, which may not be the population of interest most often associated with AA/TSF). </p> <p><a href="./references#CD012880-bbs2-0004" title="BowenS , WitkiewitzK , ClifasefiSL , GrowJ , ChawlaN , HsuSH , et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry2014;71(5):547-56. [DOI: 10.1001/jamapsychiatry.2013.4546]">Bowen 2014</a> reported heavy drinking days in the past 90 days, and found no difference between treatments (MD 2.09, 95% CI ‐1.24 to 5.42; P = 0.22; 1 study, 286 participants; <a href="./references#CD012880-fig-0020" title="">Analysis 2.5</a>). </p> <p>The GRADE certainty rating for this evidence was low; we downgraded due to imprecision (moderate sample size) and due to study limitations (having no reported information to assess four different types of bias). </p> </section> <section id="CD012880-sec-0074"> <h5 class="title">Alcohol‐related consequences</h5> <p>None of the studies in this category reported this outcome.</p> </section> <section id="CD012880-sec-0075"> <h5 class="title">Alcohol addiction severity</h5> <p>None of the studies in this category reported this outcome.</p> </section> <section id="CD012880-sec-0076"> <h5 class="title">Indices reflecting quality of life or psychological well‐being, or both</h5> <p>None of the studies in this category reported this outcome.</p> </section> </section> <section id="CD012880-sec-0077"> <h4 class="title">2a Studies that employed a RCT/quasi‐RCT design with all treatments manualized and AA/TSF was compared to a different type of TSF (i.e. varying in TSF style or intensity) </h4> <p>We included five studies reported in six papers in this category (<a href="./references#CD012880-bbs2-0011" title="KahlerCW , ReadJP , RamseySE , StuartGL , McCradyBS , BrownRA . Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology2004;72(4):736-41. [DOI: 10.1037/0022-006X.72.4.736]">Kahler 2004</a>; <a href="./references#CD012880-bbs2-0022" title="TimkoC , DeBenedettiA . A randomized controlled trial of intensive referral to 12-step self-help groups: One-year outcomes. Drug and Alcohol Dependence2007;90(2-3):270-9. TimkoC , DebenedettiA , BillowR . Intensive referral to 12-step self-help groups and 6-month substance use disorder outcomes. Addiction2006;101(5):678-88. [DOI: 10.1111/j.1360-0443.2006.01391.x]">Timko 2006</a>; <a href="./references#CD012880-bbs2-0023" title="TimkoC , SutkowiA , CronkiteRC , Makin-ByrdK , MoosRH . Intensive referral to 12-step dual-focused mutual-help groups. Drug and Alcohol Dependence2011;118(2-3):194-201. [DOI: 10.1016/j.drugalcdep.2011.03.019]">Timko 2011</a>; <a href="./references#CD012880-bbs2-0024" title="VederhusJK , TimkoC , KristensenO , HjemdahlB , ClausenT . Motivational intervention to enhance post‐detoxification 12‐step group affiliation: a randomized controlled trial. Addiction2014;109(5):766-73. [DOI: 10.1111/add.12471]">Vederhus 2014</a>; <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a>). See <a href="./full#CD012880-tbl-0003">summary of findings Table 3</a> for a summary of the results for our main outcomes and certainty of evidence for each result. </p> <section id="CD012880-sec-0078"> <h5 class="title">Abstinence</h5> <section id="CD012880-sec-0079"> <h6 class="title">Proportion of participants completely abstinent</h6> <p>Three studies with 772 participants reported the proportion of participants completely abstinent (<a href="./references#CD012880-bbs2-0022" title="TimkoC , DeBenedettiA . A randomized controlled trial of intensive referral to 12-step self-help groups: One-year outcomes. Drug and Alcohol Dependence2007;90(2-3):270-9. TimkoC , DebenedettiA , BillowR . Intensive referral to 12-step self-help groups and 6-month substance use disorder outcomes. Addiction2006;101(5):678-88. [DOI: 10.1111/j.1360-0443.2006.01391.x]">Timko 2006</a>; <a href="./references#CD012880-bbs2-0023" title="TimkoC , SutkowiA , CronkiteRC , Makin-ByrdK , MoosRH . Intensive referral to 12-step dual-focused mutual-help groups. Drug and Alcohol Dependence2011;118(2-3):194-201. [DOI: 10.1016/j.drugalcdep.2011.03.019]">Timko 2011</a>; <a href="./references#CD012880-bbs2-0024" title="VederhusJK , TimkoC , KristensenO , HjemdahlB , ClausenT . Motivational intervention to enhance post‐detoxification 12‐step group affiliation: a randomized controlled trial. Addiction2014;109(5):766-73. [DOI: 10.1111/add.12471]">Vederhus 2014</a>). There were no differences at the six‐month follow‐up (RR 1.07, 95% CI 0.96 to 1.18; P = 0.23; 3 studies, 772 participants; <a href="./references#CD012880-fig-0021" title="">Analysis 3.1</a>), or the 12‐month follow‐up (RR 1.28, 95% CI 1.00 to 1.63; P = 0.05; 1 study, 307 participants; <a href="./references#CD012880-fig-0021" title="">Analysis 3.1</a>). We conducted formal tests of between‐study heterogeneity only for the six‐month follow‐up, for which there was a low probability of heterogeneity (Tau<sup>2</sup> = 0.00, P = 0.55; I<sup>2</sup> = 0%). We did not test for heterogeneity at the 12‐month follow‐up, as only one study contributed data to that time point. </p> <p>The GRADE certainty rating for this evidence was moderate; we downgraded due to imprecision (moderate to small sample). </p> </section> <section id="CD012880-sec-0080"> <h6 class="title">Percentage days abstinent (PDA)</h6> <p>Two studies reported data for PDA (<a href="./references#CD012880-bbs2-0011" title="KahlerCW , ReadJP , RamseySE , StuartGL , McCradyBS , BrownRA . Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology2004;72(4):736-41. [DOI: 10.1037/0022-006X.72.4.736]">Kahler 2004</a>; <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a>). <a href="./references#CD012880-bbs2-0011" title="KahlerCW , ReadJP , RamseySE , StuartGL , McCradyBS , BrownRA . Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology2004;72(4):736-41. [DOI: 10.1037/0022-006X.72.4.736]">Kahler 2004</a> found no difference in PDA at the six‐month follow‐up (MD ‐5.50, 95% CI ‐25.35 to 14.35; P = 0.59; 1 study, 42 participants; <a href="./references#CD012880-fig-0022" title="">Analysis 3.2</a>), and <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a> found an advantage for AA/TSF compared to the comparison at 12‐month follow‐up (MD 16.40, 95% CI 5.12 to 27.68; P = 0.004; 1 study, 95 participants; <a href="./references#CD012880-fig-0022" title="">Analysis 3.2</a>). </p> <p>Two studies reported on days of alcohol use at the six‐month follow‐up (<a href="./references#CD012880-bbs2-0023" title="TimkoC , SutkowiA , CronkiteRC , Makin-ByrdK , MoosRH . Intensive referral to 12-step dual-focused mutual-help groups. Drug and Alcohol Dependence2011;118(2-3):194-201. [DOI: 10.1016/j.drugalcdep.2011.03.019]">Timko 2011</a>; <a href="./references#CD012880-bbs2-0024" title="VederhusJK , TimkoC , KristensenO , HjemdahlB , ClausenT . Motivational intervention to enhance post‐detoxification 12‐step group affiliation: a randomized controlled trial. Addiction2014;109(5):766-73. [DOI: 10.1111/add.12471]">Vederhus 2014</a>), and found no difference between the more and less intensive AA/TSF interventions studied (MD ‐1.93, 95% CI ‐4.55 to 0.69; P = 0.15; 2 studies, 427 participants; <a href="./references#CD012880-fig-0023" title="">Analysis 3.3</a>). </p> <p>The GRADE certainty rating for this evidence was moderate; we downgraded due to imprecision (small sample). </p> </section> <section id="CD012880-sec-0081"> <h6 class="title">Longest period of abstinence</h6> <p>None of the studies in this category reported this outcome.</p> </section> </section> <section id="CD012880-sec-0082"> <h5 class="title">Drinking intensity</h5> <p><a href="./references#CD012880-bbs2-0011" title="KahlerCW , ReadJP , RamseySE , StuartGL , McCradyBS , BrownRA . Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology2004;72(4):736-41. [DOI: 10.1037/0022-006X.72.4.736]">Kahler 2004</a> found no difference between interventions for drinks per drinking day (DDD) (MD ‐4.10, 95% CI ‐10.44 to 2.24; P = 0.21; 1 study, 42 participants; <a href="./references#CD012880-fig-0024" title="">Analysis 3.4</a>). </p> <p>The GRADE certainty rating for this evidence was moderate; we downgraded due to imprecision (small sample). </p> </section> <section id="CD012880-sec-0083"> <h5 class="title">Alcohol‐related consequences</h5> <p>None of the studies in this category reported this outcome.</p> </section> <section id="CD012880-sec-0084"> <h5 class="title">Alcohol addiction severity</h5> <p>Two studies reported in three papers reported alcohol addiction severity using the ASI (<a href="./references#CD012880-bbs2-0022" title="TimkoC , DeBenedettiA . A randomized controlled trial of intensive referral to 12-step self-help groups: One-year outcomes. Drug and Alcohol Dependence2007;90(2-3):270-9. TimkoC , DebenedettiA , BillowR . Intensive referral to 12-step self-help groups and 6-month substance use disorder outcomes. Addiction2006;101(5):678-88. [DOI: 10.1111/j.1360-0443.2006.01391.x]">Timko 2006</a>; <a href="./references#CD012880-bbs2-0023" title="TimkoC , SutkowiA , CronkiteRC , Makin-ByrdK , MoosRH . Intensive referral to 12-step dual-focused mutual-help groups. Drug and Alcohol Dependence2011;118(2-3):194-201. [DOI: 10.1016/j.drugalcdep.2011.03.019]">Timko 2011</a>). There was no difference between the more and less intensive AA/TSF interventions at the six‐month follow‐up (MD 0.03, 95% CI ‐0.07 to 0.13; P = 0.53; 2 studies, 690 participants; <a href="./references#CD012880-fig-0025" title="">Analysis 3.5</a>), but there was an advantage for the more intensive AA/TSF intervention at the 12‐month follow‐up (MD 0.08, 95% CI 0.02 to 0.15; P = 0.01; 1 study, 307 participants; <a href="./references#CD012880-fig-0025" title="">Analysis 3.5</a>). </p> <p><a href="./references#CD012880-bbs2-0024" title="VederhusJK , TimkoC , KristensenO , HjemdahlB , ClausenT . Motivational intervention to enhance post‐detoxification 12‐step group affiliation: a randomized controlled trial. Addiction2014;109(5):766-73. [DOI: 10.1111/add.12471]">Vederhus 2014</a> assessed alcohol addiction severity using the European version of the ASI (EuropASI). Using the raw means and SDs from the study, showed an advantage for the more intensive AA/TSF intervention compared to the less intensive AA/TSF intervention (MD ‐0.07, 95% CI ‐0.08 to ‐0.06; P &lt; 0.001; 1 study, 113 participants; <a href="./references#CD012880-fig-0026" title="">Analysis 3.6</a>). </p> <p>The GRADE certainty rating for this evidence was moderate; we downgraded due to imprecision (small sample). </p> </section> <section id="CD012880-sec-0085"> <h5 class="title">Indices reflecting quality of life and/or psychological well‐being</h5> <p>None of the studies in this category reported this outcome.</p> </section> </section> <section id="CD012880-sec-0086"> <h4 class="title">2b Studies that employed a RCT/quasi‐RCT design where at least one comparison treatment was non‐manualized and AA/TSF was compared to a different type of TSF (i.e. varying in TSF style or intensity) </h4> <p>We included two studies in this category (<a href="./references#CD012880-bbs2-0012" title="KaskutasLA , SubbaramanMS , WitbrodtJ , ZemoreSE . Effectiveness of making alcoholics anonymous easier: a group format 12-step facilitation approach. Journal of Substance Abuse Treatment2009;37(3):228-39. [DOI: 10.1016/j.jsat.2009.01.004]">Kaskutas 2009b</a>; <a href="./references#CD012880-bbs2-0017" title="ManningV , BestD , FaulknerN , TitheringtonE , MorinanA , KeaneyF , et al. Does active referral by a doctor or 12-step peer improve 12-step meeting attendance? Results from a pilot randomised control trial. Drug and Alcohol Dependence2012;126(1-2):131-7. [DOI: 10.1016/j.drugalcdep.2012.05.004]">Manning 2012</a>). See <a href="./full#CD012880-tbl-0004">summary of findings Table 4</a> for a summary of the results for our main outcomes and certainty of evidence for each result. </p> <section id="CD012880-sec-0087"> <h5 class="title">Abstinence</h5> <section id="CD012880-sec-0088"> <h6 class="title">Proportion of participants completely abstinent</h6> <p><a href="./references#CD012880-bbs2-0012" title="KaskutasLA , SubbaramanMS , WitbrodtJ , ZemoreSE . Effectiveness of making alcoholics anonymous easier: a group format 12-step facilitation approach. Journal of Substance Abuse Treatment2009;37(3):228-39. [DOI: 10.1016/j.jsat.2009.01.004]">Kaskutas 2009b</a> found that the more intensive AA/TSF intervention had a higher proportion of participants abstinent at the 12‐month follow‐up compared to the less intensive AA/TSF intervention (RR 1.15, 95% CI 1.02 to 1.29; P = 0.02; 1 study, 382 participants; <a href="./references#CD012880-fig-0027" title="">Analysis 4.1</a>). The <a href="./references#CD012880-bbs2-0017" title="ManningV , BestD , FaulknerN , TitheringtonE , MorinanA , KeaneyF , et al. Does active referral by a doctor or 12-step peer improve 12-step meeting attendance? Results from a pilot randomised control trial. Drug and Alcohol Dependence2012;126(1-2):131-7. [DOI: 10.1016/j.drugalcdep.2012.05.004]">Manning 2012</a> study reported data for the three‐month follow‐up only, and found no difference between interventions (RR 1.16, 95% CI 0.76 to 1.79; P = 0.49; 1 study, 126 participants). </p> <p>The GRADE certainty rating for this evidence was moderate; we downgraded due to study limitations (risk of random sequence generation, allocation concealment, and attrition bias). </p> </section> </section> <section id="CD012880-sec-0089"> <h5 class="title">Drinking intensity</h5> <p>Neither of the studies in this category reported this outcome.</p> </section> <section id="CD012880-sec-0090"> <h5 class="title">Alcohol‐related consequences</h5> <p>Neither of the studies in this category reported this outcome.</p> </section> <section id="CD012880-sec-0091"> <h5 class="title">Alcohol addiction severity</h5> <p>Neither of the studies in this category reported this outcome.</p> </section> <section id="CD012880-sec-0092"> <h5 class="title">Indices reflecting quality of life and/or psychological well‐being</h5> <p>Neither of the studies in this category reported this outcome.</p> </section> </section> <section id="CD012880-sec-0093"> <h4 class="title">3a Studies that employed a non‐randomized design with all treatments manualized and where AA/TSF was compared to a different theoretical orientation (e.g. CBT) </h4> <p>We did not include any studies in this category.</p> </section> <section id="CD012880-sec-0094"> <h4 class="title">3b Studies that employed a non‐randomized design with at least one non‐manualized treatment intervention and where AA/TSF was compared to a different theoretical treatment orientation (e.g. CBT) </h4> <p>We included four studies, reported in six papers, in this category (<a href="./references#CD012880-bbs2-0001" title="BlondellRD , LooneySW , NorthingtonAP , LaschME , RhodesSB , McDanielsRL . Using recovering alcoholics to help hospitalized patients with alcohol problems. Journal of Family Practice2001;50(5):1-15. ">Blondell 2001</a>; <a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a>; <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a>; <a href="./references#CD012880-bbs2-0027" title="ZemoreSE , LuiC , MericleA , HembergJ , KaskutasLA . A longitudinal study of the comparative efficacy of Women for Sobriety, LifeRing, SMART Recovery, and 12-step groups for those with AUD. Journal of Substance Abuse Treatment2018;88:18-26. [DOI: 10.1016/j.jsat.2018.02.004]">Zemore 2018</a>). See <a href="./full#CD012880-tbl-0005">summary of findings Table 5</a> for a summary of the results for our main outcomes and certainty of evidence for each result. </p> <section id="CD012880-sec-0095"> <h5 class="title">Abstinence</h5> <section id="CD012880-sec-0096"> <h6 class="title">Proportion of participants completely abstinent</h6> <p>Three studies with 3979 participants assessed this outcome (<a href="./references#CD012880-bbs2-0001" title="BlondellRD , LooneySW , NorthingtonAP , LaschME , RhodesSB , McDanielsRL . Using recovering alcoholics to help hospitalized patients with alcohol problems. Journal of Family Practice2001;50(5):1-15. ">Blondell 2001</a>; <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a>; <a href="./references#CD012880-bbs2-0027" title="ZemoreSE , LuiC , MericleA , HembergJ , KaskutasLA . A longitudinal study of the comparative efficacy of Women for Sobriety, LifeRing, SMART Recovery, and 12-step groups for those with AUD. Journal of Substance Abuse Treatment2018;88:18-26. [DOI: 10.1016/j.jsat.2018.02.004]">Zemore 2018</a>). Of note, because <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a> compared two types of AA/TSF interventions (the purer '12‐step' intensive inpatient model and the 'eclectic' AA/TSF‐CBT hybrid inpatient model) and a standard inpatient CBT model ('C‐B'), we include here the comparison between 12‐step and CBT (because this comparison compares an AA/TSF intervention with a different theoretical orientation ‐ CBT) and in section 4b, below, we compare the 12‐step model to the eclectic intervention since these are two AA/TSF variants. All of these studies favored the AA/TSF intervention at all three follow‐up times: six months (RR 1.50, 95% CI 1.16 to 1.92; P = 0.002; 1 study, 314 participants; <a href="./references#CD012880-fig-0028" title="">Analysis 5.1</a>); 12 months (RR 1.25, 95% CI 1.09 to 1.43; P = 0.002; 2 studies, 2692 participants; <a href="./references#CD012880-fig-0028" title="">Analysis 5.1</a>); and 24 months (RR 1.34, 95% CI 1.20 to 1.49; P &lt; 0.001; 1 study, 1774 participants; <a href="./references#CD012880-fig-0028" title="">Analysis 5.1</a>). Formal tests of between‐study heterogeneity indicated very low probability of heterogeneity at the six‐month follow‐up (Tau<sup>2</sup> = 0.00, P = 0.46, I<sup>2</sup> = 0%) and a moderate probability of heterogeneity at the 12‐month follow‐up (Tau<sup>2</sup> = 0.01, P = 0.14, I<sup>2</sup> = 46%). </p> <p>The GRADE certainty rating for this evidence was very low; we downgraded because of study limitations (lack of control of sample selection and non‐randomized nature of the study). </p> </section> <section id="CD012880-sec-0097"> <h6 class="title">Percentage days abstinent</h6> <p>None of the studies in this category reported this outcome.</p> </section> <section id="CD012880-sec-0098"> <h6 class="title">Longest period of abstinence</h6> <p>None of the studies in this category reported this outcome.</p> </section> </section> <section id="CD012880-sec-0099"> <h5 class="title">Drinking intensity</h5> <p>Just one study in this category reported drinking intensity in terms of drinks per drinking day (DDD) (<a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a>), which were calculated from ounces of pure ethanol consumed (based on a standard USA drink of 14 g/drink) and found no difference between interventions at 36‐month follow‐up (MD 0.00, 95% CI ‐3.38 to 3.38; P = 1.00; 1 study, 201 participants; <a href="./references#CD012880-fig-0029" title="">Analysis 5.2</a>). </p> <p>The GRADE certainty rating for this evidence was very low; we downgraded due to imprecision (moderate sample size) and indirectness (comparability of cohorts for baseline characteristics and outcome measures, and protection against contamination). </p> </section> <section id="CD012880-sec-0100"> <h5 class="title">Alcohol‐related consequences</h5> <p>Two studies reported this outcome (<a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a>; <a href="./references#CD012880-bbs2-0027" title="ZemoreSE , LuiC , MericleA , HembergJ , KaskutasLA . A longitudinal study of the comparative efficacy of Women for Sobriety, LifeRing, SMART Recovery, and 12-step groups for those with AUD. Journal of Substance Abuse Treatment2018;88:18-26. [DOI: 10.1016/j.jsat.2018.02.004]">Zemore 2018</a>). <a href="./references#CD012880-bbs2-0027" title="ZemoreSE , LuiC , MericleA , HembergJ , KaskutasLA . A longitudinal study of the comparative efficacy of Women for Sobriety, LifeRing, SMART Recovery, and 12-step groups for those with AUD. Journal of Substance Abuse Treatment2018;88:18-26. [DOI: 10.1016/j.jsat.2018.02.004]">Zemore 2018</a> found no difference at the 12‐month follow‐up (MD ‐0.71, 95% CI ‐1.68 to 0.27; P = 0.15; 1 study, 647 participants; <a href="./references#CD012880-fig-0030" title="">Analysis 5.3</a>). Similarly, <a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a> found no difference at the 36‐month follow‐up (MD 0.20, 95% CI ‐1.34 to 1.74; P = 0.80; 1 study, 201 participants; <a href="./references#CD012880-fig-0031" title="">Analysis 5.4</a>). </p> <p>The GRADE certainty rating for this evidence was very low; we downgraded due to study limitations (lack of control of sample selection and non‐randomized nature of the study); and indirectness (comparability of cohorts for baseline characteristics and outcome measures, and protection against contamination). </p> </section> <section id="CD012880-sec-0101"> <h5 class="title">Alcohol addiction severity</h5> <p>Just one study reported alcohol addiction severity in this category; <a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a> used the Alcohol Dependence Scale, and found no difference between interventions (MD ‐0.30, 95% CI ‐2.20 to 1.60; P = 0.76; 1 study, 201 participants; <a href="./references#CD012880-fig-0032" title="">Analysis 5.5</a>). </p> <p>The GRADE certainty rating for this evidence was very low; we downgraded due to imprecision (moderate sample size) and indirectness (comparability of cohorts for baseline characteristics and outcome measures, and protection against contamination). </p> </section> <section id="CD012880-sec-0102"> <h5 class="title">Indices reflecting quality of life or psychological well‐being, or both</h5> <p>None of the studies in this category reported this outcome.</p> </section> </section> <section id="CD012880-sec-0103"> <h4 class="title">4a Studies that employed a non‐randomized design with all treatments manualized and where AA/TSF was compared to a different type of TSF (i.e. varying in style or intensity) </h4> <p>We did not include any studies in this category.</p> </section> <section id="CD012880-sec-0104"> <h4 class="title">4b Studies that employed a non‐randomized design with at least one non‐manualized treatment intervention and where AA/TSF was compared to a different TSF variant (i.e. in varying in TSF style or intensity) </h4> <p>We included two studies, reported in four papers, in this category (<a href="./references#CD012880-bbs2-0008" title="GrantKM , YoungLB , TylerKA , SimpsonJL , PulidoRD , TimkoC . Intensive referral to mutual-help groups: a field trial of adaptations for rural veterans. Patient Education and Counseling2018;101(1):79-84. [DOI: 10.1016/j.pec.2017.07.012]">Grant 2018</a>; <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a>). See <a href="./full#CD012880-tbl-0006">summary of findings Table 6</a> for a summary of the results for our main outcomes and certainty of evidence for each result. </p> <section id="CD012880-sec-0105"> <h5 class="title">Abstinence</h5> <section id="CD012880-sec-0106"> <h6 class="title">Proportion of participants completely abstinent</h6> <p>At six‐month follow‐up <a href="./references#CD012880-bbs2-0008" title="GrantKM , YoungLB , TylerKA , SimpsonJL , PulidoRD , TimkoC . Intensive referral to mutual-help groups: a field trial of adaptations for rural veterans. Patient Education and Counseling2018;101(1):79-84. [DOI: 10.1016/j.pec.2017.07.012]">Grant 2018</a> found no difference between interventions (RR 1.01, 95% CI 0.86 to 1.19; P = 0.90; 1 study, 140 participants), and at the 12‐month follow‐up <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a> found an advantage for the more intensive 12‐step‐oriented treatment (RR 1.24, 95% CI 1.05 to 1.46; P = 0.01; 1 study, 1870 participants; <a href="./references#CD012880-fig-0033" title="">Analysis 6.1</a>). </p> <p>The GRADE certainty rating for this evidence was very low; we downgraded due to study limitations (risk of attrition bias). </p> </section> <section id="CD012880-sec-0107"> <h6 class="title">Percentage days abstinent</h6> <p>Only the <a href="./references#CD012880-bbs2-0008" title="GrantKM , YoungLB , TylerKA , SimpsonJL , PulidoRD , TimkoC . Intensive referral to mutual-help groups: a field trial of adaptations for rural veterans. Patient Education and Counseling2018;101(1):79-84. [DOI: 10.1016/j.pec.2017.07.012]">Grant 2018</a> study reported this outcome and found no difference between interventions (MD ‐0.01, 95% CI ‐7.14 to 7.12; P = 1.00; 1 study, 140 participants; <a href="./references#CD012880-fig-0034" title="">Analysis 6.2</a>). </p> <p>The GRADE certainty rating for this evidence was very low; we downgraded due to study limitations (risk of attrition bias) and due to imprecision (moderate sample size). </p> </section> <section id="CD012880-sec-0108"> <h6 class="title">Longest period of abstinence</h6> <p>None of the studies in this category reported this outcome.</p> </section> </section> <section id="CD012880-sec-0109"> <h5 class="title">Drinking intensity</h5> <p>As shown in <a href="./references#CD012880-fig-0035" title="">Analysis 6.3</a>, only the <a href="./references#CD012880-bbs2-0008" title="GrantKM , YoungLB , TylerKA , SimpsonJL , PulidoRD , TimkoC . Intensive referral to mutual-help groups: a field trial of adaptations for rural veterans. Patient Education and Counseling2018;101(1):79-84. [DOI: 10.1016/j.pec.2017.07.012]">Grant 2018</a> study reported this outcome, and only at six‐month follow‐up. It should be noted that this study reported drinks per drinking day (DDD) only for those participants who were not abstinent during the follow‐up period (25 participants) and found no difference in DDD between the rural‐adapted intensive referral (RAIR) (mean 17.63, SD 23.71) and the standard referral (SR) (mean 11.47, SD 5.94), P = 0.49. </p> <p>The GRADE certainty rating for this evidence was very low; we downgraded due to study limitations (risk of attrition bias) and due to imprecision (moderate sample size). We conducted a narrative synthesis and therefore estimates are not precise. </p> </section> <section id="CD012880-sec-0110"> <h5 class="title">Alcohol‐related consequences</h5> <p>None of the studies in this category reported this outcome.</p> </section> <section id="CD012880-sec-0111"> <h5 class="title">Alcohol addiction severity</h5> <p><a href="./references#CD012880-bbs2-0008" title="GrantKM , YoungLB , TylerKA , SimpsonJL , PulidoRD , TimkoC . Intensive referral to mutual-help groups: a field trial of adaptations for rural veterans. Patient Education and Counseling2018;101(1):79-84. [DOI: 10.1016/j.pec.2017.07.012]">Grant 2018</a> was the only study to report this outcome, measured with ASI‐Lite, and found no difference between interventions (MD 0.01, 95% CI ‐0.05 to 0.07; P = 0.74; 1 study, 140 participants; <a href="./references#CD012880-fig-0036" title="">Analysis 6.4</a>). </p> <p>The GRADE certainty rating for this evidence was very low; we downgraded due to study limitations (risk of attrition bias) and due to imprecision (moderate sample size). </p> </section> <section id="CD012880-sec-0112"> <h5 class="title">Indices reflecting quality of life and/or psychological well‐being</h5> <p>None of the studies in this category reported this outcome.</p> </section> </section> <section id="CD012880-sec-0113"> <h4 class="title">5 Economic analysis studies (e.g. healthcare cost offset)</h4> <p>As noted previously, given that AA/TSF interventions attempt to link people with AUD to freely available AA meetings, and that other individuals may go directly to AA instead of pursuing professionally‐provided treatment, an important consideration is the extent to which participation in such meetings can help reduce healthcare costs by reducing reliance on more expensive, professionally‐delivered treatments in favor of the peer‐led AA groups. We included five reports relating to four studies (1 RCT/quasi‐RCT, and 3 non‐randomised) with 2657 participants that addressed the potential healthcare cost offset from AA participation (<a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a>; <a href="./references#CD012880-bbs2-0057" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [10.1046/j.1360-0443.2000.9579993.x]">Holder 2000</a> (from the <a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a> study); <a href="./references#CD012880-bbs2-0060" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-6.">Humphreys 2001</a> and <a href="./references#CD012880-bbs2-0062" title="HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]">Humphreys 2007</a> (from the <a href="./references#CD012880-bbs2-0020" title="MundtMP , ParthasarathyS , ChiFW , SterlingS , CampbellCI . 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002]">Mundt 2012</a> study); <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a>). See <a href="./full#CD012880-tbl-0007">summary of findings Table 7</a> for a summary of the results for our main outcomes and certainty of evidence for each result. </p> <p>The GRADE certainty rating for this evidence was moderate; we downgraded due to random sequence generation bias, problems with comparability of cohorts at baseline; and protection against contamination between study interventions. </p> <section id="CD012880-sec-0114"> <h5 class="title">Methodological quality</h5> <p>In keeping with the Cochrane recommendations for appraising the methodological quality of economic studies (<a href="./references#CD012880-bbs2-0094" title="ShemiltI , MugfordM , ByfordS , DrummondM , EisensteinE , KnappM , et al. Chapter 15: Incorporating economics evidence. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Shemilt 2011b</a>), we evaluated each of the four primary economic studies using a 19‐item checklist to assess study quality (<a href="./references#CD012880-bbs2-0050" title="EversS , GoossensM , deVetH , vanTulderM , AmentA . Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. International Journal of Technology Assessment in Health Care2005;21(2):240-5.">Evers 2005</a>). Overall, we deemed the four studies to be of high quality given that they met between 16 and 18 of the 19 criteria used in the checklist to appraise quality (see <a href="#CD012880-tbl-0010">Table 3</a>). </p> <div class="table" id="CD012880-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Assessment of methodological quality of economic evaluationsa </span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Item number</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Item</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Humphreys 1996</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Holder 2000</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Humphreys 2001, Humphreys 2007</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mundt 2012</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Is the study population clearly described?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are competing alternatives clearly described?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Is a well‐defined research question posed in answerable form?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Is the economic study design appropriate to the stated objective?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Is the chosen time horizon appropriate to include relevant costs and consequences?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Is the actual perspective chosen appropriate?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are all important and relevant costs for each alternative identified?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are all costs measured appropriately in physical units?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are costs valued appropriately?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are all important and relevant outcomes for each alternative identified?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are all outcomes measured appropriately?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are outcomes valued appropriately?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Is an incremental analysis of costs and outcomes of alternatives performed?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are all future costs and outcomes discounted appropriately?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>b</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>b</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>c</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>d</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are all important variables, whose values are uncertain, appropriately subjected to sensitivity analysis? </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>e</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>f</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>f</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Do the conclusions follow from the data reported?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Does the study discuss the generalizability of the results to other settings and patient/client groups? </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Does the article indicate that there is no potential conflict of interest of study researcher(s) and funder(s)? </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are ethical and distributional issues discussed appropriately?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1<sup>g</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1<sup>g</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1<sup>g</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1<sup>g</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>According to <a href="./references#CD012880-bbs2-0050" title="EversS , GoossensM , deVetH , vanTulderM , AmentA . Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. International Journal of Technology Assessment in Health Care2005;21(2):240-5.">Evers 2005</a>.<br/><sup>b</sup>The data were retrospective analyses over a period of three years.<br/><sup>c</sup>The data were retrospective analyses over a period of one year (2001) and two years (2007).<br/><sup>d</sup>The data were retrospective analyses over a period of seven years.<br/><sup>e</sup>We made this N/A because none of the values were 'uncertain', but rather estimated based on Veterans Affairs clinical data costs.<br/><sup>r</sup>We made this N/A because none of the values were 'uncertain'.<br/><sup>g</sup>We understood this to mean the potential for the benefits to healthcare system utilizers because they could obtain the same effects or better from AA instead of utilizing health care. </p> </div> </div> </section> <section id="CD012880-sec-0115"> <h5 class="title">Healthcare cost savings</h5> <p>Three out of the four included studies in this category (4 out of 5 reports; <a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a>; <a href="./references#CD012880-bbs2-0060" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-6.">Humphreys 2001</a>; <a href="./references#CD012880-bbs2-0062" title="HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]">Humphreys 2007</a>; <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a>) found an important healthcare cost saving in favor of the AA/TSF intervention. <a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a> found that at baseline, the AA group had a worse prognosis, as characterized by lower income, less education, and more adverse consequences from alcohol use than did individuals entering professionally‐provided outpatient treatment. Despite this, across the three‐year follow‐up period, AA participants had alcohol‐related outcomes similar to the outpatient treatment group. Furthermore, the treatment costs for the AA group were 45% lower than the outpatient group, at USD 1826 less per person based on 1994 US dollars (equivalent to USD 2856 in 2018 US dollars). In the <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a> study, <a href="./references#CD012880-bbs2-0060" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-6.">Humphreys 2001</a> found that compared with inpatients in CBT programs, inpatients in AA/TSF programs had greater involvement in AA self‐help groups at post‐treatment follow‐up. In contrast, participants treated in CBT programs averaged almost twice as many outpatient continuing care visits after discharge (22.5 visits) as participants treated in 12‐step treatment programs (13.1 visits), and also received more days of inpatient care (17.0 days in CBT versus 10.5 in 12‐step), resulting in 64% higher annual costs for the participants initially treated in the CBT programs, or USD 4729 per patient (equivalent to USD 7128 in 2018 US dollars; P = 0.001). Psychiatric and substance use outcomes were comparable across treatments, except that AA/TSF participants had higher rates of abstinence at follow‐up (45.7% versus 36.2% for participants from CBT programs; P = 0.001). Similarly, in a subsequent analysis of the two‐year outcomes and healthcare costs, participants initially in the CBT programs relied more on outpatient and inpatient mental health services, leading to 30% lower costs among participants initially in the AA/TSF treatment programs. The two‐year follow‐up notably showed that in the previous 12 months costs for AA/TSF participants had been reduced by USD 2440 per patient (equivalent to USD 3678 in 2018 US dollars; P = 0.01). </p> <p><a href="./references#CD012880-bbs2-0020" title="MundtMP , ParthasarathyS , ChiFW , SterlingS , CampbellCI . 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002]">Mundt 2012</a> found that for each additional 12‐step group meeting attended, there was an observed incremental medical cost reduction of 4.7% during the seven‐year follow‐up. The medical cost offset was largely due to reductions in hospital inpatient days, psychiatric visits, and alcohol and other drug treatment costs culminating in an estimated total medical use cost savings of USD 145 for each 12‐step meeting attended per year (USD 180 in 2018 dollars). In the <a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a> study, <a href="./references#CD012880-bbs2-0057" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [10.1046/j.1360-0443.2000.9579993.x]">Holder 2000</a> identified substantial medical cost savings during treatment and across follow‐up; the mean estimated monthly post‐treatment costs for the three treatments (MET, CBT, AA/TSF) ranged from a low of USD 254 (MET) to a high of USD 315 (CBT) with AA/TSF in between (USD 310) (P = 0.13). The total medical care costs declined from pre‐ to post‐treatment overall and for each modality. Although matching effects independent of clinical prognosis in the analysis showed that MET had potential for medical care cost savings, this was not the case once clinical prognosis indicators were included. Specifically, participants with poor prognostic characteristics (greater alcohol addiction severity, psychiatric severity and/or social network support favoring alcohol use) had better cost savings potential with CBT or TSF, or both, than with MET. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012880-sec-0116" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012880-sec-0116"></div> <section id="CD012880-sec-0117"> <h3 class="title" id="CD012880-sec-0117">Summary of main results</h3> <p>The current review demonstrates that Alcoholics Anonymous/Twelve‐Step Facilitation (AA/TSF) is superior to other well‐established treatments when it comes to increasing abstinence, and is at least as effective as other well‐established treatments for other alcohol‐related outcomes such as drinking consequences, drinking intensity, and addiction severity. AA/TSF also appears to produce important healthcare cost offsets. The benefits of AA and TSF were observed in rigorous trials, as well as less rigorous, non‐randomized studies. Although AA/TSF was not consistently superior when compared to well‐established treatments or less‐intensive TSF, it was at least as helpful for reducing the intensity of drinking and alcohol‐related consequences, and in lowering severity of alcohol addiction. In addition, when different types of TSF interventions were tested against each other, the more intensive TSF interventions (e.g. those that include actively prescribing AA participation and ongoing monitoring of AA attendance and related experiences; personal linkages to existing AA members) often worked better at improving drinking‐related outcomes than the 'treatment as usual (TAU) TSF' intervention. This suggests that although many treatment professionals may believe that they "already do 12‐step" (i.e. implement TSF strategies) because they hand out 12‐step literature or mention 12‐step groups to patients, this alone may not be sufficient to achieve a superior benefit (<a href="./references#CD012880-bbs2-0073" title="KellyJF , HumphreysK , YeterianJ . Mutual-Help Groups. In: HerieM , SkinnerWJW , editors(s). Fundamentals of Addiction: A Practical Guide for Counsellors. Toronto (ON): Centre on Addiction and Mental Health, 2013:321-48.">Kelly 2013c</a>). The types of TSF strategies used matter, and the more intensive strategies, such as those evaluated herein, enhance participation rates and outcomes compared to the more routine 12‐step‐oriented TAU. Some of these strategies could be clinical linkage to existing members (e.g. <a href="./references#CD012880-bbs2-0017" title="ManningV , BestD , FaulknerN , TitheringtonE , MorinanA , KeaneyF , et al. Does active referral by a doctor or 12-step peer improve 12-step meeting attendance? Results from a pilot randomised control trial. Drug and Alcohol Dependence2012;126(1-2):131-7. [DOI: 10.1016/j.drugalcdep.2012.05.004]">Manning 2012</a>; <a href="./references#CD012880-bbs2-0022" title="TimkoC , DeBenedettiA . A randomized controlled trial of intensive referral to 12-step self-help groups: One-year outcomes. Drug and Alcohol Dependence2007;90(2-3):270-9. TimkoC , DebenedettiA , BillowR . Intensive referral to 12-step self-help groups and 6-month substance use disorder outcomes. Addiction2006;101(5):678-88. [DOI: 10.1111/j.1360-0443.2006.01391.x]">Timko 2006</a>), or active prescription of attendance versus leaving it to people to decide for themselves whether they want to attend AA (e.g. <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a>). It is worth noting that, because many participants in these studies assigned to non‐TSF interventions still elected to attend AA (participation in which is correlated with better outcomes), the positive effects of AA/TSF interventions, where observed, are likely to be conservative. Also, as detailed below, the reason why AA/TSF outperforms other well‐established treatments is because it successfully links people to a free, ubiquitous, long‐term recovery, peer support organization (i.e. AA) that, in turn, mobilizes other therapeutic mechanisms ‐ such as increasing relapse prevention coping skills, abstinence self‐efficacy, recovery motivation, and reducing craving and impulsivity ‐ and facilitates recovery‐supportive changes in people's social networks (<a href="./references#CD012880-bbs2-0069" title="KellyJF , MagillM , StoutRL . How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous. Addiction Research &amp; Theory2009;17(3):236-59. [http://dx.doi.org/10.1080/16066350902770458]">Kelly 2009b</a>; <a href="./references#CD012880-bbs2-0075" title="KellyJ . Is Alcoholics Anonymous religious, spiritual, neither? Findings from 25 years of mechanisms of behavior change research. Addiction2017;112(6):929-36. [DOI: 10.1111/add.13590]">Kelly 2017a</a>). </p> </section> <section id="CD012880-sec-0118"> <h3 class="title" id="CD012880-sec-0118">Overall completeness and applicability of evidence</h3> <p>Follow‐up after intervention ranged from three to 60 months, with a modal length of 12 months (see <a href="#CD012880-tbl-0008">Table 1</a>). On the whole, study samples were quite large and adequately powered to detect effects. However, sample sizes were highly variable and skewed across studies, ranging from a low of 48 participants in <a href="./references#CD012880-bbs2-0011" title="KahlerCW , ReadJP , RamseySE , StuartGL , McCradyBS , BrownRA . Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology2004;72(4):736-41. [DOI: 10.1037/0022-006X.72.4.736]">Kahler 2004</a> to a high of 3018 in <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a>, with an average of 400 participants per study (mean 406.4; SD 616.2; median 201). Measurement in the included studies comprised psychometrically validated assessment tools. </p> <p>Overall, the review found that in scientifically rigorous, randomized controlled trials (RCTs) that compared AA/TSF to interventions of a different theoretical orientation (e.g. cognitive behavioral therapy (CBT), motivational enhancement therapy (MET)), where all treatments were manualized and delivered with high degrees of objectively rated clinical fidelity, AA/TSF interventions most often produced increased rates of continuous abstinence of large magnitude compared to interventions such as CBT and MET, which many people have considered to be state‐of‐the‐art behavioral interventions for alcohol use disorder (AUD). For instance, in <a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a> the proportion of participants completely abstinent throughout the entire first year following the intervention among outpatients who were assigned to the AA/TSF intervention was 24%, whereas 15% and 14% of participants assigned to CBT and MET, respectively, were completely abstinent during that timeframe. This reflects an absolute advantage of 9 percentage points in favor of AA/TSF, and a relative advantage for AA/TSF compared to CBT of 60% in the number of participants completely abstinent, and when compared to MET, reflects an increase of 64% in the number of participants completely abstinent. This pattern of relative advantage for AA/TSF interventions on this outcome appeared quite consistent across both RCTs/quasi‐RCTs and non‐randomized studies. </p> <p>Also, although the magnitude was not as large, the average percentage of days on which participants were abstinent (PDA), tended to show an advantage in favor of AA/TSF interventions, especially in the more rigorous RCTs with manualized therapies compared to other active treatment orientations (e.g. CBTs), but studies involving young people (<a href="./references#CD012880-bbs2-0013" title="KellyJF , KaminerY , KahlerCW , HoeppnerB , YeterianJ , CristelloJV , et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction2017;112(12):2155-66. [DOI: 10.1111/add.13920]">Kelly 2017b</a>), and couples therapy (<a href="./references#CD012880-bbs2-0019" title="McCradyBS , EpsteinEE , HirschLS . Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]McCradyBS , EpsteinEE , HirschLS . Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x]McCradyBS , EpsteinEE , KahlerCW . Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870]">McCrady 1996</a>), showed equivalence, but not advantages for PDA. Also of note, one study with dual diagnosis participants in the Veterans Administration (VA) healthcare system (<a href="./references#CD012880-bbs2-0016" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453-65. [DOI: 10.1037/a0019943]">Lydecker 2010</a>), found a disadvantage for PDA with AA/TSF. This may be because, although participants met criteria for AUD, the primary problem was mood disorder as opposed to AUD, which may represent a poorer fit with AA (<a href="./references#CD012880-bbs2-0066" title="KellyJF , McKellarJD , MoosRH . Major depression in patients with substance use disorders: Relationships to 12-step self-help involvement and substance use outcomes. Addiction2003;98(4):499-508.">Kelly 2003a</a>). That said, a recent meta‐analysis by <a href="./references#CD012880-bbs2-0098" title="ToniganJS , PearsonMR , MagillM , HaglerKJ . AA attendance and abstinence for dually diagnosed patients: a meta-analytic review. Addiction2018;113(11):1970-81. [DOI: 10.1111/add.14268]">Tonigan 2018</a> found fairly consistent abstinence benefits from participation in AA by dually‐diagnosed individuals. Thus, it is currently not clear why the <a href="./references#CD012880-bbs2-0016" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453-65. [DOI: 10.1037/a0019943]">Lydecker 2010</a> study did not find benefits, but similar to the <a href="./references#CD012880-bbs2-0066" title="KellyJF , McKellarJD , MoosRH . Major depression in patients with substance use disorders: Relationships to 12-step self-help involvement and substance use outcomes. Addiction2003;98(4):499-508.">Kelly 2003a</a> findings, it may relate to the specific treatment of severe major depression in particular, or perhaps idiosyncrasies related to military veterans, or being treated in the VA healthcare system. More work is needed to clarify this. </p> <p>For measures of intensity of drinking, AA/TSF most often performed as well as comparison interventions. This is, perhaps, surprising given that the major focus of AA/TSF interventions is on complete abstinence, rather than reductions in intensity, which may be of a focus in CBT‐oriented relapse prevention interventions. Of note, however, was that despite a greater relative emphasis on reducing the intensity of any drinking that might occur in CBT interventions (e.g. through a focus on coping with the abstinence violation effect) in no case did AA/TSF fare worse on this outcome, and, where there were differences, AA/TSF showed an advantage. Consquently, these findings do not support the once‐popular theory that by emphasizing the uncontrollability of alcohol consumption (i.e. 'powerlessness' over alcohol), AA creates an abstinence violation effect that makes the relapses more severe (<a href="./references#CD012880-bbs2-0082" title="MarlattGA , GordonJR . Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York (NY): Guilford Press, 1985.">Marlatt 1985</a>). </p> <p>In terms of reductions in alcohol‐related consequences and alcohol addiction severity, AA/TSF most often did as well as comparison treatments. Notably, however, three out of four of the TSF variant studies, reflected advantages for more intensive AA/TSF procedures versus less intensive AA/TSF procedures (<a href="./references#CD012880-bbs2-0006" title="BrownTG , SeraganianP , TremlayJ , AnnisH . Process and outcome changes with relapse prevention versus 12-step aftercare programs for substance abusers. Addiction2002;976(6):677-89. ">Brown 2002</a>; <a href="./references#CD012880-bbs2-0022" title="TimkoC , DeBenedettiA . A randomized controlled trial of intensive referral to 12-step self-help groups: One-year outcomes. Drug and Alcohol Dependence2007;90(2-3):270-9. TimkoC , DebenedettiA , BillowR . Intensive referral to 12-step self-help groups and 6-month substance use disorder outcomes. Addiction2006;101(5):678-88. [DOI: 10.1111/j.1360-0443.2006.01391.x]">Timko 2006</a>; <a href="./references#CD012880-bbs2-0024" title="VederhusJK , TimkoC , KristensenO , HjemdahlB , ClausenT . Motivational intervention to enhance post‐detoxification 12‐step group affiliation: a randomized controlled trial. Addiction2014;109(5):766-73. [DOI: 10.1111/add.12471]">Vederhus 2014</a>), suggesting that better articulated and more intensive TSF strategies (e.g. peer linkage) may produce better results for these outcomes. </p> <p>Importantly, when compared to TAU AA/TSF interventions, the <a href="./references#CD012880-bbs2-0022" title="TimkoC , DeBenedettiA . A randomized controlled trial of intensive referral to 12-step self-help groups: One-year outcomes. Drug and Alcohol Dependence2007;90(2-3):270-9. TimkoC , DebenedettiA , BillowR . Intensive referral to 12-step self-help groups and 6-month substance use disorder outcomes. Addiction2006;101(5):678-88. [DOI: 10.1111/j.1360-0443.2006.01391.x]">Timko 2006</a> and <a href="./references#CD012880-bbs2-0012" title="KaskutasLA , SubbaramanMS , WitbrodtJ , ZemoreSE . Effectiveness of making alcoholics anonymous easier: a group format 12-step facilitation approach. Journal of Substance Abuse Treatment2009;37(3):228-39. [DOI: 10.1016/j.jsat.2009.01.004]">Kaskutas 2009b</a> studies both showed advantages for the more intensive AA/TSF. This suggests the potential importance of not just recommending and referring people to AA, but of being strategic and deliberate in the methods used to get patients connected with AA. Methods highlighted in these studies, indicate those strategies (i.e. direct linkage to existing AA members; explicit focus on the major elements of AA meetings, sponsorship, and referral with clinical monitoring and discussion of AA participation during the active AA/TSF clinical treatment) were clinically superior. Notably, in the <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a> study the more directive style of TSF was superior to the client‐centered motivational interviewing style of TSF, for increasing AA engagement and enhancing clinical alcohol use outcomes. Thus, while motivational interviewing styles are popular, people may be more likely to have better outcomes if AA participation is actively prescribed, recommended, and monitored, by clinicians, rather than left for the patient alone to consider and decide. Furthermore, when compared to the eclectic/TSF interventions in the <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a> study, the purer, more intensive,TSF treatment was superior for increasing complete abstinence among participants. This was also the case for the <a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a> study, which found a AA/TSF advantage for the continuous abstinence and PDA outcomes that was not enhanced by adding contingency management. This suggests that keeping an undiluted and consistent central theoretical focus could yield better clinical dividends than a combination or 'kitchen sink' approach that attempts to include the 'best of' other interventions. That said, more research is needed in this regard, because when the <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a> study combined TSF and CBT approaches (using a more directive and prescriptive AA/TSF style), it outperformed the two comparison interventions (CBT alone and CBT with a motivational interviewing‐TSF style). </p> <p>The economic analyses found benefits in favor of AA/TSF compared to outpatient treatment, and CBT interventions. The magnitude of these benefits can be sizeable. For example, the economic analysis of the <a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a> study (<a href="./references#CD012880-bbs2-0060" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-6.">Humphreys 2001</a> and <a href="./references#CD012880-bbs2-0062" title="HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]">Humphreys 2007</a>) found that, in addition to increasing abstinence rates, AA/TSF interventions were able to reduce the mental health and substance use related healthcare costs over the next two years by over USD 10,000 per patient (when 1994 figures are converted to 2018 USD) compared to CBT interventions delivered in residential VA settings. More than one million people are treated for AUD in the USA every year and reducing each of their healthcare costs by this amount would produce an enormous aggregate economic saving (more than USD 10 billion in the US alone), as well as improving clinical outcomes. </p> <p>The goal of TSF is to stimulate AA participation during and following treatment, but TSF itself is not AA. The theoretical causal chain that may underlie the advantage of TSF clinical interventions is that AA/TSF leads to higher abstinence rates via its strong ability to get people with AUD involved in AA (<a href="./references#CD012880-bbs2-0069" title="KellyJF , MagillM , StoutRL . How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous. Addiction Research &amp; Theory2009;17(3):236-59. [http://dx.doi.org/10.1080/16066350902770458]">Kelly 2009b</a>; <a href="./references#CD012880-bbs2-0075" title="KellyJ . Is Alcoholics Anonymous religious, spiritual, neither? Findings from 25 years of mechanisms of behavior change research. Addiction2017;112(6):929-36. [DOI: 10.1111/add.13590]">Kelly 2017a</a>; <a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a>; <a href="./references#CD012880-bbs2-0079" title="LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]]">Longabaugh 1998</a>; <a href="./references#CD012880-bbs2-0083" title=" Project MATCH . Project MATCH hypotheses: results and causal chain analyses. In: LongabaughR , WirtzPW , MattsonME , MyersJK , editors(s). National Institute on Alcohol Abuse and Alcoholism Project MATCH Monograph Series Volume 8. Vol. 8. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 2001.">MATCH 2001</a>; <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a>). Several studies, including two comparative clinical trials that were included in the current review, have examined this. In these, use of appropriate temporally‐lagged mediational analyses supported a causal chain in which TSF led to higher AA participation, which subsequently led to better alcohol use outcomes (<a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a>; <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a>). Specifically, the <a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a> study found post‐treatment AA attendance partially mediated the effect of the TSF Network Support treatment on PDA (particularly post‐treatment PDA), and <a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a> found that AA involvement during treatment and at six‐month follow‐up increased subsequent PDA. Such studies demonstrate that TSF is able to increase AA participation and by doing so, AA leads to better alcohol use outcomes. </p> <p>The lack of reporting of any outcomes regarding quality of life, functioning, or psychological well‐being was noteworthy. </p> </section> <section id="CD012880-sec-0119"> <h3 class="title" id="CD012880-sec-0119">Certainty of the evidence</h3> <p>The certainty of the evidence in this review was generally appraised as very low to high using the GRADE rating system (<a href="./references#CD012880-bbs2-0092" title="SchunemannH , BrozekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schunemann 2013</a>). This was driven by the rigor of the included studies. Specifically, both RCTs/quasi‐RCTs and non‐randomized studies were permissible as long as they met the other inclusion criteria (e.g. had a comparison intervention). Consequently, by default, we generally judged the evidence of non‐randomized studies (of which there were 5 of 27) to be of low certainty (as recommended by the GRADE system), while we judged RCTs/quasi‐RCTs generally to be of higher certainty. There was some inconsistency in the evidence across studies that could be due to variation in the clinical characteristics of the samples used, follow‐up time points, error in memory recall for certain outcomes, and differences in intervention durations, or therapist effects. There were some small sample sizes and larger variability around mean estimates of the longest periods of abstinence, and high variability around mean estimates of DDD. Although we observed heterogeneity in the magnitude of the effects for AA/TSF in comparison to other treatments or TSF variants, the direction of the findings in almost every case was in the same direction, with AA/TSF doing as well as, or better than, comparison interventions. There was only one instance where this was not the case, as detailed above in the results section (i.e. <a href="./references#CD012880-bbs2-0016" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453-65. [DOI: 10.1037/a0019943]">Lydecker 2010</a>). </p> </section> <section id="CD012880-sec-0120"> <h3 class="title" id="CD012880-sec-0120">Potential biases in the review process</h3> <p>AA/TSF and comparison interventions varied substantially in duration, intensity, style, theoretical orientation, degree of manualization, and content. Potential biases may have arisen due to the decision to pool data from this wide range of studies. This mix of interventions, whilst not necessarily impacting the amount of statistical variation between the results of the studies, does reflect a high degree of heterogeneity which can affect generalizability of the findings. </p> <p>We were not able to perform an analysis of publication bias, but consider it unlikely that we missed any high quality studies. Also, in some instances not all relevant information could be obtained, and in terms of at least some of the bias ratings, such as reporting bias, they can be difficult to assess and thus, some aspects of these ratings remain unclear. Despite this, the bias across the multiple dimensions was low in the RCTs/quasi‐RCTs, and increased as expected in the non‐randomized studies (<a href="#CD012880-fig-0004">Figure 4</a>). Two studies focused on young people (<a href="./references#CD012880-bbs2-0013" title="KellyJF , KaminerY , KahlerCW , HoeppnerB , YeterianJ , CristelloJV , et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction2017;112(12):2155-66. [DOI: 10.1111/add.13920]">Kelly 2017b</a>; <a href="./references#CD012880-bbs2-0020" title="MundtMP , ParthasarathyS , ChiFW , SterlingS , CampbellCI . 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002]">Mundt 2012</a>), but were included despite having some participants under the age of 18 years old at study onset, because the majority (as in <a href="./references#CD012880-bbs2-0013" title="KellyJF , KaminerY , KahlerCW , HoeppnerB , YeterianJ , CristelloJV , et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction2017;112(12):2155-66. [DOI: 10.1111/add.13920]">Kelly 2017b</a>), or all of the participants (as in <a href="./references#CD012880-bbs2-0020" title="MundtMP , ParthasarathyS , ChiFW , SterlingS , CampbellCI . 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002]">Mundt 2012</a>), were 18 years old or older during the follow‐up periods. (Including or omitting these studies from the review, did not alter the pattern of findings.) It is worth noting that most of the studies were conducted in the USA, where AA originated and is widely available. The extent to which these results are generalizable across other cultures where AA may be less readily available is not clear. Also, studies are needed to determine if there are ethnic or racial differences in the benefits derived from AA/TSF within different societies. </p> </section> <section id="CD012880-sec-0121"> <h3 class="title" id="CD012880-sec-0121">Agreements and disagreements with other studies or reviews</h3> <p>The evidence contained in this review is similar to, and extends that of the prior Cochrane Review (<a href="./references#CD012880-bbs2-0106" title="FerriM , AmatoL , DavoliM . Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database of Systematic Reviews2006, Issue 3. Art. No: CD005032. [DOI: 10.1002/14651858.CD005032.pub2]">Ferri 2006b</a>), which this review updates and replaces, as well as of other narrative reviews which found overall positive effects for AA/TSF interventions (e.g. <a href="./references#CD012880-bbs2-0065" title="KaskutasLA . Alcoholics Anonymous effectiveness: faith meets science. Journal of Addictive Diseases2009;28(2):145-57. [DOI: 10.1080/10550880902772464]">Kaskutas 2009a</a>; <a href="./references#CD012880-bbs2-0067" title="KellyJF . Self-help for substance-use disorders: history, effectiveness, knowledge gaps, and research opportunities. Clinical Psychology Review2003;23(5):639-663. [DOI: 10.1016/S0272-7358(03)00053-9]">Kelly 2003b</a>). The results presented in this review are also supported by other published analyses. One study from Project MATCH (<a href="./references#CD012880-bbs2-0079" title="LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]]">Longabaugh 1998</a>), found that regardless of whether outpatients' pre‐treatment network was supportive or unsupportive of alcohol use at treatment intake, AA/TSF participants were more likely to be involved with AA, which in turn, subsequently explained the observed lower drinks per drinking day (DDD) and greater PDA advantages for TSF‐treated participants observed at the 36‐month follow‐up. The prior Cochrane Review contained eight studies with 3417 participants (<a href="./references#CD012880-bbs2-0106" title="FerriM , AmatoL , DavoliM . Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database of Systematic Reviews2006, Issue 3. Art. No: CD005032. [DOI: 10.1002/14651858.CD005032.pub2]">Ferri 2006b</a>), and found that on the whole, AA/TSF interventions were as effective, but not more effective, than the interventions to which they were compared. This new review is based on 27 studies reported in 36 articles and has a total of 10,565 participants. It is considerably larger, comprises more rigorous studies, and found that, compared to other active psychosocial interventions for AUD, AA/TSF interventions often produce greater abstinence ‐ notably continuous abstinence ‐ as well as some reductions in drinking intensity, fewer alcohol‐related consequences, and lower alcohol addiction severity. This review also included economic analyses, which augments prior reviews and adds important information regarding the cost‐benefits of providing AA/TSF in clinical settings. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012880-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-FIG-01" target="_blank"><b></b></a></p> </div><img alt="PRISMA study flow diagram." data-id="CD012880-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Manualized = the treatment covers standardized content in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment." data-id="CD012880-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-02.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Manualized = the treatment covers standardized content in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-FIG-03" target="_blank"><b></b></a></p> </div><img alt="S = number of studies from Cochrane ReviewR = number of reports from Cochrane ReviewN = number of participants in the cell subcategoryManualized = the treatment covers standardized content in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment.aThe total Ns added across study types will not add to 10,565 because some of the participants that are in the other groupings (e.g. non‐randomized designs) are also in the economic category. bWalitzer 2009 and its participants are included in both the 1A and 2A grouping in the review, but for the purposes of this table, the study and its participants (n = 169) are only counted once in the 1A group. cOuimette 1997 and its participants are included in both the 3B and 4B grouping, but for the purposes of this table, the study and its participants (n = 3018) are only counted in the 3B group." data-id="CD012880-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-03.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>S = number of studies from Cochrane Review</p> <p>R = number of reports from Cochrane Review</p> <p>N = number of participants in the cell subcategory</p> <p>Manualized = the treatment covers standardized content in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup>The total Ns added across study types will not add to 10,565 because some of the participants that are in the other groupings (e.g. non‐randomized designs) are also in the economic category.<br/><sup>b</sup><a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a> and its participants are included in both the 1A and 2A grouping in the review, but for the purposes of this table, the study and its participants (n = 169) are only counted once in the 1A group.<br/><sup>c</sup><a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a> and its participants are included in both the 3B and 4B grouping, but for the purposes of this table, the study and its participants (n = 3018) are only counted in the 3B group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD012880-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study.Note: 27 primary studies" data-id="CD012880-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> <p>Note: 27 primary studies</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 1: Proportion completely abstinent" data-id="CD012880-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 1: Proportion completely abstinent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 2: Percentage days abstinent (PDA)" data-id="CD012880-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 2: Percentage days abstinent (PDA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 3: Longest period of abstinence (LPA, months)" data-id="CD012880-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 3: Longest period of abstinence (LPA, months) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 4: Drinks per drinking day (DDD)" data-id="CD012880-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 4: Drinks per drinking day (DDD) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 5: Percentage days heavy drinking (PDHD)" data-id="CD012880-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 5: Percentage days heavy drinking (PDHD) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 6: Alcohol‐related consequences (DrInC)" data-id="CD012880-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 6: Alcohol‐related consequences (DrInC) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 7: Alcohol‐related consequences (SIP)" data-id="CD012880-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 7: Alcohol‐related consequences (SIP) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 8: Alcohol‐related consequences (SIP‐2R)" data-id="CD012880-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 8: Alcohol‐related consequences (SIP‐2R) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 9: Addiction Severity Index (ASI)" data-id="CD012880-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 9: Addiction Severity Index (ASI) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0015"> <p> <div class="table" id="CD012880-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Addiction Severity Index (ASI)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Result</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Brooks 2003</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This study found an advantage for the AA/TSF condition over the SMART Recovery condition in the slope for improvement over a 12‐month follow‐up period, as measured by the ASI alcohol composite score (P &lt; 0.05). </p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: 1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation, Outcome 10: Addiction Severity Index (ASI) </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0015">Navigate to figure in review</a></div> </div> <div class="figure" id="CD012880-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: 1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation, Outcome 1: Proportion completely abstinent" data-id="CD012880-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: 1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation, Outcome 1: Proportion completely abstinent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: 1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation, Outcome 2: Percentage days abstinent (PDA)" data-id="CD012880-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: 1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation, Outcome 2: Percentage days abstinent (PDA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0018"> <p> <div class="table" id="CD012880-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Percentage days abstinent (PDA)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Result</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Herman 2000</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Using a log transformed days of drinking variable, this study found a slight advantage at 2‐months post‐treatment (P = 0.03) that favored the AA/TSF condition relative to the comparison condition, but between two and 18 months post‐treatment, there was no evidence of a difference on average between the two groups (P = 0.05). The treatment by time interaction was not reported. </p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: 1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation, Outcome 3: Percentage days abstinent (PDA) </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0018">Navigate to figure in review</a></div> </div> <div class="figure" id="CD012880-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: 1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation, Outcome 4: Drinks per drinking day (DDD)" data-id="CD012880-fig-0019" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: 1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation, Outcome 4: Drinks per drinking day (DDD) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: 1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation, Outcome 5: Percentage days heavy drinking (PDHD)" data-id="CD012880-fig-0020" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: 1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation, Outcome 5: Percentage days heavy drinking (PDHD) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 1: Proportion of participants completely abstinent" data-id="CD012880-fig-0021" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 1: Proportion of participants completely abstinent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 2: Percentage days abstinent (PDA)" data-id="CD012880-fig-0022" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 2: Percentage days abstinent (PDA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 3: Days of use (PDA)" data-id="CD012880-fig-0023" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 3: Days of use (PDA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 4: Drinks per drinking day (DDD)" data-id="CD012880-fig-0024" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 4: Drinks per drinking day (DDD) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 5: Addiction Severity Index (ASI)" data-id="CD012880-fig-0025" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 5: Addiction Severity Index (ASI) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 6: European Addiction Severity Index (EuropASI)" data-id="CD012880-fig-0026" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: 2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant, Outcome 6: European Addiction Severity Index (EuropASI) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: 2B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to TSF variant, Outcome 1: Proportion of participants completely abstinent" data-id="CD012880-fig-0027" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: 2B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to TSF variant, Outcome 1: Proportion of participants completely abstinent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 1: Proportion of participants completely abstinent" data-id="CD012880-fig-0028" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 1: Proportion of participants completely abstinent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 2: Drinks per drinking day (DDD)" data-id="CD012880-fig-0029" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 2: Drinks per drinking day (DDD) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 3: Alcohol‐related consequences (SIP)" data-id="CD012880-fig-0030" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 3: Alcohol‐related consequences (SIP) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 4: Alcohol‐related consequences" data-id="CD012880-fig-0031" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 4: Alcohol‐related consequences </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-005.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 5: Alcohol addiction severity (Alcohol Dependence Scale)" data-id="CD012880-fig-0032" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-005.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-005.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5: 3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation, Outcome 5: Alcohol addiction severity (Alcohol Dependence Scale) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-005.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: 4B: Non‐randomized, 1+ treatments non‐manualized, compared to TSF variant, Outcome 1: Proportion completely abstinent" data-id="CD012880-fig-0033" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: 4B: Non‐randomized, 1+ treatments non‐manualized, compared to TSF variant, Outcome 1: Proportion completely abstinent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: 4B: Non‐randomized, 1+ treatments non‐manualized, compared to TSF variant, Outcome 2: Percentage days abstinent (PDA)" data-id="CD012880-fig-0034" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: 4B: Non‐randomized, 1+ treatments non‐manualized, compared to TSF variant, Outcome 2: Percentage days abstinent (PDA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012880-fig-0035"> <p> <div class="table" id="CD012880-tblf-0003"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Drinks per drinking day (DDD)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Result</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Grant 2018</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This study reported drinks per drinking day (DDD) only for those participants (n = 25) who were not abstinent during the follow‐up period and found no difference in DDD between the Rural Adapted Intensive Referral (mean 17.63, SD 23.71) and the standard referral (mean 11.47, SD 5.94), P = 0.49. </p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: 4B: Non‐randomized, 1+ treatments non‐manualized, compared to TSF variant, Outcome 3: Drinks per drinking day (DDD) </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0035">Navigate to figure in review</a></div> </div> <div class="figure" id="CD012880-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/urn:x-wiley:14651858:media:CD012880:CD012880-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: 4B: Non‐randomized, 1+ treatments non‐manualized, compared to TSF variant, Outcome 4: Addition Severity Index‐Lite (ASI‐L)" data-id="CD012880-fig-0036" src="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_t/tCD012880-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: 4B: Non‐randomized, 1+ treatments non‐manualized, compared to TSF variant, Outcome 4: Addition Severity Index‐Lite (ASI‐L) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/media/CDSR/CD012880/image_n/nCD012880-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012880-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol use disorder (1A)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol use disorder (RCT/quasi‐RCT evidence)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults (&gt; 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence<br/><b>Setting:</b> outpatient treatment<br/><b>Intervention:</b> AA/TSF (manualized)<br/><b>Comparison:</b> other clinical interventions (e.g. CBT) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with other clinical interventions</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with AA/TSF</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="middle"> <p>Abstinence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Proportion of participants (%) completely abstinent</p> <p>Follow‐up: 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.21<br/>(1.03 to 1.42) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1936<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>345 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>418 per 1000<br/>(356 to 490) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDA</p> <p>Follow‐up: 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PDA in the comparison group ranged from 62.3% to 84.0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 3.03 higher<br/>(4.36 lower to 10.43 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1999<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<br/><sup>a, b, c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>LPA</p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean LPA in the comparison group ranged from 0.47 to 1.71 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD 0.60 higher</p> <p>(0.30 lower to 1.50 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>136<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>d, e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Drinking Intensity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>DDD</p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DDD in the comparison group ranged from 4.66 to 5.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD 0.17 lower<br/>(1.11 lower to 0.77 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1516<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate <sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDHD</p> <p>Follow‐up: 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PDHD in the comparison group was 13.4%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 5.51 lower<br/>(14.15 lower to 3.13 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol‐related consequences (assessed with DrInC)</p> <p>Follow‐up: 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DrInC in the comparison group ranged from 21.8% to 72.9%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.88 lower<br/>(6.81 lower to 1.04 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1762<br/>(3 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate <sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Alcohol addiction severity<br/>(assessed with ASI) </p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign=""> <p>One study found an advantage for the AA/TSF intervention relative to the comparison intervention in the slope for improvement over a 12‐month follow‐up period (<a href="./references#CD012880-bbs2-0005" title="BrooksAJ , PennPE . Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training. American Journal of Drug and Alcohol Abuse2003;29(2):359-83. [DOI: 10.1081/ADA-120020519]">Brooks 2003</a>), as measured by the ASI alcohol composite score (P &lt; 0.05). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112<br/>(1 quasi‐RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>a, g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AA:</b> Alcoholics Anonymous; <b>ASI:</b> Addiction Severity Index; <b>CBT:</b> cognitive behavioral therapy; <b>CI:</b> confidence interval; <b>DDD:</b> drinks per drinking day; <b>DrInC:</b> Drinker Inventory of Consequences; <b>LPA:</b> longest period of abstinence; <b>MD:</b> mean difference; <b>PDA:</b> percentage days abstinent; <b>PDHD:</b> percentage days heavy drinking; <b>RCT:</b> randomized controlled trial; <b>RR</b> : risk ratio; <b>TSF:</b> Twelve‐Step Facilitation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Quasi‐RCT: studies where due to potential intervention contamination effects within single sites, it was not possible to do parallel, simultaneous randomization, but instead, sequential designs were used where the intervention was implemented and then not implemented and then reimplemented with subsequent groups of participants in an 'ON/OFF' type design. </p> <p>Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup> Downgraded due to study limitations (high risk of selection bias) </p> <p><sup>b</sup> Downgraded two levels due to inconsistency (I<sup>2</sup> = 91%) </p> <p><sup>c</sup> Downgraded due to imprecision (CI fails to exclude important benefit or important harm) </p> <p><sup>d</sup> Downgraded due to imprecision (moderate sample size (n = 148)) </p> <p><sup>e</sup> Downgraded due to study limitations (potential attrition bias and potential blinding of outcome bias) </p> <p><sup>f</sup> Downgraded due to imprecision (small sample size (n = 91) and wide confidence interval) </p> <p><sup>g</sup> Downgraded as narrative synthesis was conducted, therefore estimates are not precise </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol use disorder (1A)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012880-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to other clinical interventions for alcohol use disorder (1B)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to other clinical interventions for alcohol use disorder (RCT/quasi‐RCT evidence)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults (&gt; 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence<br/><b>Setting:</b> outpatient treatment; inpatient/residential facility<br/><b>Intervention:</b> AA/TSF (non‐manualized)<br/><b>Comparison:</b> other clinical interventions (e.g. CBT) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with other clinical interventions</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with AA/TSF</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Abstinence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Proportion of participants (%) completely abstinent</p> <p>Follow‐up: 9 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.71</p> <p>(0.70 to 4.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>167 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118 more per 1000<br/>(50 fewer to 530 more) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDA<br/>Follow‐up: 9 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PDA in the comparison group was 70%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 3.00 higher</p> <p>(0.31 higher to 5.69 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>LPA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Drinking Intensity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>DDD<br/>Follow‐up: 9 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DDD in the comparison group was 8.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 1.76 lower</p> <p>(2.23 lower to 1.29 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDHD</p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of heavy drinking days in the comparison group ranged from 1.44 to 3.89 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.09 higher</p> <p>(1.24 lower to 5.42 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>e,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol‐related consequences</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Alcohol addiction severity</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AA:</b> Alcoholics Anonymous; <b>CBT:</b> cognitive behavioral therapy; <b>CI</b> : confidence interval; <b>DDD:</b> drinks per drinking day; <b>LPA:</b> longest period of abstinence; <b>MD:</b> mean difference; <b>PDA:</b> percentage days abstinent; <b>PDHD:</b> percentage days heavy drinking; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio; <b>TSF:</b> Twelve‐Step Facilitation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Quasi‐RCT: studies where due to potential intervention contamination effects within single sites, it was not possible to do parallel, simultaneous randomization, but instead, sequential designs were used where the intervention was implemented and then not implemented and then reimplemented with subsequent groups of participants in an 'ON/OFF' type design. </p> <p>Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup>Downgraded two levels due to imprecision (small sample size (n = 93)).<br/><sup>b</sup>Downgraded due to study limitations (risk of attrition bias).<br/><sup>c</sup>Downgraded due to imprecision (moderate sample size (n = 121)).<br/><sup>d</sup>Downgraded due to indirectness (the focus on dual diagnosis participants with severe mental illness which may not be the population of interest most associated with AA/TSF).<br/><sup>e</sup>Downgraded due to imprecision (moderate sample size (n = 286)).<br/><sup>f</sup>Downgraded due to study limitations (having no information reported to assess four different types of bias). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to other clinical interventions for alcohol use disorder (1B)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012880-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to a different type of TSF for alcohol use disorder (2A)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to a different type of Twelve‐Step Facilitation for alcohol use disorder (RCT/quasi‐RCT evidence)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults (&gt; 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence<br/><b>Setting:</b> outpatient treatment; inpatient/residential facility<br/><b>Intervention:</b> AA/TSF (manualized)<br/><b>Comparison:</b> a different type of TSF (i.e. varying in TSF style or intensity) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with different type of TSF</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with AA/TSF</b> </p> </th> </tr> <tr class="separated"> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="middle"> <p>Abstinence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Proportion of participants (%) completely abstinent</p> <p>Follow‐up: 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.28</p> <p>(1.00 to 1.63)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>307<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>404 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113 more per 1000<br/>(0 fewer to 255 more) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDA</p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PDA in the comparison group was 67.41%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 16.40 higher</p> <p>(5.12 higher to 27.68 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>LPA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Drinking Intensity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>DDD</p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DDD in the comparison group was 6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 4.10 lower</p> <p>(10.44 lower to 2.24 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDHD</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol‐related consequences</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol addiction severity<br/>(assessed with ASI) </p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ASI in the comparison group was 0.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD 0.08 higher</p> <p>(0.02 higher to 0.15 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>307</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AA:</b> Alcoholics Anonymous; <b>ASI:</b> Addiction Severity Index; <b>CI</b> : confidence interval; <b>DDD:</b> drinks per drinking day; <b>LPA:</b> longest period of abstinence; <b>MD:</b> mean difference; <b>PDA:</b> percentage days abstinent; <b>PDHD:</b> percentage days heavy drinking; <b>RCT:</b> randomized controlled trial; <b>RR</b> : risk ratio; <b>TSF:</b> Twelve‐Step Facilitation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Quasi‐RCT: studies where due to potential intervention contamination effects within single sites, it was not possible to do parallel, simultaneous randomization, but instead, sequential designs were used where the intervention was implemented and then not implemented and then reimplemented with subsequent groups of participants in an 'ON/OFF' type design. </p> <p>Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup>Downgraded due to imprecision (moderate sample size (n = 307)).<br/><sup>b</sup>Downgraded due to imprecision (small sample size (n = 95)).<br/><sup>c</sup>Downgraded due to imprecision (small sample size (n = 48)). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to a different type of TSF for alcohol use disorder (2A)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012880-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to a different type of TSF for alcohol use disorder (2B)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized)</b> <b>compared to a different type of TSF for alcohol use disorder (RCT/quasi‐RCT evidence)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults (&gt; 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence<br/><b>Setting:</b> outpatient treatment; inpatient/residential facility<br/><b>Intervention:</b> AA/TSF (non‐manualized)<br/><b>Comparison:</b> a different type of TSF (i.e. varying in TSF style or intensity) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with different type of TSF</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with AA/TSF</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Abstinence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Proportion of participants (%) completely abstinent</p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.15</p> <p>(1.02 to 1.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>382<br/>(1 quasi‐RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>713 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107 more per 1000<br/>(14 more to 207 more) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>PDA</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>LPA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="middle"> <p>Drinking intensity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>DDD</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>PDHD</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol‐related consequences</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Alcohol addiction severity</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AA:</b> Alcoholics Anonymous; <b>CI</b> : confidence interval; <b>DDD:</b> drinks per drinking day; <b>LPA:</b> longest period of abstinence; <b>PDA:</b> percentage days abstinent; <b>PDHD:</b> percentage days heavy drinking; <b>RCT:</b> randomized controlled trial; <b>RR</b> : risk ratio; <b>TSF:</b> Twelve‐Step Facilitation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Quasi‐RCT: studies where due to potential intervention contamination effects within single sites, it was not possible to do parallel, simultaneous randomization, but instead, sequential designs were used where the intervention was implemented and then not implemented and then reimplemented with subsequent groups of participants in an 'ON/OFF' type design. </p> <p>Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup>Downgraded due to study limitations (risk of random sequence generation, allocation concealment, and attrition bias). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to a different type of TSF for alcohol use disorder (2B)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012880-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol use disorder: non‐randomized studies (3B)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized)</b> <b>compared to other clinical interventions for alcohol use disorder: non‐randomized studies</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults (&gt; 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence<br/><b>Setting:</b> outpatient treatment; inpatient/residential facility<br/><b>Intervention:</b> AA/TSF (manualized)<br/><b>Comparison:</b> other clinical interventions (e.g. CBT) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with other clinical interventions</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with AA/TSF</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="middle"> <p>Abstinence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>Proportion of participants (%) completely abstinent</p> <p>Follow‐up: 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.25<br/>(1.09 to 1.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2692<br/>(2 non‐ randomized) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>286 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>358 per 1000<br/>(312 to 409) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDA</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>LPA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign=""> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Drinking intensity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>DDD<br/>Follow‐up: 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean DDD in the comparison group was 6.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.00</p> <p>(3.38 lower to 3.38 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>201<br/>(1 non‐ randomized) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDHD</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol‐related consequences (assessed with SIP)</p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean SIP in the comparison group ranged from 4.1 to 5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.71 lower</p> <p>(1.68 lower to 0.27 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>647</p> <p>(1 non‐ randomized)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol addiction severity<br/>(assessed with ADS) </p> <p>Follow‐up: 36 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ADS in the comparison group was 3.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.30 lower</p> <p>(2.20 lower to 1.60 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>201<br/>(1 non‐ randomized) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AA:</b> Alcoholics Anonymous; <b>ADS:</b> Alcohol Dependence Scale; <b>CI</b> : confidence interval; <b>DDD:</b> drinks per drinking day; <b>LPA:</b> longest period of abstinence; <b>MD:</b> mean difference; <b>PDA:</b> percentage days abstinent; <b>PDHD:</b> percentage days heavy drinking; <b>RCT:</b> randomized controlled trial; <b>RR</b> : risk ratio; <b>SIP:</b> Short Inventory of Problems; <b>TSF:</b> Twelve‐Step Facilitation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Non‐randomized: prospective, parallel, group design studies in which intact intervention groups receive either an AA/TSF intervention or a comparison intervention without being randomly assigned to interventions. </p> <p>Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup>Downgraded due to study limitations (the lack of control of sample selection and non‐randomized nature).<br/><sup>b</sup>Downgraded due to indirectness (comparability of cohorts for baseline characteristics and outcome measures, and protection against contamination).<br/><sup>c</sup>Downgraded due to imprecision (being a single study with a moderate sample size (N = 201)). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol use disorder: non‐randomized studies (3B)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012880-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to a different type of TSF for alcohol use disorder: non‐randomized studies (4B)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized)</b> <b>compared to a different type of TSF for alcohol use disorder: non‐randomized studies</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults (&gt; 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence<br/><b>Setting:</b> inpatient/residential facility<br/><b>Intervention:</b> AA/TSF (non‐manualized)<br/><b>Comparison:</b> a different type of TSF (i.e. varying in TSF style or intensity) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="2" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with different type of TSF</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with AA/TSF</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Abstinence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Proportion of participants (%) completely abstinent</p> <p>Follow‐up: 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.24</p> <p>(1.05 to 1.46)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1870</p> <p>(1 non‐</p> <p>randomized)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>203 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49 more per 1000<br/>(10 more to 94 more) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDA</p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean PDA in the comparison group was 92.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.01 lower</p> <p>(7.14 lower to 7.12 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>195<br/>(1 non‐randomized) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>LPA</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="middle"> <p>Drinking Intensity</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>DDD<br/>Follow‐up: 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>One study (<a href="./references#CD012880-bbs2-0008" title="GrantKM , YoungLB , TylerKA , SimpsonJL , PulidoRD , TimkoC . Intensive referral to mutual-help groups: a field trial of adaptations for rural veterans. Patient Education and Counseling2018;101(1):79-84. [DOI: 10.1016/j.pec.2017.07.012]">Grant 2018</a>) reported DDD based on n = 25 across both groups who were participants who drank any alcohol during the follow‐up period and found no evidence of a difference between the more (mean 17.63, SD 23.71) and less (mean 11.47, SD 5.94) intensive AA/TSF interventions, P = 0.49. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>195<br/>(1 non‐ randomized) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were not pooled because authors reported only those participants that drank any alcohol and not the total proportion of participants that drank. They also did not provide numbers by treatment intervention. </p> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>PDHD</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Alcohol‐related consequences</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>None of the studies in this category reported this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Alcohol addiction severity (assessed with ASI‐L)</p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean ASI‐L in the comparison group was 0.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.01 higher</p> <p>(0.05 lower to 0.07 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140<br/>(1 non‐ randomized) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data available for 12‐month follow‐up</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>AA:</b> Alcoholics Anonymous; <b>ASI‐L:</b> Addiction Severity Index‐Lite; <b>CI:</b> confidence interval; <b>DDD:</b> drinks per drinking day; <b>LPA:</b> longest period of abstinence; <b>MD:</b> mean difference; <b>PDA:</b> percentage days abstinent; <b>PDHD:</b> percentage days heavy drinking; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio; <b>TSF:</b> Twelve‐Step Facilitation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Non‐randomized: prospective, parallel, group design studies whereby intact intervention groups receive either an AA/TSF intervention or a comparison intervention without being randomly assigned to interventions. </p> <p>Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the same treatment. </p> <p><sup>a</sup>Downgraded due to study limitations (risk of attrition bias).<br/><sup>b</sup>Downgraded due to imprecision (a single study with a moderate sample size (N = 195)).<br/><sup>c</sup>Downgraded as narrative synthesis was conducted, therefore estimates are not precise. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) (non‐manualized) compared to a different type of TSF for alcohol use disorder: non‐randomized studies (4B)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012880-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) compared to other clinical interventions and a different type of TSF for alcohol use disorder: cost‐effectiveness studies (5)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) compared to other clinical interventions and a different type of TSF for alcohol use disorder: cost‐effectiveness studies</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> alcohol use disorder<br/><b>Setting:</b> outpatient treatment; inpatient/residential facility<br/><b>Intervention:</b> AA/TSF<br/><b>Comparison:</b> other clinical interventions and a different type of TSF </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Impact</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthcare cost savings<br/>(assessed with total medical care cost savings) </p> <p>Follow‐up: 6 months to 7 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5348<br/>(4 studies) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Four studies contributed five separate published reports. In three studies (four study reports), AA/TSF had higher healthcare cost savings than outpatient treatment, CBT, and no AA/TSF treatment. One other study found that total medical care costs decreased for participants attending CBT, MET, and AA/TSF treatment, but that AA/TSF had higher cost‐savings potential compared to MET among participants with worse prognostic characteristics. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>AA/TSF:</b> Alcoholics Anonymous/Twelve‐Step Facilitation; <b>CBT:</b> cognitive behavioral therapy; <b>MET:</b> motivational enhancement therapy </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>a</sup>Downgraded due to random sequence generation bias, and problems with comparability of cohorts at baseline; protection against contamination between study interventions. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Alcoholics Anonymous (AA)/Twelve‐Step Facilitation (TSF) compared to other clinical interventions and a different type of TSF for alcohol use disorder: cost‐effectiveness studies (5)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012880-tbl-0008"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Follow‐up time points, treatment duration and treatment setting</span></div> <tbody> <tr> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Follow‐up time period (months)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Treatment duration</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Setting</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0001" title="BlondellRD , LooneySW , NorthingtonAP , LaschME , RhodesSB , McDanielsRL . Using recovering alcoholics to help hospitalized patients with alcohol problems. Journal of Family Practice2001;50(5):1-15. ">Blondell 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A single session of either a <b>peer intervention</b> (30‐60 minutes), <b>brief intervention</b> (5‐15 minutes), or <b>usual care</b> (60 minutes) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0002" title="BlondellRD , FrydrychLM , JaanimaqiU , AshrafiounL , HomishGG , FoschioEM , et al. A randomized trial of two behavioral interventions to improve outcomes following inpatient detoxification for alcohol dependence. Journal of Addictive Diseases2011;30(2):136-48. [DOI: 10.1080/10550887.2011.554777]">Blondell 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TAU:</b> 3 to 5 calendar days treatment<br/><b>TSF:</b> TAU + single 45‐ to 60‐minute session of TSF </p> <p><b>MET:</b> TAU + single 45‐ to 60‐minute session of MET </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0003" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12-step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403-11. [DOI: 10.1016/j.jsat.2013.12.009]">Bogenschutz 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TSF:</b> TAU + 12 weekly sessions of TSF therapy </p> <p><b>TAU:</b> TAU in the clinical dual diagnosis program </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0004" title="BowenS , WitkiewitzK , ClifasefiSL , GrowJ , ChawlaN , HsuSH , et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry2014;71(5):547-56. [DOI: 10.1001/jamapsychiatry.2013.4546]">Bowen 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks of either <b>MBRP</b> (1 weekly 2‐hour session), <b>RP</b> (1 weekly 2‐hour session), </p> <p>or <b>TAU</b> (1‐2 sessions/week for 1.5 hours) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0005" title="BrooksAJ , PennPE . Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training. American Journal of Drug and Alcohol Abuse2003;29(2):359-83. [DOI: 10.1081/ADA-120020519]">Brooks 2003</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both treatment groups met for 5 hours per day, 5 days per week over a 6‐month course of treatment </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0006" title="BrownTG , SeraganianP , TremlayJ , AnnisH . Process and outcome changes with relapse prevention versus 12-step aftercare programs for substance abusers. Addiction2002;976(6):677-89. ">Brown 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TSF:</b> 10 weekly 90‐minute 12‐step aftercare group sessions<br/><b>RP:</b> 10 weekly 90‐minute relapse prevention aftercare group sessions<br/><b>UC:</b> non‐specific support groups that encourage participants to maintain their substance use goals and include discussion of problems and potential solutions </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0007" title="DavisWT , CampbellL , TaxJ , LieberCS . A trial of 'standard' outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment2002;23(1):9-19. [DOI: 10.1016/S0740-5472(02)00227-1]">Davis 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months of either <b>MT</b> (1 weekly session during which participants viewed an alcoholism education movie, with a post‐film discussion held once per month) or <b>ST</b> (3‐week orientation period consisting of 6 group therapy sessions, 3 alcohol education sessions during which alcohol education films were shown, 3 community meetings and a minimum of 6 AA meetings, followed by weekly group and/or individual therapy sessions for the remainder of the treatment period, and optional alcohol education sessions beyond the orientation period) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0008" title="GrantKM , YoungLB , TylerKA , SimpsonJL , PulidoRD , TimkoC . Intensive referral to mutual-help groups: a field trial of adaptations for rural veterans. Patient Education and Counseling2018;101(1):79-84. [DOI: 10.1016/j.pec.2017.07.012]">Grant 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RAIR:</b> standard treatment + rural‐adapted intensive referral (3 sessions) </p> <p><b>SR:</b> standard treatment and referral </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0009" title="HermanSE , FrankKA , MowbrayCT , RibislKM , Davidson WS 2nd, Boots MillerB , et al. Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. Journal of Behavioral Health Services &amp; Research2000;27(3):286-302. [DOI: doi.org/10.1007/BF02291740]">Herman 2000</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>STW:</b> treatment in the standard short‐term treatment ward only (average length of stay = 31.1 days; staff not trained in substance use treatment)<br/><b>MHCD program:</b> treatment provided by mental health staff trained in substance use treatment and included educational lectures, AA and/or NA groups (participants required to attend at least 2 meetings per week), gender‐specific support groups, and family education sessions (average length of stay = 51.4 days) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0057" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [10.1046/j.1360-0443.2000.9579993.x]">Holder 2000</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks of either <b>TSF/CBT</b> with weekly treatment sessions, or <b>MET</b> with four sessions that occurred during weeks 1, 2, 6, and 12 </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous assessment of community‐based AA participation during the follow‐up period (i.e. 36 months) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See footnote*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0060" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-6.">Humphreys 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 to 28 days</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0062" title="HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]">Humphreys 2007</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 to 28 days</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0011" title="KahlerCW , ReadJP , RamseySE , StuartGL , McCradyBS , BrownRA . Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology2004;72(4):736-41. [DOI: 10.1037/0022-006X.72.4.736]">Kahler 2004</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>ME‐12:</b> one 60‐minute session<br/><b>BA:</b> one 5‐minute session<br/>Both interventions also included daily sessions with a psychiatrist, daily AA/NA meetings, and one group session per day (range of program stay = 2 to 8 days (mean 4.6, SD 1.6)) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0012" title="KaskutasLA , SubbaramanMS , WitbrodtJ , ZemoreSE . Effectiveness of making alcoholics anonymous easier: a group format 12-step facilitation approach. Journal of Substance Abuse Treatment2009;37(3):228-39. [DOI: 10.1016/j.jsat.2009.01.004]">Kaskutas 2009b</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MAAEZ:</b> six 90‐minute MAAEZ sessions replaced six usual care 12‐step education groups<br/><b>TAU:</b> usual care groups only </p> <p>(mean length of program stay was 112 days (SD 80) for long‐term residents, 33 days (SD 32) for short‐term residents, 44 days (SD 42) for outpatients) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient,</p> <p>inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0013" title="KellyJF , KaminerY , KahlerCW , HoeppnerB , YeterianJ , CristelloJV , et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction2017;112(12):2155-66. [DOI: 10.1111/add.13920]">Kelly 2017b</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weekly sessions: <b>iTSF</b> consisted of one 60‐ to 75‐minute individual session, one 30‐ to 50‐minute individual session, and eight 90‐minute group sessions; <b>MET/CBT</b> consisted of two 60‐minute individual MET sessions and eight 90‐minute group CBT sessions </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 &amp; 24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks (weekly 60‐minute sessions)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0015" title="LittMD , KaddenRM , TennenH , Kabela-CormierE . Network Support II: randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug and Alcohol Dependence2016;165:203-12. [DOI: 10.1016/j.drugalcdep.2016.06.010]">Litt 2016</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks (weekly 60‐minute sessions)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0016" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453-65. [DOI: 10.1037/a0019943]">Lydecker 2010</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 weeks. Both interventions consisted of two consecutive phases of treatment. Phase I included bi‐weekly hour‐long group sessions and monthly individual medication management visits. Phase II included weekly hour‐long group sessions and monthly medication management. </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0017" title="ManningV , BestD , FaulknerN , TitheringtonE , MorinanA , KeaneyF , et al. Does active referral by a doctor or 12-step peer improve 12-step meeting attendance? Results from a pilot randomised control trial. Drug and Alcohol Dependence2012;126(1-2):131-7. [DOI: 10.1016/j.drugalcdep.2012.05.004]">Manning 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PI:</b> one 30‐ to 45‐minute session </p> <p><b>DI:</b> one 30‐ to 45‐minute session </p> <p><b>NI:</b> participants provided with a list of meetings only </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12, 36 &amp; EOT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks: <b>TSF/CBT</b> consisted of weekly treatment sessions; <b>MET</b> consisted of four sessions that occurred during weeks 1, 2, 6, and 12 </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0019" title="McCradyBS , EpsteinEE , HirschLS . Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]McCradyBS , EpsteinEE , HirschLS . Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x]McCradyBS , EpsteinEE , KahlerCW . Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870]">McCrady 1996</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6, 18 &amp; EOT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 weeks (weekly 90‐minute sessions)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0020" title="MundtMP , ParthasarathyS , ChiFW , SterlingS , CampbellCI . 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002]">Mundt 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous assessment of community‐based AA participation during the follow‐up period (i.e. 60 months) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 to 28 days</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0022" title="TimkoC , DeBenedettiA . A randomized controlled trial of intensive referral to 12-step self-help groups: One-year outcomes. Drug and Alcohol Dependence2007;90(2-3):270-9. TimkoC , DebenedettiA , BillowR . Intensive referral to 12-step self-help groups and 6-month substance use disorder outcomes. Addiction2006;101(5):678-88. [DOI: 10.1111/j.1360-0443.2006.01391.x]">Timko 2006</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 &amp; 12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 sessions of either <b>IR</b> or <b>SR</b> across the course of 1 month </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0023" title="TimkoC , SutkowiA , CronkiteRC , Makin-ByrdK , MoosRH . Intensive referral to 12-step dual-focused mutual-help groups. Drug and Alcohol Dependence2011;118(2-3):194-201. [DOI: 10.1016/j.drugalcdep.2011.03.019]">Timko 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>IR:</b> standard outpatient mental health care + four additional outpatient group sessions within one month<br/><b>SR:</b> standard outpatient mental health care during which counselors gave participants a schedule of local dual‐focused 12‐step meetings </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0024" title="VederhusJK , TimkoC , KristensenO , HjemdahlB , ClausenT . Motivational intervention to enhance post‐detoxification 12‐step group affiliation: a randomized controlled trial. Addiction2014;109(5):766-73. [DOI: 10.1111/add.12471]">Vederhus 2014</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MI:</b> two weekly, 30‐minute education sessions + standard detox<br/><b>BA:</b> brief advice to attend 12‐step groups in participants' home communities + standard detox (days on the ward averaged 12.6 days (SD 6.5) in the MI group and 9.9 days (SD 3.2) in the BA group) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/</p> <p>residential facility</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 x 60‐minute sessions and one 90‐minute session over the course of 12 weeks</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0026" title="WalitzerKS , DeffenbacherJL , ShyhallaK . Alcohol-adapted anger management treatment: a randomized controlled trial of an innovative therapy for alcohol dependence. Journal of Substance Abuse Treatment2015;59:83-93. [DOI: 10.1016/j.jsat.2015.08.003]">Walitzer 2015</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 x 60‐minute sessions over the course of 12 weeks</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012880-bbs2-0027" title="ZemoreSE , LuiC , MericleA , HembergJ , KaskutasLA . A longitudinal study of the comparative efficacy of Women for Sobriety, LifeRing, SMART Recovery, and 12-step groups for those with AUD. Journal of Substance Abuse Treatment2018;88:18-26. [DOI: 10.1016/j.jsat.2018.02.004]">Zemore 2018</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Continuous assessment of community‐based AA participation during the follow‐up period (i.e. 12 months) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>*This study consisted of participants recruited from inpatient/residential facilities as well as those seeking treatment through an information and referral helpline (<a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a>), and were naturalistically followed. </p> <p><b>AA:</b> Alcoholics Anonymous<br/><b>BA:</b> brief advice<br/><b>CBT:</b> cognitive behavioral therapy<br/><b>DI:</b> doctor intervention<br/><b>EOT:</b> end of treatment<br/><b>IR:</b> intensive referral<br/><b>iTSF:</b> integrated 12‐Step Facilitation<br/><b>MAAEZ:</b> Making AA Easier<br/><b>ME‐12:</b> extended motivational enhancement<br/><b>MET:</b> motivational enhancement therapy<br/><b>MBRP:</b> mindfulness‐based relapse prevention<br/><b>MHCD:</b> Mental Health Chemical Dependence<br/><b>MI:</b> motivational intervention<br/><b>MT:</b> minimal treatment<br/><b>NA:</b> Narcotics Anonymous<br/><b>NI:</b> no intervention<br/><b>PI:</b> peer intervention<br/><b>RAIR:</b> rural‐adapted intensive referral<br/><b>RP:</b> relapse prevention<br/><b>SD:</b> standard deviation<br/><b>SR:</b> standard referral<br/><b>ST:</b> standard outpatient treatment<br/><b>STW:</b> standard short‐term treatment ward<br/><b>TAU:</b> treatment as usual<br/><b>TSF:</b> Twelve‐Step Facilitation<br/><b>UC:</b> usual care </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Follow‐up time points, treatment duration and treatment setting</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012880-tbl-0009"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">How studies handled any missing data</span></div> <tbody> <tr> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign="middle"> <p><b>Study</b> </p> </th> <th align="center" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Missing data</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0001" title="BlondellRD , LooneySW , NorthingtonAP , LaschME , RhodesSB , McDanielsRL . Using recovering alcoholics to help hospitalized patients with alcohol problems. Journal of Family Practice2001;50(5):1-15. ">Blondell 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0002" title="BlondellRD , FrydrychLM , JaanimaqiU , AshrafiounL , HomishGG , FoschioEM , et al. A randomized trial of two behavioral interventions to improve outcomes following inpatient detoxification for alcohol dependence. Journal of Addictive Diseases2011;30(2):136-48. [DOI: 10.1080/10550887.2011.554777]">Blondell 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0003" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12-step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403-11. [DOI: 10.1016/j.jsat.2013.12.009]">Bogenschutz 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Missing data were reconstructed by participant self‐report when participants returned for later follow‐up assessments. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0004" title="BowenS , WitkiewitzK , ClifasefiSL , GrowJ , ChawlaN , HsuSH , et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry2014;71(5):547-56. [DOI: 10.1001/jamapsychiatry.2013.4546]">Bowen 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intention‐to‐treat analyses conducted using sample size weighted orthogonal contrasts and parameters estimated using maximum likelihood estimation, which provides the estimated variance‐covariance matrix for the available data. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0005" title="BrooksAJ , PennPE . Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training. American Journal of Drug and Alcohol Abuse2003;29(2):359-83. [DOI: 10.1081/ADA-120020519]">Brooks 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hierarchical linear modeling used to analyze change over time in the whole sample and to test for treatment intervention differences on the outcome variables. Hierarchical linear modeling allows for the inclusion of cases with incomplete data, weighting cases with more complete data and reliable trajectories more heavily. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0006" title="BrownTG , SeraganianP , TremlayJ , AnnisH . Process and outcome changes with relapse prevention versus 12-step aftercare programs for substance abusers. Addiction2002;976(6):677-89. ">Brown 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0007" title="DavisWT , CampbellL , TaxJ , LieberCS . A trial of 'standard' outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment2002;23(1):9-19. [DOI: 10.1016/S0740-5472(02)00227-1]">Davis 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0008" title="GrantKM , YoungLB , TylerKA , SimpsonJL , PulidoRD , TimkoC . Intensive referral to mutual-help groups: a field trial of adaptations for rural veterans. Patient Education and Counseling2018;101(1):79-84. [DOI: 10.1016/j.pec.2017.07.012]">Grant 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0009" title="HermanSE , FrankKA , MowbrayCT , RibislKM , Davidson WS 2nd, Boots MillerB , et al. Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. Journal of Behavioral Health Services &amp; Research2000;27(3):286-302. [DOI: doi.org/10.1007/BF02291740]">Herman 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0057" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [10.1046/j.1360-0443.2000.9579993.x]">Holder 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Providers, hospitals and insurance companies were contacted to provide cost and utilization data for all patient contacts in order to collect data that may have otherwise been unreported by participants via self‐report. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0010" title="HumphreysK , MoosRH . Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous. Psychiatric Services1996;47(7):709-13. [DOI: 10.1176/ps.47.7.709]">Humphreys 1996</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intention‐to‐treat analyses were conducted with worst case scenarios attributed to participants who were lost to follow‐up. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0060" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-6.">Humphreys 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No missing data (healthcare utilization data extracted from Veterans Affair's centralized database) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0062" title="HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]">Humphreys 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No missing data (Veterans Affairs healthcare data available for all participants)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0011" title="KahlerCW , ReadJP , RamseySE , StuartGL , McCradyBS , BrownRA . Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology2004;72(4):736-41. [DOI: 10.1037/0022-006X.72.4.736]">Kahler 2004</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only participants who provided outcome data for at least two‐thirds of follow‐up (i.e. 4 months) were included in the analyses. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0012" title="KaskutasLA , SubbaramanMS , WitbrodtJ , ZemoreSE . Effectiveness of making alcoholics anonymous easier: a group format 12-step facilitation approach. Journal of Substance Abuse Treatment2009;37(3):228-39. [DOI: 10.1016/j.jsat.2009.01.004]">Kaskutas 2009b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intention‐to‐treat analyses were conducted with worst case scenarios attributed to participants who were lost to follow‐up. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0013" title="KellyJF , KaminerY , KahlerCW , HoeppnerB , YeterianJ , CristelloJV , et al. A pilot randomized clinical trial testing integrated 12‐step facilitation (iTSF) treatment for adolescent substance use disorder. Addiction2017;112(12):2155-66. [DOI: 10.1111/add.13920]">Kelly 2017b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intention‐to‐treat analyses were conducted with worst case scenarios attributed to participants who were lost to follow‐up. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0014" title="LittMD , KaddenRM , Kabela-CormierE , PetryN . Changing network support for drinking: initial findings from the network support project. Journal of Consulting and Clinical Psychology2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]LittMD , KaddenRM , Kabela-CormierE , PetryNM . Changing network support for drinking: Network Support Project 2-year follow-up. Journal of Consulting and Clinical Psychology2009;77(2):229-42. [DOI: 10.1037/a0015252]">Litt 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intention‐to‐treat analyses were conducted with worst case scenarios attributed to participants who were lost to follow‐up. Participants who had missing data were excluded from the analyses. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0015" title="LittMD , KaddenRM , TennenH , Kabela-CormierE . Network Support II: randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder. Drug and Alcohol Dependence2016;165:203-12. [DOI: 10.1016/j.drugalcdep.2016.06.010]">Litt 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Generalized estimating equations were used to maximize use of all available data.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0016" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453-65. [DOI: 10.1037/a0019943]">Lydecker 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>To compensate for missing observations and variation in covariate values, comparisons of outcome summary data were made with adjusted means. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0017" title="ManningV , BestD , FaulknerN , TitheringtonE , MorinanA , KeaneyF , et al. Does active referral by a doctor or 12-step peer improve 12-step meeting attendance? Results from a pilot randomised control trial. Drug and Alcohol Dependence2012;126(1-2):131-7. [DOI: 10.1016/j.drugalcdep.2012.05.004]">Manning 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0018" title="HolderHD , CislerRA , LongabaughR , StoutRL , TrenoAJ , ZwebenA . Alcoholism treatment and medical care costs from Project MATCH. Addiction2000;95(7):999-1013. [DOI: 10.1046/j.1360-0443.2000.9579993.x]LongabaughR , WirtzPW , ZwebenA , StoutRL . Network support for drinking, Alcoholics Anonymous and long-term matching effects. Addiction1998;93(9):1313-33. [DOI: 10.1046/j.1360-0443.1998.93913133.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs1997;58(1):7-29. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research1998;22(6):1300-11. [DOI: 10.1111/j.1530-0277.1998.tb03912.x]Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. 1998 Journal of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/jsa.1998.59.631]">MATCH 1997</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participants who missed a follow‐up assessment were asked at the next assessment period to provide data regarding their alcohol consumption for the previous period. Participants for whom more than 4 of the 12 months of drinking outcome data were missing were excluded from latent growth analyses. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0019" title="McCradyBS , EpsteinEE , HirschLS . Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment. Journal of Studies on Alcohol and Drugs1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]McCradyBS , EpsteinEE , HirschLS . Maintaining change after conjoint behavioral alcohol treatment for men: Outcomes at 6 months. Addiction1999;94(9):1381-96. [DOI: 10.1046/j.1360-0443.1999.949138110.x]McCradyBS , EpsteinEE , KahlerCW . Alcoholics Anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-Month outcomes. Journal of Consulting and Clinical Psychology2004;72(5):870-8. [DOI: 10.1037/0022-006X.72.5.870]">McCrady 1996</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0020" title="MundtMP , ParthasarathyS , ChiFW , SterlingS , CampbellCI . 12-step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug and Alcohol Dependence2012;126(1-2):124-30. [DOI: 10.1016/j.drugalcdep.2012.05.002]">Mundt 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Data was analyzed for the 403 participants who completed at least 1 follow‐up interview.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0021" title="HumphreysK , MoosR . Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research2001;25(5):711-16. HumphreysK , MoosRH . Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohlism: Clinical and Experimental Research2007;31(1):64-8. [DOI: 10.1111/j.1530-0277.2006.00273.x]OuimettePC , FinneyJW , MoosRH . Twelve-step and cognitive-behavioral treatment for substance abuse: A comparison of treatment effectiveness. Journal of Consulting and Clinical Psychology1997;65(2):230-40. [DOI: 10.1037//0022-006X.65.2.230]">Ouimette 1997</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0022" title="TimkoC , DeBenedettiA . A randomized controlled trial of intensive referral to 12-step self-help groups: One-year outcomes. Drug and Alcohol Dependence2007;90(2-3):270-9. TimkoC , DebenedettiA , BillowR . Intensive referral to 12-step self-help groups and 6-month substance use disorder outcomes. Addiction2006;101(5):678-88. [DOI: 10.1111/j.1360-0443.2006.01391.x]">Timko 2006</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0023" title="TimkoC , SutkowiA , CronkiteRC , Makin-ByrdK , MoosRH . Intensive referral to 12-step dual-focused mutual-help groups. Drug and Alcohol Dependence2011;118(2-3):194-201. [DOI: 10.1016/j.drugalcdep.2011.03.019]">Timko 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0024" title="VederhusJK , TimkoC , KristensenO , HjemdahlB , ClausenT . Motivational intervention to enhance post‐detoxification 12‐step group affiliation: a randomized controlled trial. Addiction2014;109(5):766-73. [DOI: 10.1111/add.12471]">Vederhus 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Procedures for accounting for missing data were not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0025" title="WalitzerKS , DermenKH , BarrickC . Facilitating involvement in alcoholics anonymous during out-patient treatment: A randomized clinical trial. Addiction2009;104(3):391-401. [DOI: 10.1111/j.1360-0443.2008.02467.x]">Walitzer 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Missing data imputed using the expectation maximization algorithm in Statistical Package for the Social Sciences and cases were only included if participants had completed at least one post‐treatment Timeline Followback. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0026" title="WalitzerKS , DeffenbacherJL , ShyhallaK . Alcohol-adapted anger management treatment: a randomized controlled trial of an innovative therapy for alcohol dependence. Journal of Substance Abuse Treatment2015;59:83-93. [DOI: 10.1016/j.jsat.2015.08.003]">Walitzer 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mixed effects models were used to accommodate for missing data with maximum likelihood estimation. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p><a href="./references#CD012880-bbs2-0027" title="ZemoreSE , LuiC , MericleA , HembergJ , KaskutasLA . A longitudinal study of the comparative efficacy of Women for Sobriety, LifeRing, SMART Recovery, and 12-step groups for those with AUD. Journal of Substance Abuse Treatment2018;88:18-26. [DOI: 10.1016/j.jsat.2018.02.004]">Zemore 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preliminary and main analyses were conducted using cases with outcome data at 6 and/or 12 months and data on all model covariates. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">How studies handled any missing data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012880-tbl-0010"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Assessment of methodological quality of economic evaluationsa </span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Item number</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Item</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Humphreys 1996</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Holder 2000</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Humphreys 2001, Humphreys 2007</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mundt 2012</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Is the study population clearly described?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are competing alternatives clearly described?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Is a well‐defined research question posed in answerable form?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Is the economic study design appropriate to the stated objective?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Is the chosen time horizon appropriate to include relevant costs and consequences?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Is the actual perspective chosen appropriate?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are all important and relevant costs for each alternative identified?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are all costs measured appropriately in physical units?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are costs valued appropriately?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are all important and relevant outcomes for each alternative identified?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are all outcomes measured appropriately?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are outcomes valued appropriately?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Is an incremental analysis of costs and outcomes of alternatives performed?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are all future costs and outcomes discounted appropriately?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>b</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>b</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>c</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>d</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are all important variables, whose values are uncertain, appropriately subjected to sensitivity analysis? </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>e</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>f</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A<sup>f</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Do the conclusions follow from the data reported?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Does the study discuss the generalizability of the results to other settings and patient/client groups? </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Does the article indicate that there is no potential conflict of interest of study researcher(s) and funder(s)? </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Are ethical and distributional issues discussed appropriately?</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1<sup>g</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1<sup>g</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1<sup>g</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1<sup>g</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>According to <a href="./references#CD012880-bbs2-0050" title="EversS , GoossensM , deVetH , vanTulderM , AmentA . Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. International Journal of Technology Assessment in Health Care2005;21(2):240-5.">Evers 2005</a>.<br/><sup>b</sup>The data were retrospective analyses over a period of three years.<br/><sup>c</sup>The data were retrospective analyses over a period of one year (2001) and two years (2007).<br/><sup>d</sup>The data were retrospective analyses over a period of seven years.<br/><sup>e</sup>We made this N/A because none of the values were 'uncertain', but rather estimated based on Veterans Affairs clinical data costs.<br/><sup>r</sup>We made this N/A because none of the values were 'uncertain'.<br/><sup>g</sup>We understood this to mean the potential for the benefits to healthcare system utilizers because they could obtain the same effects or better from AA instead of utilizing health care. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Assessment of methodological quality of economic evaluationsa </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/full#CD012880-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012880-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Proportion completely abstinent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1726</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.92, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.66 [1.09, 2.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 12‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1936</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [1.03, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.4 24‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>403</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [1.04, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.5 36‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>952</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [1.17, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Percentage days abstinent (PDA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1586</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.91 [‐1.42, 5.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.21 [‐10.82, 8.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 12‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.03 [‐4.36, 10.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.4 18‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.89 [‐30.65, 12.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.5 24‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.91 [7.55, 18.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.6 36‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>806</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.64 [1.54, 11.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Longest period of abstinence (LPA, months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐0.30, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Drinks per drinking day (DDD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1636</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐1.07, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.96 [‐3.22, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.3 12‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐1.11, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.4 24‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐0.80, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.5 36‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>806</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.02 [‐1.83, ‐0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Percentage days heavy drinking (PDHD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.62 [‐0.93, 20.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 12‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.51 [‐14.15, 3.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.3 24‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.09 [‐11.57, 9.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Alcohol‐related consequences (DrInC) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1532</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.38 [‐8.66, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 12‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1762</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.88 [‐6.81, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.3 24‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.09 [‐8.11, 3.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Alcohol‐related consequences (SIP) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [‐4.51, 5.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Alcohol‐related consequences (SIP‐2R) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.43, 0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Addiction Severity Index (ASI) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.09, ‐0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Addiction Severity Index (ASI) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">1A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to different theoretical orientation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012880-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Proportion completely abstinent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 3‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>126</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.80, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 9‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.71 [0.70, 4.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Percentage days abstinent (PDA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 3‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.94 [‐14.73, 6.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 9‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.31, 5.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Percentage days abstinent (PDA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Drinks per drinking day (DDD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 9‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.76 [‐2.23, ‐1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Percentage days heavy drinking (PDHD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 12‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.09 [‐1.24, 5.42]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">1B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to different theoretical orientation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012880-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Proportion of participants completely abstinent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>772</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.96, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 12‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [1.00, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Percentage days abstinent (PDA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.50 [‐25.35, 14.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 12‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.40 [5.12, 27.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Days of use (PDA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>427</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.93 [‐4.55, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Drinks per drinking day (DDD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.10 [‐10.44, 2.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Addiction Severity Index (ASI) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>690</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.07, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.2 12‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.02, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 European Addiction Severity Index (EuropASI) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.08, ‐0.06]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">2A Grouping: RCT/quasi‐RCT, all treatments manualized, compared to TSF variant</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012880-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">2B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to TSF variant</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Proportion of participants completely abstinent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 3‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>126</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.76, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 12‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>382</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [1.02, 1.29]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">2B Grouping: RCT/quasi‐RCT, 1 + treatments non‐manualized, compared to TSF variant</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012880-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Proportion of participants completely abstinent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [1.16, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.2 12‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2692</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [1.09, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.3 24‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1774</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [1.20, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Drinks per drinking day (DDD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 36‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐3.38, 3.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Alcohol‐related consequences (SIP) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.1 12‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>647</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.71 [‐1.68, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Alcohol‐related consequences <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.1 36‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐1.34, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.5 Alcohol addiction severity (Alcohol Dependence Scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5.1 36‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐2.20, 1.60]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">3B: Non‐randomized, 1+ treatments non‐manualized, compared to different theoretical orientation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012880-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">4B: Non‐randomized, 1+ treatments non‐manualized, compared to TSF variant</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Proportion completely abstinent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.86, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.2 12‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1870</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [1.05, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Percentage days abstinent (PDA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐7.14, 7.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Drinks per drinking day (DDD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 Addition Severity Index‐Lite (ASI‐L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.1 6‐month follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.05, 0.07]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">4B: Non‐randomized, 1+ treatments non‐manualized, compared to TSF variant</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012880.pub2/references#CD012880-tbl-0016">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012880.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012880-note-0019">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012880-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012880-note-0017">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD012880-note-0015">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD012880-note-0014">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD012880-note-0018">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD012880-note-0012">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD012880-note-0013">ภาษาไทย</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012880\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012880\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012880\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012880\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012880\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=BqmVIxTs&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012880.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012880.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012880.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012880.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012880.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725212664"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012880.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725212667"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012880.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e75bada391be5',t:'MTc0MDcyNTIxMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 